S-phase checkpoint activity and function throughout the cell cycle by Can, Geylani
UNIVERSITY OF CAMBRIDGE 
SIDNEY SUSSEX COLLEGE 
 
S-phase checkpoint activity and 
function throughout the cell cycle 
 
 
GEYLANI CAN	
 
 
 
 
 
This dissertation is submitted for the degree of Doctor of Philosophy 
 
October 2016
 
 
I 
Summary 
S-phase checkpoint activity and function throughout the cell cycle 
Geylani Can 
DNA damage or replication stress during S-phase can activate the S-phase checkpoint 
which executes a variety of responses, such as the inhibition of origin firing and replication fork 
stabilisation. Deregulation of the S-phase checkpoint leads to genomic instability, which has 
been implicated in diseases such as cancer. In this thesis, I aimed to address whether the S-
phase checkpoint is regulated outside of S-phase, and how the S-phase checkpoint targets its 
substrates in budding yeast. 
Although this checkpoint has thus far been associated exclusively with S-phase, it 
remains unknown whether its responses such as inhibition of origin firing can also occur in 
other phases of the cell cycle. To investigate this, the targets of the S-phase checkpoint for the 
inhibition of origin firing were analysed outside of S-phase upon DNA damage. Interestingly, I 
showed that the S-phase checkpoint effector kinase Rad53 phosphorylates its targets to inhibit 
origin firing outside of S-phase upon DNA damage when there is no replication. I then set out 
to test whether inhibition of origin firing by Rad53 outside of S-phase might be important for 
faithful DNA replication.  
Having shown that the checkpoint response is not specific for any cell cycle phases, I 
then tested how the specificity of Rad53 for its substrates might be determined. After 
demonstrating that the essential replication protein Cdc45 is required for Rad53 to 
phosphorylate the initiation factor Sld3, the key residues of Cdc45 necessary for Rad53 
interaction were identified. A Cdc45 allele was produced by mutating the identified residues. 
This allele of Cdc45 is a separation-of-function mutant which prevents Sld3 phosphorylation 
upon DNA damage, but retains its function in DNA replication. Because Cdc45 travels with the 
replication fork, it is possible that Cdc45 also targets Rad53 to the replication fork to stabilise 
it upon replication stress. Overall, this thesis provides evidence that the S-phase checkpoint 
can function throughout the cell cycle and that Cdc45 targets Rad53 to some of its substrates, 
and possibly plays a role in replication fork stabilisation.
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Chapter 1 I
Introduction 
1.1. The cell cycle 
The process of cell division results in the production of two daughter cells, and is tightly 
regulated through a series of events termed the cell cycle. The cell cycle consists of three 
fundamental steps in all living organisms: growth, genome duplication, and division. In contrast 
with bacteria, where genome duplication and division take place simultaneously, the eukaryotic 
cell cycle has four distinct phases: gap 1 (G1) phase, synthesis (S) phase, gap 2 (G2) phase 
and mitosis (M phase). Cells grow during G1 phase and prepare for the transition to S-phase, 
during which nuclear DNA is replicated. Following a specific checkpoint in G1, cells are no 
longer able to halt this process until the completion of the cell cycle. In G2 phase, cells grow 
further to prepare for mitosis, when genomic information is dispensed into two daughter cells. 
Cells can also exit the cell cycle and enter a resting state known as the G0 phase, usually in 
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response to entering an unfavourable environment or following differentiation (Alberts et al., 
1997). 
This cell cycle duration differs heavily depending on the eukaryotic cell being studied. In S. 
cerevisiae, the budding yeast, the cell cycle is completed in approximately 90 minutes 
(Forsburg & Nurse, 1991). This speed is in marked contrast to the cycle in many animal cells, 
which can occur over up to 24 hours in some human cell types. However, there remains 
considerable variation between cell types, and the stage of development can also play a role 
in cycle length. 
1.1.1. Cell cycle control 
To ensure that each daughter cell contains a full and high-fidelity copy of the genome, it is 
necessary for the transition between cell cycle phases to be robustly regulated. Without this 
regulation, genomic instability can accrue, increasing the risk of cancer development (Shen, 
2011). The main eukaryotic regulators of cell cycle progression are cyclins, and the cyclin-
dependent kinases (CDK). These CDKs dimerise with cyclin, and the resultant activity of the 
complex is responsible for many of the cellular alterations in each cycle stage (Bloom & Cross, 
2007; Harashima et al., 2013; Morgan, 1995; Pines, 1995). CDKs are often categorised by the 
cell cycle phase during which they are active, resulting in three sub-categories: G1-CDKs, S-
CDKs, and M-CDKs. Whilst in the mammalian systems studied there are numerous CDKs 
which associate with many cyclins, resulting in a highly complex regulatory network, in S. 
cerevisiae Cdc28 is the main CDK, with its changing role in the cell cycle deriving from its 
association with different cyclins at each phase (Bloom & Cross, 2007). These are Cln1-3 in 
G1, Clb5/6 in S-phase, and Clb1-4 in M phase (Bloom & Cross, 2007). CDKs are themselves 
regulated through numerous mechanisms including phosphorylation, inhibitor binding, as well 
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as through the regulation of cyclin levels at both the transcriptional and post-transcriptional 
stages.  
Progression through the cell cycle is also controlled by a number of checkpoints, ensuring this 
only occurs once the previous stage has been completed successfully. Two crucial 
checkpoints in S. cerevisiae are the S-phase checkpoint, which determines whether replication 
was successful, and the spindle assembly checkpoint during M phase that ensures sister 
chromatids are faithfully segregated into the daughter cells (Hartwell & Weinert, 1989). 
1.1.2. Cancer and disease 
It has previously been suggested that all cancer cells possess a series of unique identifiers. 
These include the avoidance of apoptosis, the maintenance of growth signalling, resistance to 
anti-proliferative signalling, angiogenesis, metastasis and tissue invasion, and the ability to 
replicate without encountering the Hayflick limit on cell division (Hanahan & Weinberg, 2000). 
Subsequent additions to this list have included the ability of cancerous cells to avoid targeting 
by the immune system, and the possession of an abnormal metabolome (Hanahan & 
Weinberg, 2011). This list of identifiers continues to be modified as new information on cancer 
cells is discovered. Recently, genomic instability has been suggested as an additional hallmark 
(Kroemer & Pouyssegur, 2008; Negrini et al., 2010), reflecting its presence in all cancers 
regardless of stage and progression (Hills & Diffley, 2014). Genomic instability, which is 
present in all studied cancers, is therefore important to fully understand. However, whilst 
genomic instability has been previously shown to be a key hallmark of cancer cells, it has not 
yet been determined whether this genomic instability plays an active role in tumour progression 
or whether it is only a product of other aberrant functions in cancerous cells.  
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The role that replication stress plays in tumorigenesis appears to be complex and multifaceted, 
and it has been proposed that replicative stress can both halt or induce tumour progression 
(Lecona & Fernández-Capetillo, 2014). Replication stress, and subsequent genomic instability, 
are found in early-stage tumours and can be induced through oncogene disruption 
(Halazonetis et al., 2008), such as through the overexpression of the S-phase CDK modulator 
cyclin E (Ekholm-Reed et al., 2004; Jones et al., 2013) or slowing of replication rates through 
Chk1 overexpression (López-Contreras et al., 2012). However, replication stresses can also 
prove lethal or otherwise deleterious to cancer cells due to their potentially disruptive effect on 
mitosis (Lecona & Fernández-Capetillo, 2014). In addition, buffering replication stress and 
genomic instability through maintenance of high nucleotide concentrations is a known 
consequence of Myc oncogene activation, suggesting that a disruption of Myc function would 
induce genomic instability and potentially provide a mechanism for tumorigenesis (Bester et 
al., 2011). Replication stress can also function as an anti-tumorigenic mechanism due to its 
activation of DNA damage checkpoints, which can result in cell cycle arrest or apoptosis. The 
development of subsequent mutations allowing the cell to bypass these checkpoints can lead 
to tumour development in addition to further genomic instability. Therefore, the role of 
replicative stress and genomic instability in tumorigenesis appears to be dynamic and context-
dependent, and may provide insight into potential novel cancer treatments. 
1.2. Budding yeast as a model organism  
The budding yeast Saccharomyces cerevisiae is a single-celled fungus with a relatively small 
and simple genome. Due to their rapid growth rate and the evolutionary conservation of many 
of their cellular processes, S. cerevisiae is a well-established model organism in the field of 
molecular genetics, and has a strong knowledge base facilitating further research such as a 
sequenced and well-annotated genome. S. cerevisiae is approximately 3-5 µm in diameter, 
and is protected by a tough cell wall. The cell cycle of S. cerevisiae begins with the formation 
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of a small bud which grows continuously throughout S and M phases, culminating in the 
distribution of one set of chromosomes into the daughter cell at the end of mitosis. S. cerevisiae 
has a long G1 during the cell cycle, followed by a relatively short S phase. However, there is 
no clearly-defined G2 between S phase and M phase.  
S. cerevisiae can proliferate in both haploid and diploid states. Haploid cells can be two mating 
types, called a and a. These mating types secrete the specific pheromones a-factor and a-
factor, respectively. These pheromones bind to cell-surface receptors on cells of the opposite 
mating type, activating signal cascades which result in G1 arrest and the synthesis of a wide 
variety of proteins. The morphology of these arrested cells then changes into a shape called a 
shmoo before fusing to form a diploid cell. The ability to arrest cells in G1 using pheromones 
provides a unique opportunity for the study of early cell cycle events in synchronized cells.  
S. cerevisiae diploids cells also sporulate following extreme environmental conditions. 
Sporulation begins with meiosis in order to produce haploid cells. Four haploid cells produced 
after this meiosis are enclosed in a protective shell called the ascus. When these 
environmental conditions change, the spores germinate and mate again to produce two diploid 
cells. Since yeast cells can proliferate in haploid states as well, this allows for research to be 
undertaken on a simplified genome. More importantly, mating haploid cells with dedicated 
mutant yeast libraries provides the ability to perform genetic screens, through which several 
important genes and pathways have been identified thus far. 
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1.3. The molecular basis of DNA replication 
1.3.1. Replication initiation 
1.3.1.1. Origin of replication 
In eukaryotic organisms, replication initiation occurs at hundreds to thousands of sites 
throughout the genome, the number of which is species-dependent (Nieduszynski et al., 2007; 
Raghuraman et	al., 2001; Wyrick et al., 2001; Yabuki et al., 2002). The origin sites of budding 
yeast are best characterised, having been identified as autonomous replicating sequences 
(ARS) due to their ability to replicate plasmids (Dhar et al., 2012; Stinchcomb et al., 1979; 
Vallet et al., 1984). ARS sequences are approximately 200bp in length, with a strongly 
conserved consensus sequence rich in A and T (Nieduszynski et al., 2007). This consensus, 
termed the ACS, is either 11 or 17bp in length, and allows ORC complex binding to occur (Bell 
& Dutta, 2002; Theis & Newlon, 1997). The consensus sequence is found between the B1, B2, 
and B3 elements when present, which play respective roles in ORC binding, Mcm2-7 helicase 
binding and the binding of the transcription-associated ARS binding factor 1 (Abf1) (Miyake et 
al., 2002; Rao & Stillman, 1995; Rowley et al., 1995; Wilmes & Bell, 2002). Despite the 
presence of around 12,000 such consensus sequences throughout the S. cerevisiae genome, 
only 400 of these are utilised during replication, suggesting that factors beyond the presence 
of the ACS, such as the presence of B elements or nearby chromatin status, also play a role 
in determining ARS usage (Eaton et al., 2010; Nieduszynski et al., 2007). Numerous studies 
have been undertaken to determine which of these origins are utilised in both S. cerevisiae 
and S. pombe, using diverse methods such as chromatin immunoprecipitation to determine 
ORC or MCM2-7 complex binding regions, ssDNA analysis, copy number analysis, Okazaki 
fragment analysis via sequencing and a bioinformatic analysis of origin sequence conservation 
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(Feng et al., 2006; McGuffee et al., 2013; Müller et al., 2013; Nieduszynski et al., 2006; Wyrick 
et al., 2001; Yabuki et al., 2002). 
In contrast to budding yeast, however, other eukaryotic species do not appear to use specific 
sequences for origins. Whilst an examination of fission yeast determined that origins were 
most likely to occur in AT-rich sequences, human studies seeking to identify sequence-specific 
factors mediating ORC binding and initiation have been unsuccessful (Dai et al., 2005; 
Segurado et al., 2003). Furthermore, although the possibility has been raised that GC-rich 
sequences are more often utilised in humans, drawing a parallel with fission yeast, it remains 
likely that origins are determined through chromatin environment as opposed to sequence 
specificity (Fragkos et al., 2015; Leonard & Méchali, 2013). 
1.3.1.2. Loading of inactive replicative helicase onto DNA 
In late mitosis and early G1-phase, an inactive replicative helicase is loaded onto double 
stranded DNA. This process is also called origin licensing, which is a stepwise process (Figure 
1-1). Recent biochemical and structural analyses have identified many of the steps in the 
loading of inactive replicative helicase onto DNA. There are 3 main steps in this process, which 
are the binding of the Origin-Recognition Complex (ORC) to DNA, binding of CDC6 to ORCs, 
and finally the loading of the heptameric protein MCM•CDT1 onto dsDNA. 
The first step in the loading of the MCM helicase is the binding of ORCs to dsDNA. 5 of the 6 
ORC subunits (Orc1,-2,-3,-4,-5) possess sequence homology with AAA+ proteins, but only the 
Orc1 and Orc5 components bind ATP. It has been shown that ORC associates with chromatin 
during the cell cycle in S. cerevisiae, however this function is inhibited by CDK during S and 
G2 phases (Liang & Stillman, 1997).  
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ORC binding to DNA is sequence-specific in S. cerevisiae, however there is no such sequence 
specificity in metazoans (Leonard & Méchali, 2013). The binding of ORCs to DNA is followed 
by the recruitment of Cdc6, which is indispensable for the loading of MCM•Cdt1 proteins to the 
DNA. Cdc6 binding is ATP-dependent and highly transient, only being detected when ATP 
hydrolysis is inhibited (Speck et al., 2005). The in vivo and in vitro removal of Cdt1 does not 
hinder the binding of Cdc6 to ORC, however the association of MCM•Cdt1 with ORC requires 
Cdc6. 
Once ORC and CDC6 bind to DNA, the Minichromosome Maintenance Complex (MCM2-7) is 
loaded onto dsDNA as an inactive double hexamer forming the inactive replicative helicase. 
Recent works using single molecule microscopy suggest that a single MCM•Cdt1 is loaded 
onto DNA as an intermediate step, followed by the loading of another MCM•Cdt1 to assemble 
an inactive double MCM 2-7 helicase with a head-to-head orientation (Ticau et al., 2015). After 
the loading of the first MCM, Cdc6 and Cdt1 are released from the intermediate complex and 
another Cdc6 is required for the loading of the second MCM•CDT1. The single MCM bound 
with ORC and Cdc6 has also been observed using cryo-EM analysis (Sun et al., 2013), which 
supports the stepwise loading of MCM. The ring structure of MCM2-7 must be opened in order 
to load dsDNA into the central channel of the ring, and closed afterwards before DNA melting 
occurs. An elegant work indicated that the Mcm2-Mcm5 gate has to be opened in order to load 
DNA into the central channel of the MCM, and forcing the gate to stay closed prevents MCM 
loading in vitro and is lethal in vivo (Samel et al., 2014). It has been shown in several organisms 
that multiple inactive MCM2-7 helicases are loaded onto DNA (Dimitrova et al., 1999; Donovan 
et al., 1997; Krude et al., 1996). However, only 1-10% of these are activated during replication 
(Hyrien et al., 2003). This inactive helicase, and its associated licensing factors, are collectively 
known also as the Pre-Replication Complex(Pre-RC). 
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1.3.1.3. DNA origin firing 
The inactive MCM double hexamer has to be activated in order for DNA replication to begin. 
This involves the formation of the CMG complex, which contains Cdc45, MCM and GINS 
proteins. This process is tightly regulated through the activity of two essential kinases, DDK 
and CDK. For the initiation of DNA replication, a number of steps must occur: 1) DNA melting, 
2) localisation of ssDNA into the central ring of a single MCM hexamer, 3) recruitment of other 
 
Figure 1-1Loading of MCM double hexamers. Head-to-head double hexamers are loaded 
in a stepwise procces. Binding of Cdc6 on ORC recruits a single MCM•Cdt1. The Mcm2-Mcm5 
gate then opens and encircles dsDNA. The second MCM•Cdt1 requires a new Cdc6. 
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replication fork factors, 4) activation of MCM. The precise order of those events is still not well 
understood. Recent in vitro works have also indicated that 9 replication factors, which are DDK, 
CDK, Cdc45, Sld3, Dpb11, Sld2, GINS, Mcm10 and DNA Polymerase e (Pol e), are necessary 
and sufficient for the activation of the MCM (Yeeles et al., 2015). 
Different in vitro and in vivo studies indicated that DDK phosphorylates MCM (Randell et al., 
2010; Y J Sheu & Stillman, 2010) which is necessary for the recruitment of Sld3/7 and Cdc45 
on the MCM (Heller et al., 2011; Tanaka et al., 2011). Cdc45 and Sld3 are mutually dependent 
on one another for their association with the origins, and these proteins are recruited to the 
origin with Sld7. Because the role of DDK can be bypassed with the mcm5-bob1 allele, it 
suggests that MCMs are the only targets of DDK (Hardy et al., 1997). Further studies have 
shown that several MCM subunits are phosphorylated by DDK (Francis et al., 2009; Lei et al., 
1997; Yi Jun Sheu & Stillman, 2006). However, the effect of MCM phosphorylation by DDK on 
Cdc45 and GINS recruitment is still unclear. On the other hand, it has been established that 
CDK phosphorylation of Sld2 and Sld3 results in their binding to DPpb11 followed by the 
recruitment of GINS (Tanaka et al., 2007; Zegerman & Diffley, 2007). There are 12 predicted 
CDK phosphorylation sites (S/TP) in Sld3, two of which (T600 and T622) are essential. Alanine 
substitutions of Sld3-T600 cells grow very slowly, while T600A, T622A double mutants are not 
Figure 1-2 The formation of CMG complex in S. cerevisiae. The factors necessary for 
CMG formation are listed in the figure.  
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viable indicating that phosphorylation of Sld3-T600 and T622 requires CDK, and that this 
phosphorylation is essential for DNA replication. Biochemical studies indicate that 
phosphorylated Sld3 binds to N-terminal BRCT repeats of Dpb11 (Zegerman & Diffley, 2007). 
Although it is not possible to bypass CDK phosphorylation of Sld3 using phosphomimetics, a 
sld3-dpb11 fusion protein can fulfil the CDK requirement (Zegerman & Diffley, 2007). On the 
other hand, there are 11 CDK phosphorylation consensus sequences in Sld2, however only 
one of these (T84) is essential and CDK phosphorylation of this residue can be bypassed using 
phosphomimetic mutants (Zegerman & Diffley, 2007). It has been previously shown that 
phosphorylation of Sld2 by CDK results in binding of the C-terminal BRCT repeats of Dpb11 
(Zegerman & Diffley, 2007). Taken together, this suggests that Sld2 and Sld3 are the minimal 
set of CDK targets required for DNA replication initiation. 
It has been suggested that binding of Sld2 to Dpb11 via CDK phosphorylation results in the 
formation of a very fragile pre-loading complex (preLC) consisting of Sld2, Dpb11, GINS and 
Pole (Muramatsu et al., 2010). The assembly of the preLC requires CDK activity but no other 
replication proteins. As described above, Sld3 is associated with the MCM and phosphorylated 
by CDK. Thus, it has been suggested that CDK phosphorylation of Sld3 brings the preLC to 
origins, resulting in the assembly of the preIC (Tanaka & Araki, 2013). A recent work by Yeeles 
et. al. (2015) used purified proteins to demonstrate that, although DDK and CDK activities are 
indispensable for helicase activation and origin firing, the sequential activities of DDK and CDK 
are not necessary. These two events result in the assembly of the CMG complex and the 
release of Sld3, Sld2, Dbp11 and Sld7 from origins.  
1.3.2. Elongation 
Before DNA synthesis can begin, the recruitment of polymerase α is required. Polymerase α 
functions as an RNA polymerase, synthesising RNA primers of approximately 10bp which are 
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utilised by Pol ε and Pol δ to begin synthesis and elongation (Langston & O’Donnell, 2006; 
Tanaka & Araki, 2013). As the leading strand polymerase, only one such priming event is 
required for the function of Pol ε, in contrast to the lagging strand polymerase Pol δ which 
relies on the presence of such RNA primers every 1-2 kb (Leman & Noguchi, 2013). This 
lagging strand synthesis therefore does not produce a continuous DNA strand, in contrast to 
leading strand synthesis, and instead creates a series of 100-200 bp DNA products known as 
Okazaki fragments. The Polα-dependent displacement of these RNA primers, the filling of 
gaps between Okazaki fragments, and the fusion of fragments through the action of DNA 
ligase, is therefore required to produce a continuous DNA lagging strand (Waga & Stillman, 
1998). Throughout this elongation process, the dsDNA is unwound by the active replicative 
helicase and the resulting ssDNA is bound by Replication Protein A (RPA), which ensures that 
no secondary structures form which could disrupt the replication process (Wold, 1997). 
The characterisation of the replication fork has shown that, during elongation, a number of 
subsidiary proteins can bind to facilitate DNA replication. An example of this is the Csm3-Tof1-
Mrc1 complex, which is believed to help stabilise the replication fork (Bando et al., 2009). Given 
that Mrc1 interacts with MCM6 and Pol ε (Komata et al., 2009; Lou et al., 2008), and Csm3-
Tof1 interacts with MCM2 (Bando et al., 2009), it has been hypothesised that Csm3-Tof1-Mrc1 
links the helicase to Pol ε. In addition, the homologous recombination-associated repair 
proteins Rad51 and Rad52 have been shown to be associated with replication forks in S. 
cerevisiae (González-Prieto et al., 2013).  
The type IB topoisomerase Top1 is also known to be associated with the replication fork 
(Bermejo et al., 2007). Type IB topoisomerases create ssDNA breaks to regulate supercoiling 
(Wang, 1996). This removal of supercoiling is supplemented through the action of the type II 
isomerase Top2, which removes supercoils by creating dsDNA. Given that the replication fork 
can induce supercoiling in nearby DNA, and that the product of DNA replication is a pair of 
sister chromatids which requires unravelling before mitosis can occur, the joint action of Top1 
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and Top2 allows both for the resolution of positive supercoils, and for the requisite chromatid 
separation through Top2 function. Together, therefore, these topoisomerases ensure 
chromosomal stability during and subsequent to DNA replication (Jeppsson et al., 2014; Wang, 
2002). 
1.4. DNA replication control 
DNA must be replicated once and only once in every cell cycle, and any additional replication 
during the cell cycle results in gene duplication, polyploidy or chromosomal re-arrangements 
which are a hallmark of several diseases such as cancer (B. M. Green et al., 2010). The 
initiation of replication in eukaryotic cells is a two-step process. The first step occurs during 
either G1 phase or late in mitosis, and entails the loading of an inactive Mcm2-7 helicase 
complex onto dsDNA at sites known as origins of replication. During the second step, in S-
phase, this helicase is activated to form the CMG complex. As both of these steps take place 
at mutually exclusive times in the cell cycle, it is essentially guaranteed that each origin of 
replication is initiated only once per cycle. Thus, the temporally separated two-step nature of 
this process provides a further level of fidelity to the replication process.  
The initiation process is regulated through differential expression, and therefore activity, of the 
antagonistic factors CDK and APC/C (King et al., 1995). The E3 ubiquitin ligase APC/C targets 
a number of proteins involved in cell cycle control such as Cyclins and targets them for 
proteasome-dependent degradation (Visintin et al., 1997), whilst CDK affects cell cycle factors 
through phosphorylation. At the start of G1, CDK exhibits little activity, but increases over the 
course of the phase and maintains a strong activity from thereon. This is contrasted by APC/C, 
which accumulates throughout both anaphase and telophase and maintains this level until the 
end of G1, when it is inactivated by CDK. This system is further maintained through the action 
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of CDK inhibitors (CKIs), which exhibit an activity profile similar to APC/C and are degraded at 
the end of G1 following phosphorylation by CDK (E Schwob et al., 1994).  
Studies in S. cerevisiae have been successful in elucidating the mechanisms through which 
CDK activity in S-phase inhibits the assembly of the pre-RC, consistent with the observed roles 
for CDK as a safeguard against re-replication, and the simultaneous modification of CDK 
targets results in multiple re-replication events during S or G-2 phase (For details see next 
section).  
This CDK-dependent regulation is not the only level of control ensuring re-replication does not 
occur, as regulation of DDK has also been show to play a role. DDK is a conserved protein 
kinase composed of catalytic (Cdc7) and regulatory (Dbf4) subunits. Given that DDK 
phosphorylates the Mcm2-7 complex during S-phase replication initiation, the lack of Dbf4 
during both mitosis and G1 ensures that Mcm2-7 can only be activated at the correct stage of 
the cell cycle. 
 
Figure 1-3 The control of cell cycle. The cell cycle is controlled by the activity of different 
CDKs.  
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This temporal separation of licensing and activation is conserved in metazoans, whilst 
additional levels of control have also been identified. The first relies on geminin, a nuclear 
protein which inhibits Cdt1 binding to chromatin in both the S and M phases, whilst being 
degraded following APC/C targeting during G1 (C. Lee et al., 2004; Wohlschlegel et al., 2000). 
The second is the phosphorylation of any Cdt1 bound to chromatin by CDK in S-phase, which 
results in Cdt1 degradation through SCFCRL4 ubiquitin ligase activity (Senga et al., 2006; Zhong 
et al., 2003). 
1.4.1. Cell cycle regulation of preRC formation 
To prevent re-replication, loading of the replicative helicase – termed origin licensing - is 
temporally separated from helicase activation and replisome assembly. Specifically, origin 
licensing is exclusively allowed in late Mitosis and G1 phase, whereas helicase activation and 
replisome assembly is allowed in S-phase.  
Although they can vary between different organisms, several molecular mechanisms have 
evolved to prevent origin licensing during S and G2 phases. In S. cerevisiae, modification of 
preRC components by CDK inhibits the loading of the MCM2-7 complex onto dsDNA outside 
of G1 phase (Figure 1-4). CDK can also phosphorylate Orc2 and Orc6, which prevents Cdt1-
mediated MCM2-7 loading. The ORC6 has four CDK consensus sites which are 106, 116, 123, 
and 146, whereas ORC2 has six which are 16, 24, 70, 174, 188, and 206 (Nguyen et al., 2001). 
The Serine/Threonine substitutions of those residues with Alanine can bypass the regulation 
by CDK. On the other hand, CDC6 is degraded in a SCFCDC4-dependent manner and the 
degradation of CDC6 can be prevented by removing the N-terminal part of Cdc6 (CDC6DNT) 
(Drury et al., 1997). Finally, MCM2-7•Cdt1 can be excluded from the nucleus, and forcing the 
localisation of Mcm7 via the addition of a Nuclear Localization Signal (NLS) results in the 
constitutive localisation of Mcm2-7•Cdt1 to the nucleus (Nguyen et al., 2000). Introducing 
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these mutations and modifications bypasses the control of CDK on origin licensing, and can 
induce re-replication in G2 phase (Nguyen et al., 2001).  
Unlike S. cerevisiae, CDT1 and the S. pombe CDC6 homolog CDC18 are degraded during S 
and G2 phase, and the overexpression of CDT1 and CDC18DNT are enough to bypass the 
control of origin licensing and result in re-replication in S. Pombe (Nishitani et al., 2000). The 
S. pombe CDT1 is degraded in a Cul4–Ddb1– Cdt2 dependent manner (Ralph et al., 2006). 
The degradation of CDT1 is a conserved mechanism for controlling origin licensing among 
other eukaryotes. It has been shown that redundant pathways degrade CDT1 in a cell cycle-
dependent manner. Chromatin-bound CDT1 is degraded in a Cul4-DBP1-Cdt2 E3 ligase-
dependent manner and is mediated by PCNA, ensuring that degradation of chromatin-bound 
CDT1 only occurs during S-phase (Senga et al., 2006). On the other hand, the degradation of 
CDT1 by SCF-Skp2 occurs in both S- and G2-phase. The function of CDT1 is also mediated 
 
Figure 1-4 Prevention of re-replication by CDK in S. cerevisiae. The diagram shows the 
targets of CDK to prevent origin licensing in S and G2 phases. 1) CDK phosphorylates Orc2 
and Orc6 which prevents the loading of MCM•Cdt1. 2) CDK regulates the degradation of Cdc6. 
3) CDK control the nuclear export of MCM•Cdt1 
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by the inhibitor Geminin. The overexpression of CDT1 in Human, Xenopus and C. elegans 
also results in re-replication (Mech, 2014; Melixetian et al., 2004; Vaziri et al., 2003).  
1.4.2. Cell cycle control of origin firing 
Prevention of re-replication is not only regulated via origin licensing, but also through the 
temporal separation of origin firing. Origin firing requires the activity of two kinases: DDK and 
S-CDK. S-CDK phosphorylates Sld2 and Sld3, which allows their binding to the amino and 
carboxy terminals of Dpb11 (Tanaka et al., 2007; Zegerman & Diffley, 2007). Yeast cells 
expressing the phosphomimetic mutant of Sld2 and Sld3-Dpb11 fusion protein can initiate 
replication in the absence of CDK activity, suggesting that Sld2 and Sld3 are the only CDK 
targets for replication initiation (Zegerman & Diffley, 2007). Because G1-CDK cannot 
phosphorylate Sld2 and Sld3 during G1 phase, replication initiation can only occur in S-phase. 
DDK phosphorylates different subunits of MCM2-7 in S-phase (Francis et al., 2009; Lei et al., 
1997; Yi Jun Sheu & Stillman, 2006). Dbf4 - the regulatory subunit of DDK- level oscillates 
heavily throughout the cell cycle, with its highest expression occurring during S-phase, before 
its APC/C mediated degradation in mitosis (Godinho et al., 2000; Oshiro et al., 1999; Weinreich 
& Stillman, 1999). This degradation ablates Dbf4 levels during G1 and ensures that DDK is 
only activated in S-phase (Godinho et al., 2000).  
1.4.3. Temporal programme of replication 
DNA replication is a heavily regulated process in eukaryotic cells, and the asynchronous timing 
of S-phase origin firing is a crucial step of this process. During the transition from G1 to S 
phase, some origins are immediately activated by the CDK and DDK kinases, whilst others are 
only activated during later stages of replication. A further subset, known as dormant origins, 
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are not activated at all, instead being replicated passively following origin firing at other sites 
(Santocanale et al., 1999). Early origins start to be fired at the beginning of S phase, with other 
later origins continue to fire throughout S phase at different times. In both fission and budding 
yeasts, and higher organisms, certain areas of the genome replicate on average at early or 
late stages using multiple origins to do so (Heichinger et al., 2006; McCune et al., 2008; Zink 
et al., 1999).  
The specific timing underlying origin firing, in addition to origin sequence and location, exhibit 
strong conservation amongst members of the Saccharomyces genus (Mueller & Nieduszynski, 
2012). Furthermore, though the sequence of origins is not conserved, the broad patterns of 
replication timing found across the chromosome are conserved both in S. pombe and in higher 
organisms (Ryba et al., 2010; Xu et al., 2012; Yaffe et al., 2010). This suggests that the timing 
of replication is not controlled by factors which delineate origin location, such as sequences, 
but is determined through other factors. Recent works in S. cerevisiae and X. laevis showed 
that some replication factors become limited during replication, and an increase in the 
abundance of those factors leads to cellular and developmental defects (Collart et al., 2013; 
Mantiero et al., 2011). 
1.5. Causes and consequences of DNA replication 
stress 
1.5.1. Obstacles to DNA replication 
A number of endogenous and exogenous obstacles may halt replisome progression. These 
factors act either to hamper the action of helicases or polymerases or both, disrupting the 
integrity of the replication fork (Cortez, 2005; Zegerman & Diffley, 2009). Endogenous barriers 
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which can stall replication prior to completion are rDNA repeats, centromeres, tRNA sites, 
HMR and HML loci, G-quadruplexes, and Ty long-terminal repeats. These blocks are most 
likely able to stall replication due to their ability to form disruptive secondary structures, or due 
to associated DNA-binding proteins acting as a barrier to further replication (Durkin & Glover, 
2007; Hansen et al., 1993; H. Kim & Livingston, 2009; J. Lu et al., 1996). However, whilst some 
barriers are likely unintentional, several have been identified which are programmed. An 
example of this is the polar replication barriers in yeast rDNA repeats, which act to ensure that 
replication and transcription occur in the same direction, thus preventing the collision of the 
two complexes (Brewer & Fangman, 1988; Krings & Bastia, 2005; Linskens & Huberman, 
1988; Sacher M.nchez-Gorostiaga et al., 2004). These sites often undergo recombination, and 
bind Fob1 at the fork barrier to pause replication fork progression (J. Huang & Moazed, 2003; 
Kobayashi, 2003; Kobayashi & Horiuchi, 1996). However, it is likely that other factors also play 
a contributing role in recombination beyond the pausing of the replication fork at these repeat 
units (Labib & Hodgson, 2007; Ward et al., 2000). In order for successful fork pausing to occur, 
the Tof1-Csm3-Mrc1 complex associates with the replication fork in S. cerevisiae (Katou et al., 
2003; K Labib & Hodgson, 2007; Tourrière et al., 2005). Given that both Mrc1 and Tof1 mutants 
are associated with a decreased stability of DNA repeats, it is possible that this complex 
binding acts to prevent recombination events at stalled forks, providing added stability to the 
recombination process (Shishkin et al., 2009; Voineagu et al., 2009). Sites which are prone to 
fork collapse upon replication fork stall are known as fragile sites, and are increasingly being 
implicated in human disease (Aguilera & Gomez-Gonzalez, 2008; Cha & Kleckner, 2002; 
Lemoine et al., 2005; Mirkin, 2007; Raveendranathan et al., 2006). 
The replication fork often stalls at regions which are transcribed by RNA polymerase II and at 
sites of rRNA transcription, and stalling also occurs at tRNA sites when the tRNA is undergoing 
transcription (Azvolinsky et al., 2009; A. M. Deshpande & Newlon, 1996; Prado & Aguilera, 
2005). Together, these results suggest that replication and transcription perturb the activities 
of one anothers’ machinery, likely through the action of supercoiling inhibiting the efficiency of 
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replication, or through direct complex collision (Helmrich et al., 2013). When collision occurs, 
an RNA-DNA hybrid known as an R-loop forms, with their overabundance or increased length 
being correlated with genomic instability (Helmrich et al., 2013; Huertas & Aguilera, 2003) . 
Given that both transcription and replication induce positive supercoiling of the DNA , it is likely 
that the joint action of both machineries creates an additive effect which can lead to fork arrest 
(Brill et al., 1987; Lin & Pasero, 2012; L. F. Liu & Wang, 1987; Osborne & Guarente, 1988).  
Many chemotherapeutic drugs also induce replication fork stalling, and consequent cell cycle 
arrest, through their genotoxic action (Huls & ten Bokkel Huinink, 2003; Lanzkron et al., 2008; 
Ulukan & Swaan, 2002) (see Table 1-1). These drugs can function through a variety of 
mechanisms, and understanding these mechanisms is crucial to developing future therapies 
for widespread disorders such as cancer. One such mechanism for genotoxicity is through the 
depletion of nucleotides via inhibition of ribonucleotide reductase, resulting in a halting of dNTP 
formation (Yarbro, 1992). Through the deprivation of new nucleotides, the replication fork is 
forced to stall, resulting in an uncoupling of the helicase-polymerase complex and cell cycle 
halting through the S-phase checkpoint. Whilst one response to this checkpoint is the 
upregulation of nucleotide production, counteracting the action of genotoxic drugs such as 
hydroxyurea (HU) which deplete the nucleotide pool, the result is a shifted equilibrium wherein 
cells replicate at a significantly reduced speed. Other replication-associated proteins can also 
be targeted by drugs to impede the replication process. Topoisomerase 1 is the target of the 
chemotherapeutic camptothecin, which covalently links Top1 to DNA and creates ssDNA 
breaks (Hsiang et al., 1985). This anchorage of Top1 to DNA creates dsDNA breaks when 
encountered by replication forks, but checkpoint activation is not as potent as with HU since 
minor ssDNA is produced upon replication fork stalling. The covalent modification of bases can 
also stall replication, as evidenced by the action of methyl methanesulfonate (MMS), which 
methylates purines (Beranek, 1990). The subsequent base mispairing halts fork progression, 
with a corresponding fall in the rate of S-phase progression by as much as 10-fold (Tercero & 
Diffley, 2001; Tercero et al., 2003). Other drugs, such as phleomycin, 
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strand breaks through their intercalation in DNA. These lesions hinder progression of the 
replisome, again reducing cell cycle progression. These breaks in the DNA can also occur 
following exposure to ionising radiation, whilst UV radiation as well as 4-NQO produce adducts 
that block polymerase progression and activate the S-phase checkpoint as a result. 
Types of Stress Result Main responders 
Hydroxyurea (HU) dNTP pools depletion Mec1, Mrc1, Sgs1 
Camptothecin (CPT) Topoisomerase I inhibitor Mec1/Tel1, Rad9 
Methylemethanesulfonate 
(MMS) 
  Mec1, Rad9 
Ultraviolet light (UV) DNA adducts Mec1, Rad9, Mrc1 
4-Nitroquinoline 1-oxide 
(4-NQO) 
DNA adducts Mec1, Rad9, Mrc1 
Ionizin irradiation (IR) Single and double strand breaks Mec1/Tel1, Rad9 
Phleomycin Single and double strand breaks Mec1/Tel1, Rad9 
Table 1-1 Sources of DNA damage. The table show different sources of DNA damage and 
the responses of S. Cerevisiae. 
1.5.2. S-phase checkpoint 
Historically, the S phase checkpoint has been characterized as being responsible for the 
maintenance of genomic integrity following detection of stalled replication forks or damaged 
DNA during replication. Different types of lesions can activate the S phase checkpoint, such 
as excessive single-stranded DNA (ssDNA), single strand-double strand junctions (ss-
dsDNA), single strand DNA breaks, as well as double strand DNA breaks. The formation of 
such lesions are detected by different sensor proteins, which results in the activation of the 
master kinases Mec1/Tel1 in yeast and ATM/ATR in humans. Mec1/Tel1 transmit the signal 
to the effector kinases Chk1/Rad53 in yeast and Chk1/Chk2 in humans. Activation of these 
effectors initiates and regulates the following responses: 
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stabilization the stalled replication forks until stalling can be reversed, 3) regulation of 
transcription 4) mitotic delay. Many factors involved in this checkpoint are oncogenic, and thus 
the characterisation of this checkpoint is important for the development of novel cancer 
therapies. 
 
 
 
 
Figure 1-5 The function of the S-phase checkpoint. A simplified diagram showig the roles 
of Rad53 in S-phase checkpoint. Activation of Rad53 by Mec1 inhibitis origin firing, controls 
transcription, stablizes stalled forks and delays mitosis. 
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1.5.2.1. Activation of the S-phase checkpoint  
Single-stranded DNA often forms as a result of replication fork stalling, as a consequence of 
the uncoupling and subsequent functional loss of components of the replication machinery 
such as the helicases and polymerases (Aguilera & Gomez-Gonzalez, 2008; Branzei & Foiani, 
2007; Segurado & Tercero, 2009). The protein RPA firstly binds to ssDNA, which then binds 
the PI3K-like kinase (PIKK) Mec1, through the action of its Ddc2 regulatory subunit (Paciotti et 
al., 2000; Zou & Elledge, 2003). The stalled forks also create ss-dsDNA junctions which are 
then recognized by Rad24-RFC and results in the loading Ddc1-Rad17-Mec3 checkpoint 
clamp on the junction (9-1-1 complex in Humans) (Majka & Burgers, 2003). The Mec1-
dependent phosphorylation of Ddc1 allows the recruitment of Dpb11, which amplifies Mec1 
activation (Puddu et al., 2008).  
On the other hand, dsDNA breaks, which can be induced by the persistence of replication fork 
stalling, are recognized initially by Mre11-Rad50-Xrs2 and result in the resection of one strand 
(D’Amours & Jackson, 2001). The resected DNA forms both an ssDNA and also an ss-dsDNA 
junction which are then both recognized by RPA and Rad24-RFC. Overall, the formation of 
lesions which halt the replication fork progression activates the S-phase checkpoint in multiple 
ways. However, it appears that the abundance of stalled forks is proportional to the degree of 
checkpoint activation (Lupardus et al., 2002; Stokes et al., 2002; Tercero et al., 2003). Mec1 
and Tel1 activation can also occur in G2 and G1 phase if DNA damage occurs, but usually to 
a lesser extent (Zegerman & Diffley, 2009). 
Once, Mec1/Tel1 is activated, the signal has to be transmitted to the effector kinase Rad53 
(functional homolog of human Chk1). The activation of Rad53 requires priming by Mec1/Tel1 
and is followed by its auto-phosphorylation (Hustedt et al., 2013). Several studies indicated 
that the Mec1-dependent phosphorylation of Rad53 requires the help of the mediator proteins 
Mrc1, Rad9 or Sgs1. In this context, the phosphorylation of the replisome factor Mrc1 by Mec1 
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results in the activation of Rad53 (Alcasabas et al., 2001; Osborn & Elledge, 2003). However, 
whether this event occurs on the replication fork or not is not yet clear. Rad53 activation can 
also be mediated by Rad9. The phosphorylation of the H2A histone by Mec1/Tel1 or 
methylation of the H3 histone by Dot1 recruits Rad9 on chromatin. Rad9 is phosphorylated by 
Mec1/Tel1 to which Rad53 can bind and become activated. Sgs1 is also proposed to be 
another mediator for Rad53 activation (Hustedt et al., 2013). The Human WRN homolog of 
Sgs1 interacts with DNA Isomerase Top3l and its deletion leads to increased chromosome 
mis-segregation (Watt et al., 1995). Rad53 can bind to Sgs1 both in vivo and in vitro (Bjergbaek 
et al., 2005; Hegnauer et al., 2012). Given that the deletion of Sgs1 does not change the 
activation of Rad53 during HU-induced fork stalling (Bjergbaek et al., 2005), the full function of 
Sgs1 in Rad53 activation remains elusive.  
1.5.2.2. Function of the S-phase checkpoint 
1.5.2.2.1. Inhibition of origin firing  
The observation that patients with the Ataxia telangiectasia (AT) disease synthesised new 
DNA following ionising radiation, where their non-mutant counterparts did not, lead to the 
identification of the ATM (Ataxia Telangiectasia Mutated) gene, and resulted in the conclusion 
that ATM inhibits DNA replication after ionising radiation exposure ( Painter & Young, 1980; 
Painter, 1977). Upon further study, this was found to be due to a failure of inhibition of origin 
firing in S-phase (Larner et al., 1999; Lee et al., 1997). Rad53 can also block the initiation of 
late origins following DNA damage or replication stalling through treatment of budding yeast 
cells with HU or MMS (Paulovich & Hartwell, 1995; Santocanale & Diffley, 1998; Santocanale 
et al., 1999; Shirahige et al., 1998), through its phosphorylation-dependent inhibition of Sld3 
and Dbf4 (Duch et al., 2011; Lopez-Mosqueda et al., 2010; Zegerman & Diffley, 2010). This 
phosphorylation prevents interactions between Sld3 and the replication factors Dpb11 and 
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Cdc45, blocking the activation of pre-RCs. This mechanism is corroborated by the observation 
that Sld3 and Dbf4 alleles lacking RAD53 phosphorylation sites still show replication occurring 
following DNA damage and fires late origins (Duch et al., 2011; Lopez-Mosqueda et al., 2010; 
Zegerman & Diffley, 2010). The consequence of this action is that any further origins remain 
inhibited and do not fire upon checkpoint activation, reducing the rate of S-phase (Zegerman 
& Diffley, 2010).  
In S. pombe, whilst the S-phase slows down in response to genotoxic treatment (Kim & 
Huberman, 2001; Marchetti et al., 2002), this may not be due to inhibition of origin firing given 
that checkpoint-proficient cells show only a limited repression of origin firing (Mickle et al., 
2007). It is possible that this slowing of replication is due to a slowing of fork speed itself, 
though this remains unconfirmed. 
In higher eukaryotes, Chk1 – a functional homolog of Rad53 – again slows replication through 
origin firing inhibition, potentially by preventing the loading of Cdc45 onto origins of replication, 
stopping the assembly of CMG complex and any resultant further replication (Ge & Blow, 2010; 
Maya-Mendoza et al., 2007; Petermann, Woodcock, et al., 2010). It has been proposed that 
this occurs by inactivating S-CDK Cdk2 through the Chk1-dependent degradation of the Cdk2 
activator Cdc25 (Falck et al., 2001; Mailand et al., 2000). Chk1 may also inhibit origins by 
regulating DDK activity, which is required for loading of Cdc45 onto chromatin and therefore 
activating the helicase (Costanzo et al., 2003; Heffernan et al., 2007). It is also possible that 
the association of Treslin and TopBP1 - the yeast homolog of Sld3 with the homolog of Dbp11, 
respectively - is inhibited following activation of the S-phase checkpoint, potentially through 
the phosphorylation of Treslin (Boos et al., 2011). This proposal is supported by the recent 
observation that Chk1 can regulate origin firing by phosphorylating, and therefore inhibiting, 
Treslin during normal S-phase (Guo et al., 2015). 
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1.5.2.2.1. Replication fork stabilisation and restart 
Given that the completion of DNA replication following a temporary genotoxic drug treatment 
does not require any further origin firing, it appears that stalled forks can restart after stalling 
(Bousset & Diffley, 1998). The completion of replication following replication fork stalling relies 
on both Mec1 and Rad53, as cells lacking these kinases arrest in S-phase and are unable to 
recover from replication blockage as stalled forks eventually collapse (Desany et al., 1998; 
Lopes et al., 2001; Tercero & Diffley, 2001). The checkpoint-dependent phosphorylation of 
several fork components such as Mrc1, Psf1, Pol3, Pol31 has been observed previously (S. 
Chen et al., 2010; De Piccoli et al., 2012; Osborn & Elledge, 2003; Smolka et al., 2007) . In 
addition, since the ectopic expression of Rad53 cannot rescue the stalled fork after temporary 
HU treatment in Rad53-null cells, Rad53 stabilizes these forks possibly through the 
phosphorylation of fork components, though the exact functional relevance of this 
phosphorylation remains unknown (Tercero et al., 2003). On the other hand, analysis of fork 
proteins showed that replication fork components still associate with chromatin in the absence 
of Rad53 activity upon fork stalling. This indicates that Rad53-dependent phosphorylation is 
crucial for the maintenance of fork functionality and prevents irreversible inactivation of the fork 
(De Piccoli et al., 2012). Given that replication forks cannot restart following long exposures to 
HU – in contrast to short exposure - in human cells when the checkpoint is functional 
(Petermann et al., 2010), it is likely that checkpoint-dependent fork stabilisation must occur 
within a specific window of time if the cell cycle is to restart.  
Several lines of evidence indicate that replication forks tend to produce aberrant DNA 
structures such as four-way junctions (also known as chicken foot structures) at stalled 
replication forks in checkpoint-deficient cells (Lopes et al., 2001; Sogo et al., 2002). The 
pertinent studies indicate that Rad53 prevents the formation of aberrant DNA structures at 
stalled forks (Lopes et al., 2001; Sogo et al., 2002). Exonuclease Exo1 is recruited to stalled 
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replication forks in Rad53-deficient cells, and the deletion of Exo1 prevents irreversible fork 
collapse after fork stalling (Cotta-Ramusino et al., 2005; Segurado & Diffley, 2008). Although 
Exo1 is phosphorylated by Rad53 upon HU treatment, the exact mechanism of the regulation 
of Exo1 by Rad53 is still unknown. Given that Exo1 deletion does not suppress the HU 
sensitivity of Rad53 deficient cells, stabilisation of the stalled replication fork appears to require 
other actions of Rad53.  
Given that Exo1 deletion cannot rescue the stalled forks from collapse in mec1D cells after HU 
treatment (Segurado & Diffley, 2008), Mec1 must have other roles beyond that of Rad53 
activation. Although the main function of Mec1 is to activate effector kinases, Mec1 can also 
specifically phosphorylate some of its substrates close to stalled replication forks, such as RPA 
or Rtt107 (Liu et al., 2006; Rouse, 2004). Replication fork stabilisation therefore appears to be 
a complex and multifaceted process.  
1.5.2.2.2. Mitotic Delay 
In addition to its role in the inhibition of DNA replication initiation, the S-phase checkpoint also 
plays roles in delaying mitosis. A number of processes have been identified that block cells at 
the transition between metaphase and anaphase if DNA damage is detected. Three pathways 
have been identified thus far which lead to the stabilisation of Pds1, a securin known to inhibit 
separases. This inhibition of separases results in the increased stability of cohesins, which 
hold sister chromatids together, placing a block on mitosis at the metaphase-anaphase 
transition.  
One pathway again relies on Rad53, which has been shown to block interactions between the 
APC/C activator Cdc20 and Pds1, which normally results in Pds1 degradation (Agarwal et al., 
2003). While the exact mechanism responsible for this interaction blockage remains unknown, 
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the result is the inability for chromosomes to separate, and mitotic arrest. Chk1, the second 
checkpoint effector kinase, also plays roles in the stabilisation of Pds1 (Sanchez et al., 1999). 
The third mechanism relies on the activation of the Spindle Assembly Checkpoint (SAC) by 
the phosphorylation of Mad1, Mad2, Mad3, Bub1, and Bub3 by Mec1 and Tel1, resulting in 
Cdc20 inhibition and Pds1 stabilization (Kim & Burke, 2008). In addition to these three 
pathways resulting in Pds1 stabilization, Rad53 can also block mitosis by inhibiting Cdc5, 
resulting in the activation of Bub2/Bfa1 (Hu et al., 2001).  
It is also possible that mitosis can be prevented through the protein kinase activity of the CDK 
inhibitor Swe1. Swe1 is known to regulate the transition from G2 to M phase through its CDK 
inhibitory activity, which is controlled through the balance between phosphorylation of the 
conserved Y19 residue of Cdc28 by Swe1 and dephosphorylation by Mih1 (Booher et al., 1993; 
Harvey et al., 2005). This mitotic delay is dependent on cell size, and can be triggered by 
checkpoints which detect anomalies in cell or bud (Harvey & Kellogg, 2003; Lew & Reed, 1995; 
Lew, 2003). The mammalian homolog of Swe1 is Wee1, which can delay mitosis in response 
to replicative stress or DNA damage (Jin et al., 1996). However, the role of Swe1 in DNA 
damage-induced mitotic delay remains poorly understood in S. cerevisiae. Whilst Swe1 is 
known to accumulate in response to DNA damage response (Liu & Wang, 2006), it has not 
been confirmed that this accumulation is a result of checkpoint activation (Bastos de Oliveira 
et al., 2012; Keaton et al., 2007). However, work by Magiera et al. (2014) suggests that Swe1 
is constitutively active in wild type cells, and therefore the checkpoint could be active to a 
limited extent under normal conditions. Finally, a recent work demonstrated that Ndd1, the 
transcriptional activator for the CLB2 cluster, is inactivated by the joint action of Mec1 and 
Swe1 in response to DNA damage, suggesting that Swe1 may well play additional roles in the 
DNA damage response (Edenberg et al., 2015). 
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1.5.2.2.3. Transcriptional control 
A major result of checkpoint activation is the upregulation of several hundred genes via two 
distinct mechanisms. The first mechanism is the Rad53-dependent phosphorylation of Rad53 
related kinase Dun1 (Chen et al., 2007; Zhou & Elledge, 1993), which then acts to inhibit the 
function of the transcriptional repressor Crt1 (Huang et al., 1998), resulting in the upregulation 
of several genes including those involved in ribonucleotides synthesis and repair of DNA. This 
is corroborated by the observations that both Mec1 and Rad53 function to upregulate 
production of dNTPs for the repair of DNA damage during S-phase, and that cells which lack 
either of these proteins can be restored to viability through the activation of other mechanisms 
to upregulate dNTP production (Huang et al., 1998; Zhao et al., 2001). The second mechanism 
is the phosphorylation of Swi6, a subunit of the transcriptional activators MBF and SBF, by 
Rad53, resulting in an upregulation of other genes involved in DNA repair (Sidorova & 
Breeden, 1997). 
1.5.2.3. Checkpoint recovery 
After DNA damage has been repaired, or obstacles to fork progression have been removed, it 
is necessary for cells to inactivate the checkpoint in order for the cell cycle to continue. This 
recovery occurs alongside the dephosphorylation of Rad53, resulting in its inactivation. The 
phosphatases Ptc2, Ptc3, and Pph3 have all been shown to play a role in checkpoint recovery 
(Guillemain et al., 2007; Keogh et al., 2006; Leroy et al., 2003). These phosphatases function 
during recovery from different stresses, with Ptc2 and Pph3 required during the MMS 
response, whilst Glc7 is required during the HU response (Bazzi et al., 2010; O’Neill et al., 
2007; Szyjka et al., 2008). Other recovery pathways do not rely on the action of phosphatases, 
such as the dampening of sensor kinase activity via Srs2 or Sae2, however the molecular 
mechanisms underlying this dampening remains broadly unknown (Krejci et al., 2003; Veaute 
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et al., 2003; Yeung & Durocher, 2011). Checkpoint recovery appears to be a multifaceted 
process, involving several layers affecting different proteins depending on the nature of the 
DNA damage or replication stress which first activated the checkpoint.  
1.6. Work Presented in this thesis 
DNA damage checkpoints have been proposed to act as a barrier for the suppression of cancer 
development (Bartkova et al., 2005, 2006; Gorgoulis et al., 2005). Indeed, checkpoint kinases 
are often deregulated in many cancers, as well as in other diseases, which makes them 
important targets for effective treatments (Chen et al., 2012). In addition, this checkpoint is 
crucial for the development of in metazoans in midblastula transition (MBT) (Budirahardja & 
Gönczy, 2009; Collart et al., 2013). Despite the fact that they play vital roles in organisms, the 
mechanisms underlying the DNA damage checkpoints are poorly understood.  
The work described in this thesis aims to investigate temporal and substrate specificity of the 
S phase checkpoint in budding yeast. I mainly focus on a particular response of the S phase 
checkpoint termed the inhibition of origin firing. In the first results chapter, chapter 3, I 
investigate whether the checkpoint dependent inhibition of origin firing is targeted outside of S 
phase. Interestingly, the DNA damage checkpoint effector kinase Rad53 targets its substrates 
Sld3 and Dbf4 outside of S phase upon DNA damage. I then investigate the biological 
significance of the checkpoint-dependent inhibition of origin firing outside of S phase in chapter 
4. Having shown that the checkpoint response is not specific for any stage of the cell cycle, I 
examined how Rad53 targets its substrates in chapter 5. I found that Rad53 requires the 
disordered loop of Cdc45 to phosphorylate Sld3 upon DNA damage. Given that Cdc45 is also 
required for the DNA replication forks in addition to replication initiation, in chapter 6, I 
investigate whether Cdc45 targets Rad53 to replication fork factors in S phase.  
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The results presented in this thesis are divided into 4 separate chapters (Chapter 3-6). Each 
of these chapters has a brief introduction that explains the rationale behind the experiments, 
followed by detailed results and a subsequent discussion. The results presented underlie the 
temporal as well as substrate specificity of the S Phase checkpoint after DNA damage, and 
suggest that the S phase checkpoint functions through the cell cycle and Cdc45 is required for 
S phase checkpoint responses. 
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Chapter 2  
Materials and Methods 
2.1. Yeast-related methods 
2.1.1. Yeast strains used in this study 
Yeast strains used in this study are based on W303 ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3, 
112 can1-100 and are listed in Table 2.1. 
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Strain Relevant genotype Source 
PZ1 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 
(W303) 
PZ Lab 
PZ229 MATα ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 
(W303 alpha) 
PZ Lab 
PZ13 W303 a sml1Δ::URA3 rad53Δ::LEU2 PZ Lab 
PZ1223 W303 a SLD3-10his-13myc::KanMX bar1Δ::hisG PZ Lab 
PZ1317 W303 a DBF4-13myc::KanMx bar1::hisG PZ Lab 
PZ1523 W303 a sml1Δ::URA3 rad53Δ::LEU2 SLD3-10his-
13myc::KanMX bar1Δ::hisG 
This study 
PZ1319 W303 a sld3-37A-10his13myc::KanmX bar1::hisG PZ Lab 
PZ1593 W303 a dbf4∆::TRP1 his3::PDBF4-dbf4-4A-
13myc::KanMx::HIS3 bar1∆::hisG 
This study 
PZ125 W303 a DBF4-13myc::KanMx PZ Lab 
PZ52 W303 a SLD3-10his-13myc::KanMX PZ Lab 
PZ89 W303 a sml1Δ::URA3 rad53Δ::LEU2 SLD3-13myc::KanMX PZ Lab 
PZ228 W303 a sml1Δ::URA3 rad53Δ::LEU2 DBF4-13myc::KanMX PZ Lab 
PZ126 W303 a dbf4∆::TRP1 his3::PDBF4-dbf4-4A-
13myc::KanMx::HIS3  
PZ Lab 
PZ2 W303 a sld3-37A-10his13myc ::KanmX PZ Lab 
PZ1657 W303 a orc2-6A URA3::PGAL-CDC6-13myc::ura3 mcm-
2xNLS::ABA 
This study 
PZ1658 W303 a orc2-6A URA3::PGAL-CDC6-13myc::ura3 mcm-
2xNLS::ABA his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1659 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 mcm-
2xNLS::ABA 
This study 
PZ1660 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 mcm-
2xNLS::ABA his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1661 W303 a URA3::PGAL-CDC6-13myc::ura3 mcm-
2xNLS::ABA 
This study 
PZ1662 W303 a URA3::PGAL-CDC6-13myc::ura3 mcm-
2xNLS::ABA his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1663 W303 a orc2-6A orc6-4A URA3::PGAL-CDC6-13myc::ura3 This study 
PZ1664 W303 a orc2-6A orc6-4A URA3::PGAL-CDC6-13myc::ura3 
his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1665 W303 alpharc2-6 URA3::PGAL-CDC6-13myc::ura3 This study 
PZ1666 W303 a orc2-6A URA3::PGAL-CDC6-13myc::ura3 his3::3ld3-
A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1667 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 This study 
PZ1668 W303 a orc6-4A orc6-4A URA3::PGAL-CDC6-13myc::ura3 
his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 
This study 
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PZ1669 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 This study 
PZ1670 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 his3::3ld3-
A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1671 W303 a URA3::PGAL-CDC6-13myc::ura3 This study 
PZ1672 W303 a URA3::PGAL-CDC6-13myc::ura3 his3::3ld3-A-
PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1673 W303 a orc2-6A orc6-4A mcm-2xNLS::ABA This study 
PZ1674 W303 a orc2-6A orc6-4A mcm-2xNLS::ABA his3::3ld3-A-
PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1675 W303 a orc2-6A mcm-2xNLS::ABA This study 
PZ1676 W303 a orc2-6A mcm-2xNLS::ABA his3::3ld3-A-PGAL1-10-
dbf4-4A::HIS3 
This study 
PZ1677 W303 alpha orc6-4A mcm-2xNLS::ABA This study 
PZ1678 W303 alpha orc6-4A mcm-2xNLS::ABA his3::3ld3-A-PGAL1-
10-dbf4-4A::HIS3 
This study 
PZ1679 W303 alpha mcm-2xNLS::ABA This study 
PZ1680 W303 alpha mcm-2xNLS::ABA his3::3ld3-A-PGAL1-10-dbf4-
4A::HIS3 
This study 
PZ1681 W303 alpha orc2-6Aorc6-4A This study 
PZ1682 W303 a orc2-6A orc6-4A his3::3ld3-A-PGAL1-10-dbf4-
4A::HIS3 
This study 
PZ1683 W303 a orc2-6A This study 
PZ1684 W303 a orc2-6A his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 This study 
PZ1685 W303 a orc6-4A This study 
PZ1686 W303 a orc6-4A his3::3ld3-A-PGAL1-10-dbf4-4A::HIS3 This study 
PZ1687 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 This study 
PZ1688 W303 a orc6-4A URA3::PGAL-CDC6-13myc::ura3 his3::3ld3-
A-PGAL1-10-dbf4-4A::HIS3 
This study 
PZ1449 W303 a orc2-6A orc6-4A his3::pRS303::HIS3  PZ Lab 
PZ1450 W303 alpha orc2-6A orc6-4A his3::pRS303::HIS3  PZ Lab 
PZ1453 W303 alpha orc6-4A his3::pRS303::HIS3  PZ Lab 
PZ1454 W303 alpha orc2-6A his3::pRS303::HIS3  PZ Lab 
PZ1455 W303 a orc6-4A his3::pRS303::HIS3  PZ Lab 
PZ1456 W303 alpha orc2-6A his3::pRS303::HIS3  PZ Lab 
PZ1721 W303 a URA3::PGAL-Cdc6-13myc This study 
PZ2008 W303 a URA3::PGALl-Cdc6-13mychis3:: sld3-A-PGAL1-10-
dbf4-A::HIS3 
This study 
PZ1739 W303 a sml1Δ::URA3 cdc28-as1  This study 
PZ1741 W303 a sml1Δ::URA3 rad53Δ::LEU2 cdc28-as1  This study 
PZ1742 W303 a sml1Δ::URA3 mec1Δ::LEU2 cdc28-as1  This study 
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PZ1767 W303 a cdc28-as1 dbf4-4A::HIS3 sld3-37A-10his-13myc 
::KanNX 
This study 
PZ1922 W303 a bar1∆::TRP1 This study 
PZ1923 W303 a bar1∆::TRP1 trp1::SLD3-PGAL1-10-DBF4::TRP1  This study 
PZ1924 W303 a bar1∆::TRP1 trp1::sld3-37A-PGAL1-10-dbf4-
4A::TRP1 
This study 
PZ1925 W303 a bar1∆::TRP1 his3::PGAL-sld2-T84D::HIS3  This study 
PZ1926 W303 a bar1∆::TRP1 trp1::SLD3-PGAL1-10-DBF4::TRP1 
his3::PGAL-sld2-T84D::HIS3  
This study 
PZ1927 W303 a bar1∆::TRP1 trp1::sld3-37A-PGAL1-10-dbf4-
4A::TRP1 his3::PGAL-sld2-T84D::HIS3  
This study 
PZ1928 W303 a bar1∆::TRP1 his3::PGAL-sld2-T84D::HIS3 
ura3::PCDC6-cdc6∆NT::URA3 
This study 
PZ1929 W303 a bar1∆::TRP1 trp1::SLD3-PGAL1-10-DBF4::TRP1 
his3::PGAL-sld2-T84D::HIS3 ura3::PCDC6-cdc6∆NT::URA3 
This study 
PZ1930 W303 a bar1∆::TRP1 trp1::sld3-37A-PGAL1-10-dbf4-
4A::TRP1 his3::PGAL-sld2-T84D::HIS3 ura3::PCDC6-
cdc6∆NT::URA3 
This study 
PZ1891 W303 a CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-UBR1::HIS3 
SLD3-10his-13myc::KanMx 
PZ Lab 
PZ2167 W303 a CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-UBR1::HIS3 
SLD3-10his-13myc::KanMx URA3::PCDC45-CDC45::ura3 
This study 
PZ171 W303 a sld3-2D-10his-13myc::KanMX PZ Lab 
PZ2400 W303 a dpb11-1::KanMX SLD3-10his-13myc::KanMX  
PZ519 W303 a sml1Δ::URA3 DBF4-13myc::KanMX PZ Lab 
PZ228 W303 a sml1Δ::URA3 rad53Δ::LEU2 DBF4-13myc::KanMX PZ Lab 
PZ660 W303 a sml1Δ::URA3 DBF4-13myc::KanMx CDC45-
3HA::HIS3 
PZ Lab 
PZ2168 W303 a CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-UBR1::HIS3 
SLD3-10his-13myc::KanMX URA3::PCDC45-cdc45-
T189A::ura3 
This study 
PZ2169 W303 a CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-UBR1::HIS3 
SLD3-10his-13myc::KanMX URA3::PCDC45-cdc45-
T189D::ura3 
This study 
PZ2170 W303 a CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-UBR1::HIS3 
SLD3-10his-13myc::KanMX URA3::PCDC45-cdc45-
T189E::ura3 
This study 
PZ2198 W303 a SLD3-10his-13myc::KanMX cdc45-T189A This study 
PZ2199 W303 a SLD3-10his-13myc::KanMX cdc45-T189D This study 
PZ2200 W303 a SLD3-10his-13myc::KanMX cdc45-T189E This study 
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PZ2286 W303 alpha CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-
UBR1::HIS3 SLD3-10his-13myc::KanMX TRP1::PCDC45-
cdc45-2A::trp1 
This study 
PZ2287 W303 alpha CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-
UBR1::HIS3 SLD3-10his-13myc::KanMX TRP1::PCDC45-
cdc45-2D::trp1 
This study 
PZ2288 W303 alpha CDC45::cdc45-td::TRP1 ubr1Δ::PGAL-
UBR1::HIS3 SLD3-10his-13myc::KanMX TRP1::PCDC45-
cdc45-2E::trp1 
This study 
PZ2226 W303 a SLD3-10his-13myc::KanMX cdc45-2A This study 
PZ2336 W303 a dbf4-4A::HIS3 cdc45-2A This study 
PZ355 W303 a mrc1Δ::URA3 PZ Lab 
PZ2313 W303 a mrc1Δ::URA3 cdc45-2A This study 
PZ2325 W303 a ddc1Δ::KanMX This study 
PZ2332 W303 a ddc1Δ::KanMX cdc45-2A This study 
PZ1535 W303 a rad17Δ::URA3 PZ Lab 
PZ2446 W303 a rad17Δ::URA3 cdc45-2A This study 
PZ1545 W303 a sgs1Δ ::HPH  PZ Lab 
PZ2412 W303 a sgs1Δ ::HPH cdc45-2A This study 
PZ246 W303 a rad9∆::TRP1 PZ Lab 
PZ2444 W303 a rad9∆::TRP1 cdc45-2A This study 
PZ2448 W303 a mec3Δ::KanMX This study 
PZ2451 W303 alpha mec3Δ::KanMX cdc45-2A This study 
PZ2452 W303 a sgs1∆::HPH ddc1∆::KanMX This study 
PZ2453 W303 a sgs1∆::HPH ddc1∆::KanMX cdc45-2A This study 
PZ2485 W303 alpha ddc1Δ::KanMX rad9∆::TRP1 This study 
PZ2486 W303 a ddc1Δ::KanMX rad9∆::TRP1 cdc45-2A This study 
PZ2360 W303 a mrc1∆::HIS3 ddc1∆::KanMX sml1∆::URA3 This study 
PZ2361 W303 a mrc1∆::HIS3 ddc1∆::KanMX sml1∆::URA3 cdc45-
2A 
This study 
PZ2707 W303 a RAD53-3HA::HIS3 This study 
PZ2489 W303 a RAD53-3HA::HIS3 cdc45-2A This study 
PZ2560 W303 a RAD53-3HA::HIS3 mrc1Δ::URA3 This study 
PZ2561 W303 a RAD53-3HA::HIS3 mrc1Δ::URA3cdc45-2A This study 
PZ2565 W303 a 3HA-RAD53::KanMX  This study 
PZ2567 W303 a 3HA-RAD53::KanMX cdc45-2A This study 
PZ2334 W303 a sml1Δ::URA3 MRC1-13myc::KanMX cdc45-2A This study 
PZ2227 W303 a sml1Δ::URA3 MRC1-13myc::KanMX This study 
PZ2228 W303 a sml1Δ::URA3 rad53Δ::LEU2 MRC1-13myc::KanMX This study 
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PZ568 W303 a sml1Δ::URA3 SGS1-13myc::KanMX PZ Lab 
PZ2407 W303 a sml1Δ::URA3 EXO1-13myc::KanMX This study 
PZ2410 W303 a sml1Δ::URA3 RRM3-13myc::KanMX This study 
PZ2246 W303 a sml1Δ::URA3 SRS2-13myc::KanMX This study 
PZ2601 W303 a sml1Δ::URA3 SGS1-13myc::KanMX cdc45-2A This study 
PZ2603 W303 a sml1Δ::URA3 Rrm3-13myc::KanMX cdc45-2A  This study 
PZ2607 W303 a sml1Δ::URA3 SRS2-13myc::KanMx cdc45-2A  This study 
PZ2615 W303 a sml1Δ::URA3 EXO1-13myc::KanMX cdc45-2A  This study 
  Table 2-1 Yeast strains used in this study. 
2.1.2. Yeast media 
The medium used to grow yeast was YP medium, autoclaved prior to use and supplemented 
with 2% glucose unless stated to the contrary in the appropriate text. In order to select for 
marker genes, such as TRP1, HIS3, LEU2 or URA3, SC medium or minimal medium were 
used, without the relevant amino acid or nucleic acid. Saturated cultures were mixed with 15% 
glycerol prior to long-term storage at -80oC where necessary. Yeast plates were maintained at 
4oC for short-term storage.  
2.1.3. Liquid culture and synchronisation 
MATa yeast was grown until the mid-log phase of growth (1x107 cells/ml) at 30oC. Cell counting 
was performed through the use of either a haemocytometer, or through the measurement of 
optical density at 600nm using the NanoDrop 2000c spectrophotometer. Synchronisation in 
G1 was performed through the addition of 5µg/ml alpha factor for 100min to the appropriate 
cultures except 5ng/ml alpha factor was used for bar1D cells. Successful arrest was confirmed 
by determining the ratio of budded and unbudded cells, and arrest was released by washing 
two times in YPD at room temperature and resuspending cells in the required medium. 
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Budding index was determined by taking yeast samples at specific times indicated in the 
relevant figures, sonicating them, and counting the number of budding cells using a 
microscope. M phase synchronisation was performed through the treatment of cultures with 
10µg/ml nocodazole (Roche) for 90 minutes.  
2.1.4. Mating and tetrad dissection 
To produce new combinations of genes, relevant MATα and MATa strains were crossed by 
mixing two cultures with one another on a non-selective plate and incubating for at least 4h to 
create a new diploid strain. Diploid cells were selected using diploid-specific marker genes. 
These diploid strains were grown on rich sporulation medium (RSM) for 3 or more days. Tetrad 
presence was confirmed using a microscope, and were digested using 900U of glucoronidase 
in 300µl at 37oC for 45min. These tetrads were then dissected under a tetrad dissection 
microscope, and their genotype determined through either PCR or marker selection. Mating 
type was determined by crossing the new strain with the tester strains DC14 and DC17 and 
replica plating onto minimal medium.  
2.1.5. Growth assays  
Yeast was grown to saturation overnight, then diluted to 107 cells/ml. Yeast was then serially 
diluted by 3 and spotted on plates. Pictures of plates were taken using a scanner at the 
appropriate time points, and colony images taken using a table top microscope with a 
connected Leica camera. 
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2.1.6. Yeast transformation 
50ml of 2x107 cells/ml mid-log phase yeast were washed with ddH2O, then resuspended in 
1ml ddH2O. The transformation mix (240µl 50% PEG3500, 36µl 1M lithium acetate, 10µl 
salmon sperm DNA (10mg/ml), 1µg DNA in 74µl ddH2O) was then added to 100µl of yeast 
cells, and the mixture incubated for 40min at 42oC followed by resuspension in 0.5ml ddH2O 
and plating of 250µl on the appropriate plate. If aminoglycoside antibiotics were utilised as 
selective markers, cells were grown in YPD for at least 3h prior to plating. Centrifugation was 
carried out at low speed for 2min. 
2.1.7. Yeast genomic DNA extraction  
This protocol is derived from that of Rose et al. (1990). Cells were pelleted, and 0.3ml of 
0.45mm diameter glass beads were added along with 0.2ml lysis buffer (10mM Tris pH 8, 1mM 
EDTA, 100mM NaCl, 1% SDS, 2% Triton X-100) and 0.2ml phenol/chloroform pH 8 (1:1). 
Tubes were vortexed for 2min prior to the addition of 0.2ml TE, then vortexed again. Cells were 
then centrifuged for 5min at room temperature at maximum speed, and the aqueous layer was 
transferred to a new Eppendorf tube. 2 volumes of 100% ethanol were then added, and 
samples were centrifuged for 3min after mixing. After discarding the supernatant, the pellet 
was washed with 0.5ml cold 70% ethanol and briefly centrifuged. The removal of supernatant 
was followed by pellet air drying and resuspension in 50µl TE buffer (10mM Tris, 1mM EDTA 
pH 8) containing 50µg/ml RNase A. Samples were then incubated at 37oC for 1h. 
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2.1.8. Preparation of trichloroacetic acid (TCA) whole cell 
extract 
Following collection of 5ml 2x107 cells/ml yeast culture using centrifugation, cells were 
resuspended in 200µl 20% TCA. Following the addition of 400µl of glass beads, samples were 
vortexed for 1min. 400µl of 5% TCA was then added, and the mixture centrifuged at maximum 
speed for 2min. After discarding the supernatant, the protein pellet was resuspended in 200µl 
Laemmli buffer (250mM Tris pH 6.8, 2% SDS, 40% glycerol, 20% β-mercaptoethanol and 
bromophenol blue). 50µl of 1M Tris base was added, and samples were centrifuged at 
maximum speed for 2min following boiling for 6min. Samples were stored at -20oC until use, 
or loaded onto polyacrylamide gels. 
2.2. Bacteria-related methods 
2.2.1. Bacterial media, growth and strains  
E. coli was liquid cultured in 25g/L LBM-Broth Miller (Formedium) at 37oC while shaking at 225 
rpm. LB medium supplemented with 15g/L agar was used for bacterial growth on plates. To 
select for bacteria containing resistance markers, LB medium was supplemented with 50µl/ml 
ampicillin. Competent DH5α bacteria were used for transforming and amplifying shuttle 
vectors. 
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2.2.2. Bacterial transformation 
100µl of competent bacteria was thawed on ice, and mixed with added plasmid DNA by 
pipetting, before incubation on ice for 30min. Bacteria were then heat-shocked at 42oC for 
45sec, then kept on ice for 2min. 200µl of LB medium was then added, and bacteria incubated 
at 37oC for 1h prior to plating on the appropriate LB resistance plates. 
2.3. DNA methods 
2.3.1. Plasmids 
  Table 2-2 Plasmid used in this study. 
 
Plasmid Description Source 
PZ848 pRS316-PGAL-CDC45 this study 
PZ849 pRS306-PCDC45-cdc45-T189A this study 
PZ850 pRS306-PCDC45-cdc45-T189D this study 
PZ851 pRS306-PCDC45-cdc45-T189E this study 
PZ860 pRS306-PCDC45-cdc45-T189A-3’UTR this study 
PZ861 pRS304-PCDC45-cdc45-T189D-3’UTR this study 
PZ862 pRS304-PCDC45-cdc45-T189E-3’UTR this study 
PZ953 pRS304-PCDC45-cdc45-T189A-T195A-3’UTR this study 
PZ954 pRS304-PCDC45-cdc45-T189D-T195D-3’UTR this study 
PZ955 pRS304-PCDC45-cdc45-T189E-T195E-3’UTR this study 
PZ1021 pFA6a KanMx6-PRAD53-3XHA this study 
PZ243 pFA6a-3HA-KanMX6 PZ lab 
PZ194 pFA6a-3HA-HIS3MX PZ lab 
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2.3.2. Polymerase chain reaction (PCR) 
PCR was performed using the Phusion High Fidelity DNA polymerase (NEB) in a 50µl reaction 
mixture of 5x Phusion HF Buffer, 1µl 10mM dNTP mixture, 2.5µl of both the forward and 
reverse primers diluted to 10µM, and template DNA. Reactions were then carried out using a 
peySTAR 96x Universal gradient apparatus (PE-QLAB), following the standard protocol: 98oC, 
3min; 98oC, 1 min, primer-dependent annealing temperature, 1 min, 72oC, 45sec/kb of product 
(30 cycles); 72oC, 10 min, final elongation. PCR products were visualised following agarose 
gel electrophoresis and, where necessary, were purified using the QIAquick PCR purification 
kit (Qiagen) or the QIAquick gel extraction kit (Qiagen). 
2.3.3. Agarose gel electrophoresis 
1% agarose gels were made using 1x TAE (40mM Tris, 20mM acetic acid, 1mM EDTA) 
containing 1µg/ml ethidium bromide. Samples were diluted in 6x loading buffer (0.03% w/v 
bromophenol blue, 60% glycerol, 10mM Tris pH 8, 60mM EDTA pH 8). Electrophoresis 
apparatus was run at 80-100V, and DNA bands were then visualised using a UV 
transilluminator, with their size estimated against a DNA ladder. 
2.3.4. Restriction digestion 
Plasmid DNA, or PCR products, were digested in a 40µl digestion mixture containing 4µl 10x 
digestion buffer (NEB), 5µl 10x BSA, and 5U restriction enzyme. This mixture was incubated 
at 37oC for 2h. For digestion of vectors, 1U of calf intestinal alkaline phosphatase (CIP, NEB) 
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was added after 1.5h and after 1.75h to dephosphorylate the 5’ end. Digested DNA was then 
run on a gel and purified using the QIAquick gel extraction kit. 
2.3.5. DNA ligation  
Digested PCR products were mixed with digested, phosphatase-treated vectors in a ratio of 
3:1. 2µl 10x T4 DNA ligase buffer (NEB) and 1µl T4 DNA ligase (NEB) were then added, and 
the total volume brought to 20µl. The reaction mixture was incubated for 2h at room 
temperature, or incubated overnight at 16oC. 
2.3.6. DNA cloning 
PCR products from plasmid or yeast genomic DNA templates were generated using 
oligonucleotides containing appropriate 5’ restriction sites. These oligonucleotide restriction 
sites were designed to allow for unidirectional insertion. The PCR product was electrophoresed 
on an agarose gel, and purified using the QIAquick gel extraction kit. For product digestion, 
the total volume was used. Plasmid DNA was obtained from bacterial stocks with the QIAprep 
spin miniprep kit (Qiagen), with approximately 500ng DNA used for digestion. After being run 
on an agarose gel, the PCR product and target vector were purified using the above gel 
extraction kit. Following ligation, 10µl of ligation reaction mixture was used for transformation 
into competent bacteria. 
2.3.6.1. Sanger sequencing and sequence analysis 
DNA was sequenced by the Department of Biochemistry, University of Cambridge DNA 
Sequencing Facility.  
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2.4. Preparative and analytical biochemistry 
2.4.1. SDS-PAGE  
Polyacrylamide gels were composed of a 7.5% resolving gel containing 3.27ml 40% 
acrylamide, 1.9ml 2% bis-acrylamide, 7.5ml 1M Tris-HCl pH 8.8, 100µl 20% SDS, 6.76ml 
ddH2O, 25µl of tetramethylethylenediamine (TEMED) and 100µl 10% ammonium persulfate 
(APS). Additionally, a 15% resolving gel is also an essential component of polyacrylamide gels, 
and is composed of 7.6ml 40% acrylamide, 0.88ml 2% bis-acrylamide, 7.5ml 1M Tris-HCl pH 
8.8, 100µl 20% SDS, 4ml ddH2O, 25µl TEMED, 100µl 10% APS. The stacking gels were 
composed of 1.28ml 40% acrylamide, 0.7ml 2% bis-acrylamide, 1.25ml 1M Tris-HCl pH 6.8, 
50µl 20% SDS, 6.76ml ddH2O, 40µl TEMED, and 80µl 10% APS. The PerfectBlue Dual Gel 
System Twin ExW S (VWR) was used to separate samples. Running buffer was composed of 
3g/l Tris base, 14.4g/l glycine and 5g/l 20% SDS. Samples were run through the application of 
80V. Precision plus protein dual marker (Bio-Rad) was used as a reference. Additionally, a 
15% resolving gel is also an essential component of polyacrylamide gels, and is composed of 
7.6ml 40% acrylamide, 0.88ml 2% bis-acrylamide, 7.5ml 1M Tris-HCl ph 8.8, 100µl 20% SDS, 
4ml ddH2O, 25µl TEMED, 100µl 10% APS. 
2.4.2. Phos-Tag-SDS-PAGE 
Polyacrylamide-Agarose gels were composed of a 4% resolving gel containing 484ul 40% 
acrylamide, 334ul 2% bis-acrylamide, 1875µl 1M Tris-HCl pH 8.8, 25µl 20% SDS, 1666µl 1.5% 
Agarose, 20 µl 5mM Phos-Tag (Wako-Chem), 17.5µl 10 mM MnCl2, 555µl ddH2O, 5µl of 
tetramethylethylenediamine (TEMED) and 100µl 10% ammonium persulfate (APS). Agarose 
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was boiled in ddH2O and immediately added into the gel mixture. The 3% stacking gels were 
composed of 145µl 40% acrylamide, 100µl 2% bis-acrylamide, 250µl 1M Tris-HCl 6.8, 1493µl 
ddH2O, 2µl TEMED, and 10µl 10% APS. 
2.4.3. Protein transfer and immunoblotting 
Proteins were then blotted onto Whatman Protran Nitrocellulose transfer membrane for 45min 
at 500mA using a semi-dry system (Thermo Scientific, owl hep-1) in transfer buffer (48mM 
Trizma base, 0.0375% SDS, 20% methanol, 39mM glycine). Following transfer, membranes 
were blocked in 5% milk powder diluted in 0.1% TBS with 0.1% Tween-20 (TBS-T). The 
primary antibody, diluted in 5% milk powder in TBS-T was added to the membrane and 
incubated for either 2h at RT or overnight at 4oC. The membrane was subsequently washed 
three times in TBS-T, for 5 mins per wash, and the HRP-conjugated secondary antibody diluted 
in 5% milk powder in TBS-T was added. The Amersham ECL Western Blotting Detection 
Reagents from GE Healthcare were used to detect protein bands.  
2.4.4. Antibodies 
Antigen Species Source Concentration 
Rad53 Rabbit Abcam, ab104232 1:5000 
Orc6 Mouse Stillman Laboratory 1:5000 
c-Myc Mouse Roche, clone 9e10		 1:5000 
Dpb11 Rabbit Diffley Laboratory 1:1000 
Mouse-IgG Horse Vectorlabs, PI-2000 1:10000 
Rabbit-IgG Donkey Abcam, ab16284 1:10000 
Table 2-3 Antibodies used in this study. 
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2.4.5. Purification of Cdc45 antibody 
2.4.5.1. Purification of Cdc45 (1-238) fragment 
BL21 DE3 pLysS cells carrying pGEX 2TKP Cdc45 (1-238)-6His plasmid were cultured in 2TY 
media containing Ampicillin and Chloramphenicol overnight at 37oC. Next day, the saturated 
bacterial culture was diluted in 1:100 into 2 litres of 2TY media containing Ampicillin and 
Chloramphenicol and cultured again for approximately 4h at 37oC until the OD600 reached 
0.4-0.5. The expression of Cdc45 (1-238) fragment was induced by adding a final 
concentration of 0.5 mM IPTG and incubating for 3 hours at 37oC. Cells were harvested by 
centrifugation at 4000 rpm for 10min at 4oC. The cell pellet was suspended in 10ml of ice cold 
lysis buffer (8M Urea, 20mM NaPhosphate buffer pH7.4, 300mM NaCl, 20mM Imidazole pH 
8.0) and sonicated 2 times for 30sec (40%) with a 30 sec break in between. The cell lysate 
was spun down at 9500rpm for 10 minutes at 4oC and the supernatant transferred to a Ni-
Sepharose (GE-healthcare) column. The beads were washed once with 5ml lysis buffer 
containing 70 mM Imdizadole and once with 3ml lysis buffer containing 90 mM Imidazole. The 
Cdc45 (1-238) fragment was eluted with 8ml lysis buffer containing 175mM imidazole. To 
precipitate Cdc45 (1-238) fragments, 4 volumes of ice cold acetone were added to the elution 
and incubated overnight at -20oC. Protein precipitates were collected by centrifugation at 4000 
rpm for 20min at room temperature and washed twice with acetone to remove Urea crystals. 
Excess acetone was removed by evaporation at room temperature and Cdc45 (1-238) 
fragments were dissolved in 500µl 8M Urea pH 9.0 and mixed with an equal volume of 2X 
coupling buffer (0.2 M NaCO3, 1M NaCl at pH9). Protein concentration was measured and 
diluted to 5 mg/ml with 1X coupling buffer containing 4M Urea. 
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2.4.5.2. Coupling the Cdc45 (1-238) fragment to CN-Br sepharose 
beads 
0.25g of CN-BR sepharose beads were swollen in 5ml of 1mM HCl for 15 minutes at room 
temperature and spun down at 700x g for 2min. After removing the supernatant, beads were 
washed twice with 1 ml of 1mM HCl and once in 10 ml coupling buffer (0.1 M NaCO3, 0.5 M 
NaCl at pH9). 1 ml of 5mg/ml Cdc45 (1-238) fragment which was dissolved in coupling buffer 
containing 4M Urea, added to beads, and rotated of 2 hours at room temperature. Beads were 
then washed twice with 5ml of blocking buffer (coupling buffer+1M Ethanolamine) and 
incubated with 10ml blocking buffer for 2h at room temperature. After incubation with blocking 
buffer, beads were washed 2 times  with 10ml low pH buffer (0.1M acetic acid, 0.5M NaCl), 2 
times with 10ml coupling buffer, and 1 once 10 ml 1X PBS.  
2.4.5.3. Affinity purification of Cdc45 polyclonal antibody 
To purify the Cdc45 specific polyclonal antibody, 2 rabbits were immunized with the Cdc45 (1-
238) fragment (BioGenes GmbH). 100µl of immunized rabbit serum and 900µl of PBS were 
added to Cdc45 (1-238)-Sepharose beads and rotated overnight at 4oC. Beads were washed 
3 times with 1ml of PBS and antibodies were eluted with 500µl of 200mM glycine pH 2.8. This 
elution step was repeated 4 times and each fraction was neutralized with 50µl 1M Tris pH 8.0. 
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Chapter 3  
Activation of the S-phase checkpoint 
outside of S-phase 
3.1. Introduction 
Endogenous or exogenous stress can modify or damage DNA. Depending on the type of DNA 
damage, lesions are recognized by different sensor proteins which lead to the activation of two 
master kinases called ATM and ATR in humans (Mec1 and Tel1 in yeast). Activation of the 
master kinases transduces the signal to the effector kinases Chk1 and Chk2 in humans (Rad53 
and Chk1 in yeast) which leads to the execution of several responses. The activation of the 
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DNA damage checkpoint in G1 ensures that the transition to a new SPhase does not occur 
before the damage is repaired, whereas in G2 phase it prevents cells from entering mitosis 
(Siede et al., 1994; Weinert & Hartwell, 1988). On the other hand, different responses of the 
DNA damage checkpoint have been observed when it is activated in S phase, including the 
stabilization of stalled replication forks, inhibition of origin firing and transcriptional control.  
Because different responses are observed depending on the cell cycle stages, the DNA 
damage checkpoint has been categorized into three groups as G1, S and G2 checkpoints 
(Niida & Nakanishi, 2006). However, it is still not clear whether there is a separation of the 
DNA damage checkpoints between the different phases of the cell cycle. Indeed, the same 
effector kinase - Rad53 - is activated independently of the cell cycle phase in yeast. But, to 
investigate the temporal specificity of the checkpoint, these responses have never been tested 
outside of S-phase, as the substrates of checkpoint kinases are not well understood. 
Recently it has been shown in yeast that, in S-phase, the checkpoint effector kinase Rad53 
phosphorylates two replication factors upon DNA damage to inhibit origin firing (Lopez-
Mosqueda et al., 2010; Zegerman & Diffley, 2010). These 2 factors are Sld3 and the DDK 
regulatory subunit Dbf4 (Lopez-Mosqueda et al., 2010; Zegerman & Diffley, 2010). In order to 
address whether DNA damage checkpoint responses are temporally separated, I decided to 
investigate if Rad53 targets origin firing outside of S-phase. To do so, I analysed the 
phosphorylation of Sld3 and Dbf4 upon DNA damage in G1 and G2 phase (Figure 3-1).  
 
 
50 
 
3.2.  Analysis of Rad53 target phosphorylation 
through the cell cycle 
To establish whether Sld3 is phosphorylated in G1 phase upon DNA damage, I compared the 
phosphorylation status of Sld3 with or without DNA damage in G1 phase. To arrest the cells in 
G1 phase, the mating pheromone a-factor was used. To be sure that cells cannot escape from 
G1 arrest in the presence of a-factor, I decided to use bar1D cells. Bar1 is a protease which 
cleaves a-factor and bar1D cells are hyper-sensitive to a-factor (Chan & Otte, 1982). Once 
cells were arrested with a-factor in G1 phase the culture was divided into two: one group of 
 
Figure 3-1 Does Rad53 phosphorylate Sld3 and Dbf4 in G1 and G2 phase? 
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cells was kept without treatment, and in the second group DNA damage was induced using 4-
NQO which mimics the effect of ultraviolet light. Flow cytometry analysis indicated that cells 
were effectively arrested in G1 phase during the experiment (Figure 3-2.A). Next, I wanted to 
analyse whether DNA damage was induced successfully by 10µg/ml 4-NQO. For the rest of 
the experiments same concentration of 4-NQO was used unless indicated. Activation of DNA 
damage signalling results in the phosphorylation of the checkpoint effector kinase Rad53, 
which can be monitored by the mobility shift in Western-blot analysis. As can be seen in Figure 
3-2.B, induction of DNA damage by 4-NQO resulted in the mobility shift of Rad53 in the treated 
cells, suggesting that DNA damage was induced.  
Next, I decided to analyse the phosphorylation status of Sld3. It has been shown that activation 
of the DNA damage checkpoint in S-phase causes Rad53-dependent phosphorylation of Sld3 
(Lopez-Mosqueda et al., 2010; Zegerman & Diffley, 2010). Although Rad53-dependent Sld3 
phosphorylation can be monitored through the standard western blot protocol, it does not allow 
for the assessment of all phosphorylation events (Figure 3-2.B.•). In order to increase the 
resolution of Sld3 western blots, I decided to optimise the SDS-Page protocol used in the lab 
for the separation of the proteins. I performed several optimization experiments with the Phos-
Tag reagent, which is a chemical that binds to the phosphate groups of proteins and slows 
down their relative speed compared to non-phosphorylated ones in the SDS-page gel 
(Kinoshita et al., 2009). The western blot analysis with the optimized protocol showed that Sld3 
was hyper-phosphorylated in G1 phase upon DNA damage whereas no mobility shift was 
observed in the non-treated group (Figure 3-2.B.♦), suggesting that Sld3 is phosphorylated in 
G1 upon DNA damage. 
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Given that Dbf4 is another checkpoint substrate and phosphorylated upon DNA damage in 
order to inhibit late origin firing in S-phase (Lopez-Mosqueda et al., 2010; Zegerman & Diffley, 
2010), I investigated whether it is also phosphorylated in G1 phase. To do this, the 
phosphorylation status of Dbf4 was analysed upon DNA damage in G1 phase as in Figure 
3-2. A slow-running subset of Dbf4 was observed in western blot analysis upon DNA damage 
whereas this subset was not observed in non-treated cells suggesting that Dbf4 is 
phosphorylated in G1 phase upon DNA damage (Figure 3-3). 
 
Figure 3-2 Analysis of Sld3 phosphorylation upon DNA damage in G1 phase. Cells were 
arrested in G1 phase with a-factor and divided in to two populations, without treatment (-) or 
with 4-NQO  A) Flow cytometry analysis of the cells. B) Western-blot analysis of Sld3 and 
Rad53. Sld3 proteins were resolved either with standard SDS-Page (•) or Phos-Tag-SDS-Page 
(♦) protocol. Sld3 was tagged with Myc-Tag and Anti-Myc antibody was used for Sld3 detection. 
Anti-Rad53 antibody was used for Rad53 detection. Ponceau S staining was used as a loading 
control.  
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Next, I wondered whether the phosphorylation of Sld3 upon DNA damage observed in G1 
phase is Rad53-dependent. To test this, I decided to analyse the phosphorylation of Sld3 upon 
DNA damage in the absence of Rad53. To do so, I compared the phosphorylation of Sld3 in 
sml1D bar1D and rad53D sml1D bar1D cells as in (Figure 3-2). The mobility shift of Sld3 was 
greatly reduced in rad53D sml1D bar1D cells after addition of 4-NQO compared to sml1D bar1D 
cells (Figure 3-4), suggesting that the phosphorylation of Sld3 is Rad53-dependent.  
 
Figure 3-3 Analysis of Dbf4 phosphorylation upon DNA damage in G1 phase. Cells were 
arrested in G1 phase with a-factor and divided into two, without treatment (-) or with 4-NQO   
A) Flow cytometry analysis of the cells. B) Western blot analysis of Dbf4 and Rad53. Dbf4 was 
tagged with Myc-Tag and Anti-Myc antibody was used for Dbf4 detection. Anti-Rad53 antibody 
was used for Rad53 detection. Ponceau S staining was used as a loading control. 
 
 
54 
 
Next, I wondered whether the phosphorylation of Sld3 and Dbf4 by Rad53 occurs at the 
previously described sites (Zegerman & Diffley, 2010). It has been shown that the sld3-A 
(S306A, T310A, S421A, S434A, T435A, S438A, T442A, T445A, S450A, T451A, S452A, 
S456A, S458A, S459A, S479A, S482A, T507A, S509A, S514A, S519A, S521A, S524A, 
S529R T540A, T541A, S546A, S547A, T548A, T550A, S556A, S558A, T559A, T565A, S569A, 
T582A, T607A, S653A and S654A) and dbf4-4A (S518A, S521A, S526A and S528A) alleles 
in which their Rad53-dependent phosphorylation sites were replaced with alanine can indeed 
no longer be inhibited by Rad53 and can overcome the inhibition of origin firing in S-phase 
(Zegerman & Diffley, 2010). I hypothesised that, if Sld3 and Dbf4 are phosphorylated in G1 
phase at the previously described sites, then the sld3-A and dbf4-4A alleles should not be 
phosphorylated in G1 phase upon DNA damage. To test this, I compared the phosphorylation 
of sld3-A and dbf4-4A with their wildtype counterparts as in Figure 3-4. Contrary to wildtype 
cells, neither sld3-A nor dbf4-A cells showed any mobility shift in the western blot analysis 
 
Figure 3-4 Analysis of Sld3 phosphorylation by Rad53 upon DNA damage in G1 phase. 
Cells were arrested in G1 phase with a-factor and DNA damage was induced by 4-NQO A) 
Flow cytometry analysis of the cells. B) Western blot analysis of the cells. Sld3 was 
endogenously tagged with the Myc tag. Anti-Myc antibody was used to detect Sld3. For Rad53 
detection, an anti-Rad53 antibody was used. Ponceau S staining was used as a loading 
control. Cells were isogenic for sml1D.  
 
 
55 
(Figure 3-5,Figure 3-6). From these experiments, I concluded that Rad53 phosphorylates 
Sld3 and Dbf4 at the previously described residues in G1 phase upon DNA damage. 
 
 
Figure 3-5 Phosphorylation status of previously described phosphorylation sites of 
Sld3 upon DNA damage in G1 phase. Cells were arrested in G1 phase with a-factor and 
DNA damage was induced by 4-NQO A) Flow cytometry analysis of the cells. B) Western blot 
analysis of the cells. Sld3 was endogenously tagged with myc tag. Anti-Myc antibody was used 
to detect Sld3. For Rad53 detection an anti-Rad53 antibody was used. Ponceau S staining 
was used as a loading control. 
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Since the Rad53-dependent phosphorylation of Sld3 and Dbf4 was observed in G1 phase, I 
wondered if the same response occurs in the G2 phase. To test this, the Rad53-dependent 
phosphorylation of Sld3 and Dbf4 was tested as in Figure 3-4, except cells were arrested in 
G2 phase with Nocodazole. The Western blot analysis of Sld3 in G2 phase showed 2 distinct 
bands before the addition of 4-NQO, possibly due to CDK phosphorylation in G2 phase. 
However, upon addition of 4-NQO, Sld3 became a high molecular weight smear (Figure 3-7) 
which was not present in the absence of Rad53. Dbf4 also showed 2 distinct bands in G2 
phase, possibly due to CDK phosphorylation (Holt et al., 2009; D. Lu et al., 2014; Ubersax et 
al., 2003) and the mobility shift of Dbf4 increased after addition of 4-NQ. The mobility shift of 
Dbf4 was Rad53-dependent after DNA damage (Figure 3-8). These results suggest that Sld3 
and Dbf4 are phosphorylated in a Rad53-dependent manner upon DNA damage in G2 phase. 
 
Figure 3-6 Phosphorylation status of previously described phosphorylation sites of 
Dbf4 upon DNA damage in G1 phase. Cells were arrested in G1 phase with a-factor and 
DNA damage was induced by 4-NQO A) Flow cytometry analysis of the cells. B) Western-blot 
analysis of the cells. Dbf4 was endogenously tagged with myc tag. Anti-Myc antibody was 
used to detect Dbf4. For Rad53 detection  an anti-Rad53 antibody was used. Ponceau S 
staining was used as a loading control. 
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Figure 3-7 Analysis of Sld3 phosphorylation by Rad53 upon DNA damage in G2 phase. 
Cells were arrested in G2 phase with Nocodazole and DNA damage was induced by 4-NQO 
A) Flow cytometry analysis of the cells. B) Western blot analysis of the cells. Sld3 was 
endogenously tagged with a myc tag. Anti-Myc antibody was used to detect Sld3. For Rad53 
detection an anti-Rad53 antibody was used. Ponceau S staining was used as a loading control. 
All strains are sml1D.  
 
Figure 3-8 Analysis of Dbf4 phosphorylation by Rad53 upon DNA damage in G2 phase. 
Cells were arrested in G2 phase with Nocodazole and DNA damage was induced by 4-NQO 
A) Flow cytometry analysis of the cells. B) Western blot analysis of the cells. Dbf4 was 
endogenously tagged with a myc tag. Anti-Myc antibody was used to detect Sld3. For Rad53 
detection an anti-Rad53 antibody was used. Ponceau S staining was used as a loading control. 
Cells were isogenic for sml1D. 
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In order to understand if the Rad53-dependent phosphorylation of Sld3 and Dbf4 occurs also 
in G2 phase at the previously described residues, the phosphorylation status of sld3-A dbf4-
4A cells was analysed as in Figure 3-5, except cells were arrested in G2 phase with 
Nocodazole. The hyperphosphorylation of Sld3 was greatly reduced in sld3-A cells upon DNA 
damage, compared to wildtype cells, suggesting that the phosphorylation of Sld3 occurs at the 
previously described residues (Figure 3-9). On the other hand, the phosphorylation profile of 
Dbf4 in wildtype and dbf4-4A cells showed only minor differences. As a result, it was not clear 
whether dbf4-4A was phosphorylated or not (Figure 3-10).  
 
 
  
 
Figure 3-9 Phosphorylation status of previously described phosphorylation sites of 
Sld3 upon DNA damage in G2 phase. Cells were arrested in G1 phase with a-factor and 
DNA damage was induced by 4-NQO A) Flow cytometry analysis of the cells. B) Western blot 
analysis of the cells. Sld3 was endogenously tagged with a myc tag. Anti-Myc antibody was 
used to detect Sld3. For Rad53 detection an anti-Rad53 antibody was used. Ponceau S 
staining was used as a loading control. 
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3.3. Discussion  
In this chapter, I investigated the activation of the S-phase checkpoint outside of S-phase. To 
do so, I analysed one of the well-characterized checkpoint responses; the inhibition of origin 
firing. It has previously been shown that the checkpoint effector kinase Rad53 phosphorylates 
Sld3 and Dbf4 to inhibit late origin firing upon DNA damage in S-phase in S. cerevisiae (Lopez-
Mosqueda et al., 2010; Zegerman & Diffley, 2010) 
I first investigated the phosphorylation of Sld3 and Dbf4 upon DNA damage by Western-blot 
analysis. Because the Sld3 profile in conventional western blot analysis had a low resolution, 
I optimised an SDS-PAGE protocol by using the Phos-Tag reagent which specifically binds to 
the phosphate group of proteins and slows their relative migration (Kinoshita et al., 2006). This 
new protocol greatly improved the resolution of Sld3 compared to the standard protocol used 
in the Zegerman Laboratory (Figure 3-2.B). After the optimisation of the Western blot protocol, 
I compared the phosphorylation of Sld3 and Dbf4 upon DNA damage. This showed that Sld3 
and Dbf4 are both phosphorylated upon DNA damage in G1 phase (Figure 3-2.B and Figure 
 
Figure 3-10 Phosphorylation status of previously described phosphorylation sites of 
Dbf4 upon DNA damage in G2 phase. Cells were arrested in G2 phase with Nocodazole and 
DNA damage was induced by 4-NQO. Western blot analysis of the cells. Dbf4 was 
endogenously tagged with a myc tag. Anti-Myc antibody was used to detect Dbf4. For Rad53 
detection an anti-Rad53 antibody was used. Ponceau S staining was used as a loading control. 
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3-3.B)in a Rad53-dependent manner. Next, I wondered if the phosphorylation of Sld3 and Dbf4 
occurred at previously mapped sites. To answer this question, I used the sld3-A and dbf4-4A 
alleles, in which their Rad53 phosphorylation sites in S-phase are substituted with alanine. 
This western blot analysis indicated that both Sld3 and Dbf4 were phosphorylated at previously 
described sites in G1 phase (Figure 3-5.B, Figure 3-6.B). Although I did not show directly that 
Dbf4 is not phosphorylated in Rad53 null cells, the lack of phosphorylation in dbf4-4A cells 
strongly suggests that Rad53 is the responsible kinase for the Dbf4 phosphorylation in G1 
phase upon DNA damage.  
Since I showed that both Sld3 and Dbf4 were phosphorylated in G1 in a similar way to in S-
phase upon DNA damage, I wondered if it also was similar in G2 phase. First, I showed that 
both Sld3 and Dbf4 are phosphorylated in a Rad53-dependent manner in G2 phase upon DNA 
damage (Figure 3-7, Figure 3-8). I also showed that the phosphorylation of Sld3 occurs at 
previously described residues (Figure 3-9.B). However, it was not possible to investigate the 
phosphorylation sites of Dbf4 upon DNA damage in G2 phase due to the low resolution of the 
analysis (Figure 3-10.B), which could be solved by using more sensitive techniques such as 
Phos-Tag SDS-PAGE. In summary, Rad53 targets Sld3 and Dbf4 in G1 and G2 phase upon 
DNA damage (Figure 3-11).  
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3.3.1. What is the function of inhibition of origin firing 
outside of S-phase? 
Although this chapter shows that Rad53 targets Sld3 and Dbf4 upon DNA damage outside of 
S-phase, it does not show whether there is a physiological significance to this phosphorylation. 
Three different hypotheses could explain this observation: 1) independent of their roles in 
replication initiation, Sld3 and Dbf4 might be required for other cellular event(s) outside of S-
phase which have to be inhibited by phosphorylation upon DNA damage, 2) the 
phosphorylation of Sld3 and Dbf4 might be not intended outside of S-phase, 3) the inhibition 
 
Figure 3-11 The model proposed in this chapter. 
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of origin firing by checkpoint could be a safeguard mechanism to prevent possible unscheduled 
origin firing outside of S-phase.  
Besides its function in replication initiation, DDK interacts with yeast Polo-like kinase Cdc5 via 
the N-terminal segment of Dbf4 (Chen & Weinreich, 2010). This interaction has been proposed 
to control the mitotic exit. However, whether this function of Dbf4 is targeted by checkpoint 
factors is not yet known. In contrast, the only known role of Sld3 is its requirement in replication 
initiation. It is possible to examine the other possible roles of Sld3 by its targeted degradation 
outside of S-phase by using the temperature degron system which would allow us to address 
the first two hypotheses. Given that deregulation of the cell cycle could possibly result in 
unscheduled replication initiation, targeting Sld3 and Dbf4 to prevent origin firing could be a 
safeguard mechanism to prevent further damage. This possibility is examined in Chapter 4 in 
detail. 
On the other hand, DNA damage in G1 phase delays the entry into S-phase by activation of 
Rad53 through the mediator protein Rad9 (Siede et al., 1994). It has been proposed that the 
activation of Rad53 results in deregulation of the transcription cofactor Swi6, which results in 
the repression of several proteins required for the G1/S transition including the G1 cyclins Cln1 
and Cln2 (Sidorova & Breeden, 1997). However, ectopic modulation of the G1/S transcription 
does not fully suppress the delay upon MMS treatment, suggesting that other targets of the 
checkpoint might delay the cell cycle. Given that Sld3 and Dbf4 are phosphorylated in G1 
phase, their phosphorylation upon DNA damage could be another mechanism to ensure that 
S-phase entry is delayed.  
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3.3.2. Is there an S-phase checkpoint? 
The initial observation about the checkpoint-dependent inhibition of origin firing came from 
cells obtained from Ataxia telangiectasia patients which were able to replicate their DNA after 
ionising radiation treatment, in contrast to cells obtained from healthy people (Painter & Young, 
1975, 1980). This led to the characterisation of one of the DNA damage checkpoint master 
kinases - Ataxia Telangiectasia Mutated (ATM) (Savitsky et al., 1995). Later works in yeast 
suggested that the DNA damage response requires different proteins in S- and G2 phase, 
which led to the use of the term ‘S-phase checkpoint’ (Weinert, 1992). Given that the Mec1-
Rad53 axis drastically slows down the S-phase rate upon DNA damage (Paulovich & Hartwell, 
1995) by inhibiting new replication initiations (Santocanale & Diffley, 1998; Shirahige et al., 
1998), inhibition of origin firing has been considered an S-phase checkpoint response 
(Longhese et al., 2003). By elucidating the function of other checkpoint proteins in perturbed 
S-phase, other responses of the S-phase checkpoint were described. For instance, it was 
found that replication forks cannot restart in the absence of checkpoint kinases after fork 
stalling (Tercero & Diffley, 2001), as checkpoint kinases stabilise the stalled replication forks 
to protect them from irreversible collapse (Lopes et al., 2001).  
Recently, it has been shown that the inhibition of origin firing in S-phase is achieved by the 
inhibitory phosphorylation of 2 replication factors, Sld3 and Dbf4 (Zegerman & Diffley, 2010). 
Through this finding, the molecular mechanism behind the inhibition of origin firing has been 
completed in yeast. Of course, it would be unexpected to question the inhibition of origin firing 
outside of S-phase where there is no replication. In addition, because the molecular 
mechanism behind the inhibition of origin firing is unknown, it was not possible examine this 
response through the cell cycle. 
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However, independent of its physiological significance, based on this chapter, there is no 
temporal regulation of the phosphorylation of Rad53 targets for the inhibition of origin firing 
through the cell cycle. Considering that the inhibition of origin firing is one of the major 
responses of the S-phase checkpoint (Karim Labib & De Piccoli, 2011), it is important to 
question the term ‘S-phase checkpoint’. Whether there is a distinct DNA damage checkpoint 
for S-phase has to be carefully examined in order to define the S-phase checkpoint as a 
temporally separated checkpoint. Gaining more insight into the molecular mechanisms of the 
other responses of the S-phase checkpoint would help to define its temporal specificity. It is 
known that the transcriptional control of RNR genes also occurs in G2 phase upon DNA 
damage (Mazumder et al., 2013). However, the molecular details of how stalled replication 
forks are stabilised remains unknown (Karim Labib & De Piccoli, 2011). It would be very 
interesting to explore the S-phase checkpoint targets for the stabilisation of replication fork and 
examine them outside of S-phase. This would produce a clearer picture of the responses of 
the DNA damage checkpoint through the cell cycle. However, it appears that the inhibition of 
origin firing is not a unique response of the S-phase checkpoint in yeast. Whether this is a 
conserved mechanism in higher eukaryotes is not clear. Given that the molecular mechanisms 
underlying the inhibition of origin firing in higher eukaryotes are not yet fully understood, it is 
not possible to address this question in other organisms at this point. 
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Chapter 4  
Investigating the role of checkpoint-
dependent inhibition of origin firing 
outside of S-phase 
4.1. Introduction 
 
DNA must be replicated once and only once in every cell cycle for the faithful transmission of 
the genetic information to the daughter cells. This is achieved through the temporal separation 
of origin licensing (loading of inactive helicase) and replication initiation during the cell cycle, 
which is accomplished by the coordinated actions of 2 enzymatic complexes: CDK and APC/C. 
In the absence of CDK activity, origins can be licensed in late mitosis and G1 phase. On the 
other hand, origins can only be fired in S-phase in the presence of CDK. Losing this control of 
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CDK results in re-replication (Nguyen et al., 2001), which leads to several genetic 
abnormalities (Davidson et al., 2006) such as gene amplification and gross chromosomal re-
arrangements (Green et al., 2010; Truong & Wu, 2011).  
CDK prevents the formation of the preRC in S and G2 phase by multiple mechanisms. In 
budding yeast, the inhibitory phosphorylation on Orc2 and Orc6 by CDK prevents the loading 
of inactive MCM helicase (Nguyen et al., 2001). It has also been shown that the binding of 
CDK on Orc6 prevents the function of ORCs (Wilmes et al., 2004). In addition, CDK promotes 
the nuclear exclusion of MCM•Cdt1 (Karim Labib et al., 1999; Nguyen et al., 2000). CDK also 
inhibits the function of Cdc6 via phosphorylation, promoting its degradation as well as direct 
binding (Drury et al., 1997; Mimura et al., 2004). On the other hand, replication initiation can 
only occur in S-phase through the activity of 2 kinases: CDK and DDK. CDK phosphorylates 
Sld2 and Sld3 which allows their binding to Dpb11, which is essential for the recruitment of the 
other replication factors to the inactive helicase (Zegerman & Diffley, 2007), whereas DDK 
phosphorylates other subunits of the helicase which are required for helicase activation 
(Francis et al., 2009; Lei et al., 1997; Yi Jun Sheu & Stillman, 2006).  
It is possible to bypass the control of CDK on preRC formation or replication initiation by 
deregulating those CDK targets simultaneously. This results in unscheduled origin firing re-
replication (Nguyen et al., 2001). However, bypassing the control of CDK only leads to limited 
re-replication in S. cerevisiae, giving rise to the hypothesis that multiple non-redundant 
mechanisms work together to prevent re-replication (Green et al., 2006). One possible 
mechanism in addition to CDK control could be the DNA damage checkpoint, since it is 
activated upon induction of re-replication (Davidson et al., 2006; Green & Li, 2005; Melixetian 
et al., 2004; Mihaylov et al., 2002). Given that in the previous chapter I showed that Rad53 
phosphorylates the replication initiation factor Sld3 and the regulatory subunit of DDK Dbf4 to 
prevent origin firing not only in S-phase, but also in G1 and G2 phase upon DNA damage, I 
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hypothesised that Rad53 targets Sld3 and Dbf4 outside of S-phase as a contingency 
mechanism to prevent unscheduled DNA replication in the case of CDK misregulation.  
More specifically, in this chapter, I seek to answer the following questions: 1) Does Rad53 
activation inhibit unscheduled origin firing through Sld3 and Dbf4 phosphorylation, 2) Does 
Rad53 limit the extent of re-replication by inhibiting origin firing via Sld3 and Dbf4 
phosphorylation outside of S-phase phase (Figure 4-1)? 
To obtain answers for the questions mentioned above, I used three different approaches to 
induce unscheduled replication initiation and analysed the contribution of thecheckpoint-
dependent inhibition of the origin firing by bypassing the control of Sld3 and Dbf4 by Rad53.  
In the first approach, replication initiation was achieved by bypassing the control of CDK on 
origin licensing via the deregulation of CDK targets. It has been shown before that the 
simultaneous introduction of the following modifications bypasses the control of CDK on preRC 
formation: alanine substitution of the CDK phosphorylation sites on Orc2 and Orc6, 
 
Figure 4-1 Is the Rad53-dependent inhibition of origin firing required for the prevention 
of unscheduled replication initiation and/or re-replication in G1 and G2 phase? 
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overexpression of N-terminally truncated Cdc6 resulting in partial stabilisiation, and constitutive 
localisation of MCM7 to the nucleus via a Nuclear Localisation Signal (NLS) (Nguyen et al., 
2001). For the purpose of clarity, these modifications shall be referred to as Origin Licensing 
Mutants (OMLs) and individual modifications shall be called mcm-NLS, orc2-A, orc6-A, and 
cdc6DNT.  
In the second approach to induce unscheduled origin firing, the CDK targets for replication 
initiation were bypassed. Sld2 and Sld3 are the only essential targets of CDK for replication 
initiation. CDK phosphorylates Sld2 and Sld3 which allows them to bind Dbp11 (Zegerman & 
Diffley, 2007). The regulation of CDK on replication initiation can be bypassed by 
phosphomimetic mutations of CDK targets on Sld2 (sld2-D), whereas the regulation on Sld3 
can be bypassed using an sld3-dpb11 fusion protein in which the N-terminal segment of Sld3 
is covalently fused with the C-terminal segment of Dpb11 (Zegerman & Diffley, 2007). It has 
been shown before that the simultaneous expression of these two factors results in replication 
initiation in the absence of CDK activity (Zegerman & Diffley, 2007). Given that the absence of 
CDK activity allows preRC formation, re-replication has also been observed.  
In the last approach, instead of modifying the CDK targets, I directly impaired the CDK activity 
by specifically inhibiting the catalytic subunit of CDK Cdc28. To do so, I took advantage of the 
Cdc28 allele cdc28-as1 (Bishop et al., 2000). The ATP-binding pocket cdc28-as1 is modified 
which allows the binding of the ATP analog 1-NM-PP1 that prevents its function (Bishop et al., 
2000). By using all these approaches, I addressed the contribution of checkpoint dependent 
inhibition of origin firing during unscheduled replication initiation.  
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4.2. Deregulated origin firing does not increase the 
extent of re-replication 
 
As mentioned in section 4.1, the contribution of the Rad53-dependent inhibition of origin firing 
was tested when the CDK targets (Orc2 Orc6 Mcm7 Cdc6) were deregulated. Re-replication 
causes deleterious genomic instability which exhibits decreased cell growth and increased cell 
death. Therefore, to address whether Rad53 is involved in preventing further re-replication as 
observed in OLMs through the inhibition of origin firing, I compared the growth of cells that are 
re-replicating in the presence or absence of Rad53 control on the inhibition of origin firing. 
Rad53 phosphorylates Sld3 and Dbf4 upon DNA damage to inhibit origin firing. In order to 
bypass the control of Rad53 on the inhibition of origin firing, I used the sld3-A and dbf4-4A 
alleles in which the Rad53 phosphorylation site is replaced with alanine (Zegerman & Diffley, 
2010).  
Since cells carrying origin licensing modifications simultaneously are not viable because of 
excessive genomic instability, it is necessary to develop a system which allows the assessment 
of the contribution of the inhibition of origin firing during re-replication. Although it had been 
proposed initially that all four modifications are simultaneously required for effective re-
replication in G2 phase (Nguyen et al., 2001), it has since been shown that only the mcm7-
NLS and the overexpression of cdc6DNT is enough to induce re-replication (Green et al., 
2006). Hence, the systematic analysis of modifications which lead to re-replication can provide 
a valuable insight into the importance of each modification.  
Taking advantage of the fact that all the modifications mentioned before (expression of Cdc6, 
mcm7-NLS, orc2-A, orc6-A, sld3-A, dbf-4A) are dominant, I analysed the growth of diploid cells 
that were heterozygous for each mutation with one exception. PGAL-CDC6 was used instead of 
PGAL-cdc6DNT to decrease the efficacy of preRC formation, in order to increase the probability 
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of cell growth. To bypass the control of Rad53 on the inhibition of origin firing, the sld3-A dbf4-
4A alleles were used as a second copy under a galactose-inducible promoter (PGAL). To obtain 
diploid cells by mating, equal numbers of MATa and MATa haploid cells carrying different 
mutations were mixed in liquid YPD media and incubated for 8 hours (Figure 4-2). Next, cells 
were plated on to different types of plates using a 48 Pin Multi-Blot replicator. Since both 
haploid and diploid cells grow on YPD, this media was used to control for starting cell culture 
densities. Plates lacking histidine and uracil were used to evaluate the efficiency of mating as 
only diploid cells would survive. Finally, Sc+galactose-URA-HIS plates were used to induce 
the genes under the Gal1-10 promoter (PGAL) to analyse the effect of genes under the inducible 
promoter.  
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From these crosses, it was possible to obtain most of the combinations containing PGAL-CDC6 
which were indicated in Figure 4-3. Growth on YPD plates indicated that a similar amount of 
cells were used for each mating (Figure 4-3). Growth on glucose plates indicated that similar 
amounts of diploid cells were obtained after each mating. However, no cell growth was 
observed on galactose plates. As a result, it was not possible to analyse the effect of the 
inhibition of the origin firing by Rad53 on cell viability when CDK targets for preRC formation 
were deregulated in this experimental set up.  
 
Figure 4-2 Diagram showing the experimental procedure for obtaining diploid cells 
carrying  different combinations of origin licensing mutations.  
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Given that all tested combinations of origin licensing mutants carried the PGAL-CDC6, 
introducing another gene under PGAL (in this case PGAL-sld3-A dbf4-4A) could potentially dilute 
the pool of transcription factors available for PGAL-CDC6. To overcome this possible dilution of 
CDC6 transcription, a very similar experiment was conducted, with the exception that 
endogenously mutated sld3-A dbf4-4A were used instead of a second copy of sld3-A dbf4-4A 
under PGAL. Diploid cells were obtained as mentioned above (Figure 4-2) and plated on YPD, 
and selective plates containing either glucose or galactose using a 48 Pin Multi-Blot replicator. 
However, in contrast to the previous experiment, all possible combinations of origin licensing 
mutants were obtained with or without endogenous sld3-A dbf4-4A in this experiment. Similar 
amounts of growth on YPD plates indicated that an equal amount of cells were mixed for 
individual mating. Selective plates containing glucose were used to analyse the origin licensing 
mutant combinations without Cdc6 (although cells carried PGAL-CDC6, they did not express it 
because of the lack of galactose in the media), whereas selective plates containing galactose 
 
Figure 4-3 The effect of overexpression of sld3-A dbf4-4A on the growth of different 
origin licensing mutants: Cells carrying different origin licensing mutants. Heterozygous 
diploid cells with the indicated genotypes were created through mating of haploid cells. YPD 
plates were used as a control for cell density. Sc plates do not contain uracil and histidine, in 
order to select for diploid cells. SD indicates sld3-A dbf4-4A.  
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were used to analyse the origin licensing mutant combinations with overexpression of Cdc6. 
The orc2-A orc6-A mcm7-NLS PGAL-Cdc6, orc6-A mcm7-NLS PGAL-Cdc6, and orc2-A mcm7-
NLS PGAL-Cdc6 cells with or without sld3-A dbf4-4A did not grow on selective plates containing 
galactose, suggesting that the level of genomic instability due to re-replication in those cells 
was lethal. On the other hand, no growth differences were observed between cells on selective 
plates containing galactose, suggesting that sld3-A dbf4-4A did not exacerbate the extent of 
re-replication in that cells. In addition, all tested combinations, which did not have Cdc6 
overexpression grew similarly compared to the same mutations combined with sld3-A dbf4-
4A. In conclusion, deregulating the control of Rad53 over the inhibition of the origin firing 
exhibited no growth phenotype on the different combinations of origin licensing mutants in 
diploid cells that were viable.  
 
 
Figure 4-4 The effect of endogenous sld3-A dbf4-4A on the growth of different origin 
licensing mutants: Cells carrying different origin licensing mutations. Heterozygous diploid 
cells with indicated genotypes were produced through mating of haploid cells. YPD plates 
were used as a control for cell density. Sc plates do not contain uracil and histidine in order 
to select diploid cells. SD indicates sld3-A dbf4-4A. 
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To verify the results obtained above, a similar experiment was conducted in haploid cells. The 
growth of all possible combinations of origin licensing mutants were compared with 
corresponding mutants which overexpress sld3-A dbf4-4A under PGAL. To do so, exponentially 
growing cells were plated on selective plates containing either galactose or glucose. As can 
be seen in Figure 4-5, all cells except mcm7-NLS orc2-A orc6-A PGAL-CDC6 and mcm7-NLS 
orc2-A orc6-A grew normally on selective plates containing glucose, meaning that similar 
densities of cells were used for the experiment. The mcm7-NLS orc2-A orc6-A, mcm7-NLS 
orc6-A, mcm7-NLS orc2-A, orc2-A orc6-A and mcm7-NLS cells did not grow when Cdc6 was 
overexpressed. On the other hand, orc6-A PGAL-CDC6, orc2-A PGAL-CDC6 and PGAL-CDC6 
grew on selective plates containing galactose, however the overexpression of sld3-A dbf4-4A 
did not cause any growth defect in these cells.  
For cells which did not overexpress CDC6 (Figure 4-5 lower panel) the overexpression of sld3-
A dbf4-4A resulted in some growth defects in the mcm7-NLS orc6-A orc2-A, mcm7-NLS orc6-
A, mcm7-NLS orc2-A, orc6-A orc2-A and orc6-A cells. However, this effect was not observed 
in mcm7-NLS and orc2-A cells. Overall, bypassing the Rad53-dependent inhibition of origin 
firing decreased the growth of some origin licensing mutant combinations in haploid cells, 
suggesting that inhibition of origin firing by Rad53 might decrease the extent of unscheduled 
replication initiation and rereplication.  
 
 
75 
In the previous experiment, bypassing Rad53 control of the inhibition of origin firing resulted in 
growth defects in some combinations of origin licensing mutants. However, sld3-A and dbf4-
 
Figure 4-5 The effect of overexpression of sld3-A dbf4-4A on the growth of different 
origin licensing mutants: Haploid cells carrying different origin licensing mutants. SD 
indicates sld3-A dbf4-4A. 
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4A were overexpressed in those cells. In order to rule out whether the growth defects that were 
observed were due to the overexpression of sld3-A and dbf4-4A, a similar experiment was 
performed to ask whether sld3-A dbf4-4A alleles as the only copy at their endogenous locus 
caused the same phenotype. Cells carrying origin licensing mutations indicated in Figure 4-6 
were plated both on glucose and galactose selective plates. The glucose plates do not 
overexpress CDC6, whereas galactose plates induce the overexpression of CDC6 as in 
Figure 4-4. 
As can be seen in Figure 4-6, the mcm7-NLS orc2-A orc6-A, mcm7-NLS orc6-A, mcm7-NLS 
orc2-A, mcm7-NLS and orc2-A orc6-A cells were dead when CDC6 was overexpressed. 
Interestingly, endogenous sld3-A dbf4-4A caused a slight growth defect in orc6-A PGAL-CDC6 
and PGAL-CDC6 cells when Cdc6 was overexpressed. However, these combinations were 
different than the previously observed combinations (Figure 4-5). On the other hand, 
endogenous sld3-A dbf4-4A did not cause a significant growth defect in the cells that were not 
overexpressing Cdc6. Overall, by passing the control of Rad53 on the inhibition of origin firing 
by endogenous sld3-A dbf4-4A alleles, the sickness of cells carrying different origin licensing 
mutants was exacerbated. This suggests that inhibition of origin firing by Rad53 might 
contribute to the extent of unscheduled replication initiation and rereplication.  
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Because only major differences can be observed using drop-test analysis and micro colonies 
could not be observed, the size of colonies originating from single cells was also measured in 
order to increase sensitivity. For this, I imaged growing colonies by using a camera attached 
to a microscope, and measured their size using image processing software ImageJ. Since the 
overexpression of CDC6 was synthetic lethal with some origin licensing mutants, the 
concentration of galactose was reduced in the media to decrease the expression from PGAL-
CDC6. Haploid cells with indicated mutations were plated on selective plates containing 0.5% 
galactose and 1.5% sucrose plates and colonies were examined after 39h. As seen in Figure 
4-7, overexpression of CDC6 affected the cell growth drastically even though the overall 
percentage of galactose was reduced in the growth media. However, deregulated origin firing 
via endogenous sld3-A dbf4-4A alleles did not exacerbate the sickness of re-replication 
 
 
Figure 4-6 The effect of endogenous sld3-A dbf4-4A on the growth of different origin 
licensing mutants: Haploid cells carrying different origin licensing mutants. SD indicates 
sld3-A dbf4-4A. 
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mutants overexpressing Cdc6. On the other hand, endogenous sld3-A dbf4-4A did affect the 
growth of mcm7-NLS orc2-A orc6-A, mcm7-NLS orc6-A, mcm7-NLS orc2-A, orc6-A and orc2-
A but not in orc2-A orc6-A and mcm7-NLS cells compared to controls (Figure 4-7) which was 
in line with Figure 4-5.  
 
 
Figure 4-7 The colony size analysis of origin licensing mutants. The effect of sld3-A 
dbf4-4A overexpression on the average colony size of the origin licensing mutants. 
Corresponding mutations are indicated above. Pictures were taken 39-hour post-plating. 
SC+1.5% Sucrose+0.5% galactose plates were used.   
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To verify previous results, and produce time course growth kinetics, quantitative fitness 
analysis (QFA) was performed in collaboration with Prof. Dr. David Lydall and Dr. Peter Banks 
at Newcastle University. QFA is as workflow that compares the fitness of microbial cultures in 
parallel (Banks et al., 2012). The growth fitness of the origin licensing mutants indicated in 
Figure 4-8 were compared with the same mutations plus sld3-A dbf4-4A. In addition, wildtype 
and sld3-A dbf4-4A cells were used as controls. To do so, each strain was spotted in at least 
4 biological replicates, grown for several days and photographed every 4 hours. Next, each 
image was processed and the growth curve for each strain was calculated. From each growth 
curve, 2 parameters were obtained. The first was the maximum doubling rate, and the second 
was the maximum doubling potential. The fitness of each strain was calculated by multiplying 
these 2 parameters together. Finally, the fitness of individual origin licensing mutants was 
compared to their sld3-A dbf4-4A counterparts. The fitness of control strains was assayed and 
mutants were plotted against a relative control. As shown in Figure 4-8, although different 
combinations of origin licensing mutants exhibited differential fitness levels, endogenous sld3-
A dbf4-4A did not decrease the fitness of origin licensing mutants. Very similar experiments 
were also performed on plates containing different genotoxic drugs in order to activate the 
DNA damage checkpoint, however the fitness of origin licensing mutants carrying the sld3-A 
dbf4-4A allele were similar to their SLD3+ DBF4+ counterparts, suggesting that Rad53 control 
on the inhibition of origin firing does not contribute to the fitness of these mutants. 
 
 
 
 
 
 
80 
Next, I wanted to test whether the checkpoint-dependent inhibition of origin firing prevents the 
extent of unscheduled replication initiation in G1 phase. To test this, a system which can 
bypass the requirement of CDK for replication initiation was necessary. DNA replication can 
be initiated in the absence of CDK activity in G1 phase by bypassing the CDK targets for origin 
firing and overexpressing DDK subunit Dbf4. Replication initiation requires the CDK-dependent 
phosphorylation of 2 essential replication factors Sld2 and Sld3 in S-phase, which allow them 
to bind the BRCT domains of Dpb11. It has previously been shown that the simultaneous 
expression of Dbf4, a phosphomimetic mutant of CDK sites on Sld2 sld2-D, and the sld3-dbp11 
 
Figure 4-8 The effect of sld3-A dbf4-4A on the fitness of origin licensing mutants. 
Scatter plot showing the fitness of origin licensing mutants and corresponding mutations plus 
endogenous sld3-A dbf4-4A. Each dot represents a different origin licensing mutant indicated 
in the plot.  
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fusion which consists of the N-terminal part of Sld3 and C-terminal part of Dbp11 can bypass 
the requirement of CDK, resulting in replication initiation in the absence of CDK activity in G1 
phase (Zegerman & Diffley, 2007). However, contrary to the sld3-dpb11 phusion protein, the 
sld3-D-dpb11 fusion protein in which the Rad53 phosphorylation sites on the sld3 fragment 
are replaced with aspartate is not viable in sld3D dbp11D, indicating that Rad53 could possibly 
prevent origin firing by phosphorylating the sld3-dpb11 fusion protein upon DNA damage. One 
way to bypass the control of Rad53 on sld3-dbp11 fusion protein would be by replacing Rad53 
phosphorylation sites of sld3 fragment with Alanine. Instead, I decided to overexpress Sld3, 
attempting to force it to interact with Dpb11 in G1 phase. In addition, in order to support re-
licensing after forced origin firing, the N-terminally truncated CDC6 allele cdc6DNT - which is 
partially stabilised - was used.  
To test if any of the manipulations above would result in unscheduled origin firing and if the 
deregulated Rad53 targets dbf-A and sld3-A would increase the extent of unscheduled origin 
firing, the strains indicated in Figure 4-9 were made and growth analysis was performed. Given 
that some genes were expressed under PGAL, exponentially growing cells were plated on either 
YPD as a control or YPGal to induce genes under PGAL. As indicated in Figure 4-9, 
overexpressing sld3-A and dbf-4A significantly decreased growth of the cells. However, 
overexpressing Sld3 and Dbf4 exhibited no growth differences compare to wild type cells. 
Contrarily, overexpression of sld2-D with Sld3 and Dbf4 reduced the growth of the cells, 
whereas overexpression of sld2-D alone or together with sld3-A and dbf-4A had no effect on 
the cell growth. On the other hand, cdc6Dnt decreased the growth of sld2-D sld3-A dbf4-4A 
overexpressing cells, while it did not affect the growth of the cells overexpressing sld2-D alone 
or together with Sld3 and Dbf4 (Figure 4-9). Overall, although overexpression of sld3-A and 
dbf4-4A showed marginal growth defects, these were not execrated by the combinations with 
other mutants, suggesting that the growth defects were not due to genomic instability caused 
by unscheduled origin firing.  
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Because the growth analyses so far are only a readout for the indirect growth effects of 
unscheduled replication initiation, I decided to perform an assay which gives a direct readout 
for unscheduled replication initiation. There are different approaches to assess if DNA 
replication is initiated, such as 2D gel electrophoresis, whole genome sequencing or flow 
cytometry analysis. Although flow cytometry analysis is less sensitive than other techniques 
mentioned, it is more feasible to screen multiple candidates. For these reasons, I analysed the 
increase in bulk DNA amount in G1 or G2 phase when DNA replication was forced to initiate. 
To do so, first the increase in the bulk DNA amount in G2 phase was tested using cells carrying 
different origin licensing mutations. Because glucose is a favoured carbon source in yeast, the 
addition of galactose to cells growing in glucose-containing media did not activate the 
transcription from Gal promoter. To efficiently induce the Gal promoter, cells must grow in a 
media containing a less favourable carbon source than galactose, such as raffinose. For this 
purpose, cells were grown in YP+Raffinose (YPRaff). Exponentially growing cells were 
 
Figure 4-9 Forcing the replication initiation in G1 phase. YPD plates were used as a 
control. The sld2-D, DBF4+, SLD3+, sld3-A and dbf4-4A were overexpressed under PGAL.  
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arrested in YPRaff at 30°C in G2 phase with nocodazole for 90 minutes and 2% galactose 
added to induce the expression of genes under the Gal promoter. Samples were collected 
every hour following the addition of galactose. Flow cytometry analysis indicated that orc6-A 
mcm7-NLS PGAL-Cdc6 cells could re-replicate after addition of galactose in G2 phase. 
However, overexpression of sld3-A dbf4-4A did not increase the extent of re-replication 
(Figure 4-10). In fact, orc6-A mcm7-NLS PGAL-Cdc6 PGAL-sld3-A-dbf4-4A showed less 
replication than orc6-A mcm7-NLS PGAL-Cdc6, possibly due to the dilution of transcription 
factors for each PGAL. In addition, the rest of the tested cells stayed did not show any increase 
in bulk DNA amount after the addition of galactose, suggesting that bulk DNA replication did 
not begin in these cells in G2 phase. Overall, this experiment suggested that either flow 
cytometry was not sensitive enough to monitor re-replication or no additional re-replication is 
started in G2 phase by overexpression of sld3-A dbf4-A.  
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Figure 4-10 Flow cytometry analysis cells carrying different origin licensing mutations 
in G2 phase. A) schematic representation of the experimental steps. B) flow cytometry 
profiles of the cells. SD indicates sld3-A dbf4-4A. CDC6 and sld3-A dbf4-4A were 
overexpressed under PGAL  in the cases indicated.   
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Next, to test if the Rad53-dependent inhibition of origin firing decreased the extent of replication 
initiation, the bulk DNA amount of the cells that can potentially fire replication origins in G1 
phase were analysed by flow cytometry. In order to prevent the release from G1 arrest during 
the experiment, all cells used in this experiment were lacking the Bar1 protease which 
degrades a-factor. Since CDK phosphorylates Orc6 in S but not in G1 phase, the 
phosphorylation of Orc6 was used as an indicator of G1 arrest. Western blot analysis of Orc6 
indicated that Orc6 was not phosphorylated, meaning that cells were arrested and stayed in 
G1 phase during the experiment (Figure 4-11.C). Flow cytometry analysis showed that wild-
type, SLD3+DBF4+, sld3-A dbf4-4A, and sld2-D cdc6-DNT cells did not show significant DNA 
replication after the addition of galactose (Figure 4-11.B). However, overexpression of either 
Sld3 and Dbf4 or sld3-A dbf4-4A in a sld2-D cdc6DNT background was sufficient to initiate 
DNA replication in G1 phase. Although the bulk DNA mount for those cell was similar at the 
last time point, their progression patterns were different. The replication of sld3-A dbf4-4A sld2-
D cdc6DNT cells progressed slower, whereas SLD3+DBF4+ sld2-D cdc6DNT progressed faster 
at the beginning but then almost stopped.  
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Figure 4-11 The replication initiation analysis in G1 phase. All cells were isogenic for 
bar1D.  A) schematic representation of the experimental steps. B) Flow cytometry analysis of 
the cells. C) Western blot analysis of Orc6. Anti-Orc6 antibody was used for probing.  
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4.3. Deregulated origin firing decreases the viability 
of cells when CDK activity is impaired  
 
Although the activity of CDK is well-regulated throughout the cell cycle, it is possible that it may 
fluctuate during S or G2 phases or during transitions between phases. This might occur due 
to the inefficient degradation of CDK inhibitors (CKIs) during G1-S transition, or misregulation 
of Cyclins in S- or G2 phase as observed in many cancers (Deshpande et al., 2005). The lack 
of the yeast CKI Sic1 results in significant genomic instability due to unscheduled origin firing, 
such as double strand breaks and gross chromosomal rearrangements (Lengronne & Schwob, 
2002), however sic1D cells are viable, suggesting that the DNA damage checkpoint 
compensates the severity of the damage. As a result, it is interesting to assess the contribution 
of the DNA damage checkpoint in the case of CDK misregulation. So far, I have described an 
analysis of re-replication after deregulation of individual DCDK targets. Following this, I 
wondered whether checkpoint-dependent inhibition of origin firing is important when CDK 
activity is impaired. To impair CDK activity, I used the CDC28 allele cdc28-as1, whose activity 
can be ectopically diminished by an ATP analogue 1-NMPP1 which can only bind to the 
modified Cdc28 ATP-binding cassette (Bishop et al., 2000). It has previously been shown that 
impaired CDK activity via cdc28-as1 sensitises yeast cells to DNA damaging agents (Enserink 
et al., 2009).  
In order to establish if the Rad53-dependent inhibition of origin is important when CDK activity 
was impaired, I analysed the effect of impaired CDK activity when inhibition of origin firing was 
deregulated by sld3-A dbf4-4A alleles cells. To do so, exponentially growing cells were plated 
on YPD plates containing different concentrations of 1-NM-PP1. As can be seen in Figure 
4-12 the growth of cdc28-as1 cells slowed down on 10 nM 1-NM-PP1 containing YPD and did 
not grow on 50 nM 1-NM-PP1 plates, whereas sld3-A dbf4-4A cells grew similarly on all tested 
conditions. Interestingly, although sld3-A dbf4-4A cdc28-as1 grew similarly to cdc28-as1 cells 
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up to 10 nM 1-NM-PP1, their growth was affected more than cdc28-as1 cells on plates 
containing 20 to 50 nM 1-NM-PP1. In conclusion, impaired CDK activity negatively affected 
the growth of sld3-A dbf4-4A cells more than SLD3+ DBF4+ cells, suggesting that Rad53-
dependent inhibition of origin firing is important when CDK is misregulated. 
Next, I wondered if the activation of the checkpoint by small amounts of DNA damage would 
increase the growth defect of sld3-A dbf4-4A cells when CDK activity is impaired. To test this, 
exponentially growing cells were plated on plates containing low concentrations of different 
types of DNA-damaging drugs including 30 or 40 nM 1-NM-PP1. Although sld3-A dbf4-4A 
cdc28-as1 cells grew slower than cdc28-as1 when CDK activity was decreased by 30 or 40 
nM 1-NM-PP1, this effect was not exacerbated by inducing DNA damage through low 
concentrations of DNA damaging agents (Figure 4-13).  
 
Figure 4-12 The effect of de-regulated origin firing during impaired CDK activity. Cells 
were plated on YPD plates containing indicated concentrations of 1-NM-PP1. SD indicates 
sld3-A dbf4-4A. 
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Given that sld3-A dbf4-4A cells exhibited a decreased growth phenotype when CDK activity 
was deregulated, one possible explanation is that losing the control on the inhibition of origin 
firing resulted in more unscheduled origin firing which generated more genomic instability. To 
test this, I decided to analyse the increase in bulk DNA amount when CDK activity was 
impaired by flow cytometry analysis. It is important to note that replication initiation in G2 phase 
would first require preRC formation, then origin firing. To find a window for CDK activity that 
can no longer prevent preRC formation but can still fire origins, cells were tested in different 
concentrations of 1-NM-PP1. As can be seen in Figure 4-14, the inhibition of CDK activity via 
 
Figure 4-13 The effect of de-regulated origin firing during impaired CDK activity. Cells 
were plated on YPD plates containing indicated concentrations of DNA damaging drugs and 
1-NM-PP1. SD indicates sld3-A dbf4-4A. 
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different concentrations of 1-NM-PP1 did not result in any replication in G2 phase, as cdc28-
as1 cells did not show a different pattern than sld3-A dbf4-4A cells in flow cytometry analysis. 
In addition, cdc28-as1 sld3-A dbf4-4A cells were also similar to both sld3-A dbf4-4A and cdc28-
as1 sld3-A dbf4-4A, suggesting that either replication initiation does not occur via this approach 
or that the level of replication initiation is under the detection limit of flow cytometry analysis.  
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Figure 4-14 The effect of de-regulated origin firing on replication during impaired CDK 
activity in G2 phase.  A) schematic representation of the experimental steps. B) flow 
cytometry profiles of the cells.  
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4.4. Discussion 
 
The regulation of the cell cycle is tightly controlled by multiple mechanisms and misregulation 
of these controls could result in unscheduled replication initiation as well as rereplication. 
Different experimental systems are developed for addressing the possible source and 
implication of unscheduled origin firing and re-replication from yeast to human. However, the 
extent of unscheduled replication initiation and re-replication are always limited in these 
experimental systems (Green et al., 2006; Melixetian et al., 2004; Nguyen et al., 2000). Given 
that the activation of the DNA damage checkpoint upon re-replication is observed in different 
organisims (Davidson et al., 2006; Green et al., 2006; Green & Li, 2005; McGarry, 2002; 
Melixetian et al., 2004), the DNA replication stress checkpoint might prevent the occurrence of 
excessive unscheduled replication initiation and rereplication. However, the DNA replication 
stress checkpoint has multiple responses such as inhibition of origin firing, replication fork 
stabilization, mitotic delay and transcriptional control, and which of these responses is involved 
during re-replication is not well understood. Considering that the checkpoint-dependent 
inhibition of origin firing occurs not only in S-phase but also in G1 and G2, the limited re-
replication that was observed before may be due to the inhibition of origin firing by the DNA 
damage checkpoint. To understand this, I investigated the involvement of checkpoint-
dependent inhibition of origin firing during unscheduled replication initiation.  
First, I systematically investigated the contribution of each origin licensing mutants which 
bypass the CDK control on re-replication on the unscheduled S-phase entry. I started with 
growth analysis of the different origin licensing mutants with both haploid and diploid cells. The 
drop test analysis indicated that mcm7-NLS orc2-A orc6-A, mcm-NLS orc6-A, mcm7-NLS 
orc2-A, orc6-A orc2-A and mcm7-NLS cells are not viable when CDC6+ is overexpressed 
(Figure 4-5 and Figure 4-6), possibly due to excessive genomic instability. The rest of the 
combinations were viable, and deregulation of the inhibition of origin firing by sld3-A dbf4-4A 
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alleles affected the growth of some viable origin licensing mutants. In order to be more precise 
and receive a quantitative output, the size of colonies carrying different origin licensing 
mutations was measured. Interestingly, the colony size analysis showed that deregulating the 
checkpoint control on inhibition of origin firing by overexpressing sld3-A dbf4-4A exacerbated 
the growth defect of mcm7-NLS orc2-A orc6-A, mcm7-NLS orc6-A, mcm7-NLS orc2-A, orc2-
A and orc6-A cells (Figure 4-7), although it was not possible to validate this result with 
quantitative fitness assays.  
Considering all these growth assays, inconsistencies between the experiments is a major 
issue. One explanation could be that accumulation of the several secondary mutations leads 
to increased or decreased growth phenotypes. Given that mcm7-NLS orc2-A orc6-A cells grew 
slower than the single or double mutants, some degree of mutations might have been 
introduced while preparing the cells or before the experiments as cells were originated from a 
diploid cell that was heterozygous for all the mentioned mutations. This could be ruled out by 
cloning all these mutants under an inducible promoter and only activating prior to the 
experiment. 
On the other hand, whether checkpoint-dependent inhibition of origin firing is required for the 
prevention of excessive re-replication was not clear from the growth analysis. One possible 
explanation would be that the experimental setup was not suitable to address the contribution 
of the checkpoint. Because cells were either completely dead in some combinations or showed 
no significant growth defect, this could mean that either some combinations produced 
excessive levels of re-replication and/or other detrimental consequences or other combinations 
produced no re-replication. This could be ruled out by using other systems such as different 
Orc6 mutants. CDK both phosphorylates and binds Orc6 to prevent MCM loading. It has been 
shown before that instead of mutating phosphorylation site to Orc6, removing the CDK binding 
sites (RXL) on Orc6 (orc6-RXL) partially deregulates Orc6 but not as significantly as the orc6-
A mutant (Archambault & Ikui, 2005). Using orc6-RXL instead of orc6-A might give a milder 
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initiation of unscheduled replication that would be suitable for assessing the contribution of 
checkpoint dependent inhibition of origin firing. 
The growth analysis also indicated that phosphorylation of Orc2 or Orc6 alone is not sufficient 
to disrupt the function of ORC completely. Cells carrying either orc2-A or orc6-A were not viable 
when MCM7 was constitutively localised in the nucleus and Cdc6 was overexpressed (Figure 
4-4, Figure 4-5 and Figure 4-6). This observation is further validated by measuring the bulk 
DNA amount by flow cytometry analysis (Figure 4-10) in which bulk DNA was increased in 
orc6-A mcm7-NLS cells after Cdc6 overexpression. However, this experiment did not show 
whether this increase was due to reinitiation or rereplication. Given that FACS analysis only 
shows bulk DNA replication, analysing the re-firing of origins requires different assays such as 
2D gel electrophoresis or high-throughput sequencing for copy number variations. However, 
since deregulation of Rad53 targets did not increase the bulk DNA amount in the tested cells, 
those assays were not used.  
In addition, it has been previously proposed that full-length Cdc6 does not efficiently increase 
the bulk DNA amount of mcm7-NLS orc2-A orc6-A cells (Nguyen et al., 2001) in which the 
more stable Cdc6 cdc6DNT is used. However, this work showed that even in mcm7-NLS orc6-
A cells the bulk DNA amount increased significantly when full length Cdc6 was overexpressed 
in flow cytometry analysis (Figure 4-10). It is important to note that different S. cerevisiae 
strains were used in the current study. It would be very interesting to compare genetic 
differences between these strains, which might enlighten another non-redundant mechanism 
that prevents re-replication.  
Although CDK targets at least 4 different factors in yeast (Orc2 Orc6 Mcm7 and Cdc6) to 
prevent preRC formation, and deregulating Mcm7 Orc6 Cdc6 was enough to initiate re-
replication (this study), re-replication only requires the deregulation of the Cdt1 inhibitor 
geminin in X. laevis and humans (Melixetian et al., 2004; Mihaylov et al., 2002). It is still 
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unknown why less stringent control of preRC formation evolved in higher eukaryotes. However, 
one possible explanation could be allowing more efficient endoreplication during development. 
As explained before, one way to induce unscheduled replication initiation is to bypass the 
control of CDK on preRC formation. However, bypassing the CDK control on origin firing would 
also allow unscheduled replication initiation in G1 phase. To address whether the inhibition of 
origin firing by the checkpoint has any role in the case of unscheduled replication initiation in 
G1 phase, I established a system that can initiate replication in G1 phase in the absence of 
CDK activity. I showed that the overexpression of sld2-D SLD3+ and DBF4+ in a cdc6DNT 
background is enough to initiate detectable levels of replication by flow cytometry in G1 phase 
(Figure 4-11). However, the progression of DNA replication significantly slowed down 2h after 
the of overexpression of sld2-D SLD3+ DBF4+. This could be due to another checkpoint-
dependent response or some factors becoming limited after 2h of induction, or the absence of 
G1/S transcription factors. On the other hand, the sld2-D sld3-A dbf4-4A cdc6DNT cells 
progressed slower at the beginning, however showed a similar amount of bulk DNA after 6h.  
It is important to note that flow cytometry analysis only measures the bulk DNA amount. One 
can imagine that multiple rounds of preRC formation and firing at the same origin resulted in 
re-replication in sld2-D sld3-A dbf4-4A cdc6DNT cells which then lead to replication fork 
collapse and slowed progression of replication. On the contrary, DNA replication was initiated 
once in sld2-D SLD3+ and DBF4+ cdc6DNT cells, but then the checkpoint inhibited further 
initiation which allowed the fast progression of ongoing forks. However, this hypothesis has to 
be tested with more informative assays such as 2D gel electrophoresis. Given that cells 
showed different progression patterns but the same bulk DNA amount at the end of 
experiment, it is very hard to conclude whether checkpoint-dependent inhibition of origin firing 
is required for the prevention of re-replication or not.  
 
 
96 
Other explanations could be proposed for why bypassing the checkpoint-dependent inhibition 
of origin firing did not show more bulk DNA amount at the end of the experiment. It is possible 
that this system did not produce enough initiation events. It would be worth investing time in 
optimising this system in order to generate more replication initiation. Given that cells carrying 
DPB11 on a high-copy plasmid show significant replication initiation upon overexpression of 
sld2-D in G1 phase (Tanaka et al., 2007), the overexpression of Dpb11 could be used instead 
of Sld3 overexpression, or the extra copy of Dpb11 could be added to the current system to 
increase the efficiency of replication initiation.  
Because CDK inhibits preRC formation and initiates DNA replication in S-phase, it is possible 
to deregulate origin firing by impairing the CDK activity. There are different approaches to 
impairing CDK activity. It has been shown before that transient inhibition of CDK via its inhibitor 
SIC1 results in a complete round of re-replication by reseting the cell cycle in G2 phase 
(Dahmann et al., 1995), before the completion of the previous cell cycle. To avoid total cell 
cycle reset, I decided to decrease but not totally inhibit the CDK activity. I took advantage of 
the cdc28-as1 allele, which can be inhibited using the ATP analog 1-NM-PP1 in a 
concentration-dependent manner (Bishop et al., 2000).  
It has previously been observed that cdc28-as1 is a hypomorphic allele that increases the 
viability of rad53D and mec1D cells (Manfrini et al., 2012). Interestingly, deregulating the single 
function of checkpoint –inhibition of origin firing- by sld3-A dbf4-4A alleles had a drastic effect 
on cell growth when CDK was impaired (Figure 4-12). However, it is important to note that 
different concentrations of 1-NM-PP1 were used in these experiments. It is possible that a 
slight reduction in CDK activity only delays the cell cycle, whereas decreasing further leads to 
preRC formation and unscheduled origin firing. However, sld3-A dbf4-4A cells did not show 
more bulk DNA replication in G2 phase compared to SLD3 DBF4 cells in flow cytometry 
analysis when CDK activity was decreased. It is also important to note that even the lowest 
concentration of 1-NM-PP1 (100 nM) that was used for fl
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than the growth analysis concentration (40 nM). It is possible that at 100 nM, CDK was no 
longer able to fire origins. On the other hand, given that flow cytometry analysis could only 
measure drastic changes in bulk DNA amount, there could still be some replication initiation 
below the detection threshold. Whether impairing CDK activity leads to unscheduled origin 
firing or not should be tested with more sensitive techniques such as high-throughput 
sequencing for copy number variations.  
It is known that the deletion of the yeast CDK inhibitor Sic1 causes genomic instability due to 
unscheduled origin firing in late G1 (Lengronne & Schwob, 2002). Although sic1D cells exhibit 
a slower cell cycle rate, deletion of DNA damage checkpoint master kinase Mec1 in sic1D cells 
results in an even slower cell cycle rate suggesting that the extent of DNA damage caused by 
Sic1 knockout somehow decreased the DNA damage checkpoint in sic1D cells (Lengronne & 
Schwob, 2002). Given that sic1D cells fire fewer origins in S-phase then wild type cells, it is 
possible that further replication initiations are prevented by the checkpoint-dependent 
phosphorylation of Sld3 and Dbf4. It would be very interesting to test whether sic1D cells exhibit 
more origin firing in addition to more DNA damage when the checkpoint-dependent inhibition 
of origin firing is deregulated by sld3-A dbf4-A alleles. This would give an idea of the 
importance of the checkpoint-dependent inhibition of origin firing in the case of unscheduled 
replication initiation during the G1/S transition.  
Different types of mutations could result in deregulation of replication initiation in mammals. 
Deregulated replication initiation could have 3 different outcomes, including origin under-
usage, origin over-usage or origin re-usage. These outcomes would result in genomic 
instability which could possibly drive the formation of dysplasia or progression from dysplasia 
to carcinoma. Several lines of evidence suggest that replication initiation is deregulated in 
different cancers (Hills & Diffley, 2014). In most cancers, numerous oncogenes are found to 
be mutated, which could be linked to deregulated replication initiation (Hanahan & Weinberg, 
2011). For example, Cyclin D1, a G1 cyclin in humans, is heavily deregulated in different types 
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of cancers which is possibility associated with defective replication initiation (Cheung et al., 
2001; Dickson et al., 1995; Vielba et al., 2003). Although the overexpression of Cyclin D1 is 
observed in the earliest stages of cancers but not in premalignant lesions, it is not clear whether 
Cyclin D1 is required for malignant transformation or required for the progression of cancers. 
However, because overexpression of Cyclin D1 results in re-replication and also increases 
gene amplification in cancer cells (Aggarwal et al., 2007; Sherr, 1996), it is possible to 
hypothesise that overexpression of Cyclin D1 increases the heterogeneity of cancer by gene 
amplification which might increase their survival capacity. However, whether the checkpoint-
dependent inhibition of origin firing decreases the number of initiation events when replication 
initiation is deregulated is not clear.  
In summary, I investigated the function of the inhibition of origin firing in G1 and G2 phase by 
allowing unscheduled replication initiation. I tested several approaches to initiate DNA 
replication outside of S-phase and obtained valuable information about vital cellular process 
such as origin licensing. Given that bypassing the checkpoint regulation produced a significant 
growth phenotype when CDK activity was impaired, checkpoint substrates for the inhibition of 
origin firing in human could be a good candidate for the treatment of different disease such as 
cancer. Because replication initiation is deregulated in different cancers, bypassing the 
checkpoint control on the inhibition of replication initiation by small molecules might increase 
genomic instability that would lead to cell death.  
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Chapter 5  
Cdc45 is required for the S-phase 
checkpoint  
5.1. Introduction 
Endogenous or exogenous stress may halt DNA replication, activating the S-phase checkpoint. 
The S-phase checkpoint starts with the recognition of DNA lesions by sensor proteins which 
trigger the activation of 2 phosphatidylinositol 3’ kinase-like kinases (PIKK) ATM and ATR in 
humans (Mec1 and Tel1 homolog of yeast) (Hustedt et al., 2013). Activation of these master 
kinases transduces the signal to the effector kinases Chk1 and Chk2 (functional homolog of 
Rad53 and Chk1 in yeast) which leads to the execution of different responses such as 
transcriptional control, the inhibition of late origin firing, and replication fork stabilization and 
mitotic delay.  
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Several lines of evidence indicate that misregulation of DNA damage checkpoints results in 
genomic instability which has been implicated in several diseases such as cancer (Barlow et 
al., 1996; Bartkova et al., 2005; Gorgoulis et al., 2005). The importance of the DNA damage 
checkpoint makes it one of the central target for the treatment of numerous diseases such as 
cancer (Chen et al., 2012). However, its essential roles during development as well as cellular 
homeostasis prevent its direct deregulation, which makes it necessary to deregulate its 
individual responses (de Klein et al., 2000; Lee et al., 2000). Therefore, understanding the 
checkpoint pathways is of great importance if specific responses are to be targeted instead of 
complete deregulation. However, very few checkpoint substrates have been identified so far, 
such as Sld3 and Dbf4 in yeast (Zegerman & Diffley, 2010). Although some high-throughput 
screens from yeast to humans have suggested several candidates, most of them have never 
been validated, possibly due to the high false positive rate of the applied approaches (Blasius 
et al., 2011; Chen et al., 2010; Smolka et al., 2007). In addition to that, some already known 
checkpoint substrates have never been observed in those studies. Together, different 
approaches are required to delineate the substrates of checkpoint.  
The evolutionary conservation of the S-phase checkpoint from yeast to human, as well as its 
advanced properties described in chapter 1.2, makes budding yeast an excellent organism for 
identifying novel checkpoint substrates and their functions. Rad53, the yeast functional 
homolog of human Chk1, is the main effector kinase in the S-phase checkpoint which is 
responsible for the responses explained above. However, current knowledge about its 
substrates is limited. Because, Rad53 is one of the least specific yeast kinases in vitro (Mok 
et al., 2010), it is hard to decipher its substrates by high-throughput screens. Thus, the 
discovery of new Rad53 substrates requires targeted approaches. One way to explore novel 
substrates would be by understanding the mechanisms of substrate-kinase interaction.  
The aim of this chapter was to understand how Rad53 targets its substrates in vivo, which 
might help to identify novel substrates. To do so, I investigated how Rad53 targets its 
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substrates for the inhibition of origin firing. Rad53 targets Sld3 and Dbf4 upon DNA damage to 
prevent origin firing (Lopez-Mosqueda et al., 2010; Zegerman & Diffley, 2010). It has been 
shown that Rad53 binds to the N-terminal portion of Dbf4 directly and phosphorylates it (Chen 
et al., 2013). However, how Rad53 targets Sld3 is unknown. Recently, it has been observed 
in the Zegerman Lab that C-terminally HA-tagged CDC45 (cdc45-HA) abrogates Rad53 
dependent phosphorylation of Sld3 upon DNA damage (Dr P Zegerman, and C Kleinert, data 
not shown). Cdc45 interacts with Sld3 (Yoichiro Kamimura et al., 2001) and this interaction is 
essential for replication initiation (Zegerman & Diffley, 2010). Based on this observation, this 
chapter is mostly focused on the role of Cdc45 in the checkpoint to understand how Rad53 
ensures its target specificity, more precisely, the function of Cdc45 on Rad53 dependent Sld3 
phosphorylation(Figure 5-1).  
 
 
 
Figure 5-1 How does Rad53 target its substrates? 
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5.2. Cdc45 is required for Rad53-dependent Sld3 
phosphorylation 
Given that cdc45-HA prevents Rad53-dependent Sld3 phosphorylation (personal 
communication with Dr. P Zegerman), I wondered whether Cdc45 itself is required for Sld3 
phosphorylation, or whether an HA tag somehow prevents Sld3 phosphorylation. To rule this 
out, I decided to test the requirement for Cdc45 in Rad53-dependent Sld3 phosphorylation. 
Because CDC45 is an essential replication factor, it is not possible to create CDC45 null cells 
for functional studies. To circumvent this issue, I used a powerful genetic tool called the 
temperature-activated degron method. With this technique, the desired protein can be 
degraded rapidly above a threshold temperature. Furthermore, because cdc45-td cells have 
an extra copy of Ubr1 under a Gal1-10 promoter, addition of galactose into the media enhances 
the degradation of the degron fusion. I used an endogenously modified temperature-activated 
degron CDC45 mutant cdc45-td (Tercero et al., 2000). As a control, I used a wild type copy of 
Cdc45 under its promoter in another locus, thus rescuing Cdc45 degradation upon temperature 
shift. 
Cdc45 is an essential replication factor and travels with the replication fork (Tercero et al., 
2000). In order to address its requirement in the checkpoint, the absence of Cdc45 has to be 
analysed independently from its function in replication. Since Rad53 phosphorylates Sld3 not 
only in S-phase but also in G1 and G2 phase upon DNA damage (Chapter 3), I conducted the 
experiment in G2 phase where Cdc45 would not be required for replication. I arrested cdc45-
td and cdc45-td CDC45+ strains in YPRaff at permissive temperature (24°C) in G2 using 
nocodazole and then shifted cultures to the restrictive temperature (37°C) to degrade Cdc45. 
One hour after incubation at 37°C, the DNA damaging agent 4-NQO was added and samples 
were collected every 30 minutes. The flow cytometry profiles showed that cells were arrested 
in G2 phase during the experiment (Figure 5-2.C). Western blot analysis showed a 
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phosphorylation-dependent mobility shift of Rad53, indicating that the DNA damage 
checkpoint is activated in G2 phase equally in both strains (Figure 5-2.B). While Sld3 
phosphorylation occurred in the strain with wildtype Cdc45, I did not observe any mobility shift 
of Sld3 in cdc45-td cells. This suggests that Cdc45 is required for the Rad53-dependent 
phosphorylation of Sld3 upon DNA damage, and its function is prevented by the HA tag in 
cdc45-HA cells.  
There are several possible explanations for the requirement of Cdc45 for Rad53-dependent 
Sld3 phosphorylation. It is possible that Cdc45 has a role in Rad53 regulation, or Cdc45 could 
 
Figure 5-2: Cdc45 is required for Rad53 dependent Sld3 phosphorylation. A) Schematic 
representation of the experimental steps. B) Western blot analysis of Rad53 and Sld3. An anti-
Myc antibody was used for Sld3 detection. Ponceau-S staining of the membrane was used as 
a loading control. C) Flow cyctometry analysis of the cells.  
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target Rad53 to Sld3 for Sld3 phosphorylation. Cdc45 interacts with Sld3, which is essential 
for replication initiation (Zegerman & Diffley, 2010). Given that Rad53 phosphorylation still 
occurred in the absence of Cdc45 upon DNA damage, it is possible that Cdc45 is not required 
for Rad53 regulation. However, if the second explanation is correct, interrupting the Cdc45-
Sld3 interaction would have an effect on Sld3 phosphorylation. To test this hypothesis, I used 
the sld3-2D mutant which has a reduced interaction with wild type Cdc45 (Zegerman & Diffley, 
2010). I arrested wild type and sld3-2D cells in G2 using nocodazole and induced DNA damage 
through 4-NQO to analyze whether reduced Sld3-Cdc45 interaction affects the 
phosphorylation of Sld3 by Rad53. The flow cytometry analysis showed that both strains were 
arrested in G2 phase before addition of 4-NQO (Figure 5-3.B). The phospho-dependent 
mobility shift of Rad53 indicated that the DNA damage checkpoint was activated by 4-NQO 
(Figure 5-3.C). In contrast to wild type cells, sld3-2D showed a significantly reduced mobility 
shift. Given that the sld3-2D mutant still interacts with Cdc45 but to a lesser extent, this small 
degree of interaction might explain the residual Sld3 phosphorylation. From this experiment I 
conclude that the Sld3-Cdc45 interaction is necessary for Rad53-dependent phosphorylation 
of Sld3 upon DNA damage, which would explain the result in the Cdc45 degron strain (Figure 
5-2).  
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Next, I wondered whether the effect of Cdc45 on Sld3 phosphorylation by Rad53 was specific, 
or whether other proteins that bind to Sld3 are also required. To test this, I used a hypomorphic 
Dbb11 allele called dpb11-1 which is temperature sensitive at 37°C (Kamimura et al., 1998) 
and performed the experiment in G2 phase as before. Following this, I added 4-NQO to induce 
DNA damage. Flow cytometry analysis showed that cells were entirely arrested in G2 phase 
(Figure 5-4.B). Next, I proceeded with Western blot analysis of Dpb11. A DNA damage-
dependent shift of Dbp11 was observed in wild type cells, corroborating previous work (Puddu 
et al., 2008). As expected, mobility shifts of Rad53 after addition of 4-NQO in both strains were 
indicators of checkpoint activation. Finally, I did not observe any change in the magnitude of 
the shift of Sld3. I therefore concluded that Rad53-dependent phosphorylation of Sld3 does 
not require Dpb11 interaction.  
 
Figure 5-3: Cdc45-Sld3 interaction is required for Rad53-dependent Sld3 
phosphorylation. A) Schematic representation of the experimental steps. B) Flow cytometry 
analysis of the cells. C) Western blot analysis of Rad53 and Sld3. An anti-Myc antibody was 
used for Sld3 detection. Ponceau-S staining of the membrane was used as a loading control.  
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Next, I considered whether the requirement of Cdc45 for Rad53 dependent phosphorylation is 
specific for Sld3, or whether other Rad53 substrates also require Cdc45 for Rad53-dependent 
phosphorylation upon DNA damage. To test this, I decided to assess the phosphorylation of 
Dbf4 upon DNA damage in G2 phase. Given that cdc45-HA prevents Rad53-dependent Sld3 
phosphorylation (P Zegerman, personal communication). I used cdc45-HA to investigate the 
effect of Cdc45. Taking into account several previous studies suggesting that Dbf4 is 
phosphorylated by Cdk (Holt et al., 2009; D. Lu et al., 2014; Ubersax et al., 2003), in order to 
be able to discriminate between the Rad53-dependent and independent phosphorylation 
subset of Dbf4, I used rad53D cells as a control.  
 
Figure 5-4: Cdc45, but not other Sld3 interacting proteins, is required for Rad53-
dependent Sld3 phosphorylation. A) Schematic representation of the experimental steps. 
B) Flow cytometry analysis of the cells. C) Western blot analysis of Rad53, Sld3 and Dpb11. 
An anti-Myc antibody was used for Sld3 detection. Ponceau-S staining of the membrane was 
used as a loading control. 
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I arrested cells at 30°C in G2 Phase with nocodazole and added 4-NQO to induce DNA 
damage. As expected, the flow cytometry profile of cells showed that cells were arrested in G2 
phase (Figure 5-5.B). Since cdc45-HA mutants did not affect the phosphorylation pattern of 
Dbf4 (unlike the phosphorylation of Sld3 - Dr P Zegerman and C Kleinert, data not shown), I 
conclude that Cdc45 is only required for Sld3 but not for Dbf4 phosphorylation (Figure 5-5). 
This observation is in agreement with previous work which proposes that Rad53 directly binds 
Dbf4 through the N-terminal domain of Dbf4 (Chen et al., 2013). However, since Dbf4 is 
modified in G2 phase cells even in the absence of Rad53, it is difficult to rule out whether Dbf4 
is fully phosphorylated by Rad53.  
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5.3. A disordered loop of Cdc45 is the binding site of 
Rad53 
Considering that the experiment explained above showed the requirement of Cdc45 for Rad53 
dependent Sld3 phosphorylation, I next wondered how Cdc45 targets Rad53 to Sld3. Rad53 
 
Figure 5-5: Cdc45-HA does not interfere with Rad53-dependent Dbf4 phosphorylation. 
A) Schematic representation of the experimental steps. B) Flow cytometry analysis of the cells. 
C) Western blot analysis of Rad53 and Dbf4. An anti-Myc antibody was used for Dbf4 
detection. Ponceau-S staining of the membrane was used as a loading control. All strains were 
isogenic for sml1D.  
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contains a Serine/Threonine kinase domain which is flanked by two forkhead homology-
associated (FHA1 and FHA2) domains (Wybenga-Groot et al., 2014). These FHA domains are 
described as phospho-peptide recognition domains, which are specific for phosphothreonine 
(pT)-containing epitopes. The FHA1 domain of Rad53 binds to pTXXD motifs with high affinity 
in vitro (Liao et al., 2000). Cdc45 contains 5 TXXD motifs (T147, T189, T195, T278 and T438), 
two of which (T189 and T195) are located in a unstructured loop (Figure 5-6). Aucher et al. 
have shown that the Rad53 FHA1 domain co-precipitates with Cdc45 (Aucher et al., 2010). 
Moreover, the FHA1 domain of Rad53 interacts with a Cdc45 (154-270) fragment by yeast 
two-hybrid assays, and this interaction is decreased drastically following a T189A substitution 
of the Cdc45 (154-270) fragment (Aucher et al., 2010). I therefore considered whether the 
disordered loop of Cdc45 is the binding site of Rad53 required for Rad53 targeting to Sld3 
upon DNA damage. To test this, I decided to replace the T189 residue of Cdc45 with alanine 
to abrogate possible interactions with Rad53, and also replaced the same residue with aspartic 
acid and glutamic acid to mimic possible phosphorylation events, to determine whether 
phosphorylation is required for this interaction.  
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Figure 5-6 The multiple sequence alignment of Cdc45. The disordered loop of Cdc45 
predicted for Human Cdc45 (Simon et al., 2016). Yellow boxes indicate TxxD domains on the 
disordered loop.  
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Since Cdc45 is an essential replication factor, any loss of function induced through the 
introduction of a mutation can be lethal. Hence, I decided to introduce CDC45+, cdc45-189A, 
cdc45-189D and cdc45-189E into cdc45-td cells as a second copy under the CDC45 promoter. 
To avoid confusion, I have called these mutants cdc45-1A, cdc45-1D and cdc45-1E. In order 
to analyse if the mutations affected the function of Cdc45, I tested their growth at the non-
permissive temperature where the cdc45-td was degraded (Figure 5-7). As expected, wild-
type cells (1) grew on both YPD and YPGal plates at all tested temperatures. The cdc45-td 
cells (2) grew on both YPD but not on YPGal at 30°C. On the other hand, cdc45-1A,1D,1E 
grew on all plates. This suggests that the substitution of Cdc45-T189 to A, D or E does not 
have any significant effect on the essential functions of Cdc45. 
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Figure 5-7: Cdc45 T189A-D-E mutants are viable. Growth analysis of CDC45 mutants. A 
second copy of either wild type or mutant Cdc45 mutants were tested in the cdc45-td 
background. Corresponding genotypes are indicated in the grey box. 
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I decided to analyse whether these Cdc45 mutants affect the Sld3 phosphorylation after DNA 
damage in G2 phase as in Figure 5-2. The mobility shift of Rad53 after 4-NQO addition 
indicated that the DNA damage checkpoint was activated in all strains (Figure 5-8.C). I then 
checked the mobility shift of Sld3 by western blot analysis. There was no visible mobility shift 
in cdc45-td after the addition of 4-NQO, showing the requirement of Cdc45 for Sld3 
phosphorylation by Rad53 as in Figure 5-2. The mobility shift of Sld3 was restored in cdc45-
td CDC45+ cells upon DNA damage due to the presence of a wild type copy of CDC45. Some 
mobility shift of Sld3 was observed in cdc45-td cdc45-1A cells, however the magnitude of this 
shift was greatly reduced compare to cdc45-td CDC45+ cells. This indicated that T189 is an 
important residue for Rad53-dependent Sld3 phosphorylation. Although the use of D and E 
are supposed to mimic phosphorylated residues, they both showed the same level of 
phosphorylation as cdc45-1A, suggesting that either the phosphorylation of this residue is not 
required or that D or E substitutions were unable to mimic phosphorylation. 
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The temperature-activated degron method is a robust strategy for assessing the effect of 
mutations, but is not the most optimal experimental setup since the experiments must be 
 
Figure 5-8 Cdc45 T189 residue is required for Rad53 dependent Sld3 phosphorylation 
in cdc45-td cells. A) Schematic representation of the experimental steps. B) Flow cytometry 
analysis of the cells. C) Western blot analysis of Rad53 and Sld3. Anti-Myc antibody was used 
for Sld3 detection. Ponceau-S staining of the membrane was used as a loading control. All 
strains were isogenic PGAL-UBR1. The expression of second copy genes was under PCDC45. 
 
 
115 
performed at 37°C in G2 phase and the desired protein must be expressed at a distal locus. 
After determining that cdc45-T189A, T189D and T189E substitutions are not lethal (Figure 
5-7), I mutated endogenous CDC45 to analyze the effect of 189A, D or E substitutions. I 
replaced endogenous CDC45+ with cdc45-T189A, T189D and T189E mutants respectively 
(Figure 5-9). To do so, I used a modified 2-step gene replacement protocol. At the first step, I 
cloned the coding sequence of CDC45+ with the Gal1-10 into an episomal plasmid containing 
URA3+ (pRS316). I transformed this plasmid into CDC45+/cdc45D::KanMX diploid cells and 
then isolated cdc45D strains carrying the episomal PGAL-CDC45+ plasmid by tetrad dissection 
of sporulated diploids. These cells were URA3+ KAN+ and grown using only galactose-
containing media. I then transformed these haploid cells with a PCR product of cdc45-T189A, 
T189D and T189E which carried the 5’ and 3’ UTRs of CDC45+ in order to replace the KAN+ 
gene at the Cdc45 locus by homologous recombination. I grew these cells on YPD plates in 
order to halt the expression of Cdc45 from the URA3+ episomal plasmid, and replica plated on 
5-FOA plates in order to select cells which lost the episomal plasmid. I picked 8 different 
colonies per insert and streaked them on YPD, YPD+Kanamycin, and Minimal Medium-Uracil 
in order to control the replacement and 5-FOA plates to control the plasmid loss. All 8 colonies 
per insert which were picked grew on YPD and 5-FOA plates but did not grow on uracil plates, 
suggesting that these cells lost the episomal plasmid and therefore expressed mutant Cdc45. 
As they did not grow also on Kanamycin plates, this replacement occurred in the CDC45 locus. 
To be completely sure that this integration occurred successfully, I verified insertions by PCR 
analysis and sequenced the full CDC45 locus by Sanger sequencing. PCR analysis showed 
that mutant cdc45 integrations occurred correctly and Sanger sequencing showed that cdc45-
T189A, T189D and T189E were integrated successfully into the Cdc45 locus. 
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Figure 5-9 Schematic representation of integration of mutant Cdc45 at the endogenous 
locus. 
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Next, I wondered whether these mutations had any effect on growth. After 36 hours of 
incubation, the growth of all mutated strains was similar to wild-type at all temperatures tested. 
This result demonstrates that endogenous replacement of CDC45+ with cdc45-1A, 1D and 1E 
does not have any effect on cell growth on its own (Figure 5-10).  
To test the effect of the Cdc45 mutants as the only copy of Cdc45 on Sld3 phosphorylation, I 
arrested these mutants in G1 phase using a-factor, released them synchronously into S-phase 
in the presence of 200mM HU, and collected samples every 30 minutes. As expected, flow 
cytometry analysis showed that cells were arrested in G1 phase and cells did not progress 
after release due to the inhibition of replication by HU (Figure 5-11.B). The mobility shift of 
Rad53 indicated that the checkpoint was activated equally in all tested strains. In later time 
points, a subset of Rad53 appeared dephosphorylated, which is an indication of adaptation to 
HU. The mobility shift of Sld3 was observed in all strains but the magnitude of shift was reduced 
in cdc45-1A, cdc45-1D and cdc45-1E cells, consistent with the cdc45-td data (Figure 5-8). 
 
Figure 5-10 Cdc45-T189A, D or E substitutions does not exhibit a growth phenotype. 
Exponentially growing cells were counted and 3-fold serial dilutions from initial 0.4x107cells 
were spotted onto YPD plates. 2 different isolates of cdc45 T189A, D or E cells were used. 
Pictures were taken after 36h incubation.  
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Together with Figure 5-8, this experiment suggests that the disorganized loop of Cdc45 is 
important for Rad53-dependent Sld3 phosphorylation. 
Since the effect of the Cdc45 189 mutation was partial, I wondered if Rad53 might be able to 
be recruited to Cdc45 via other sites. Interestingly, there are two TXXD motifs in the 
disorganised loop of Cdc45. I wondered if I could completely abrogate Sld3 phosphorylation 
by mutating both motifs. To answer this question, I began with the temperature degron strain 
again, as I did not know the effect of double mutation on the function of Cdc45. I mutated both 
 
Figure 5-11  Cdc45 T189  residue is required for Rad53-dependent Sld3 phosphorylation 
in S-phase. A) Schematic representation of the experimental steps. B) Flow cytometry 
analysis of the cells. C) Western blot analysis of Rad53 and Sld3. An an nti-Myc antibody was 
used for Sld3 detection. Ponceau-S staining of the membrane was used as a loading control. 
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Cdc45 T189 and T195 residues to alanine, glutamic acid or aspartic and transformed into the 
degron strain as in Figure 5-7. To prevent any confusion, these double mutants are referred 
to cdc45-2A, cdc45-2D or cdc45-2E. To test whether these mutations affect the function of 
cdc45, I performed a growth assay. After incubation for 48 hours, cdc45-td did not grow on 
YPD at 37°C as expected, whereas PCDC45-CDC45+ rescued the phenotype as they grew at a 
similar rate to wild-type cells (Figure 5-12 3rd row). In addition, I did not observe any growth 
defect in 2A, 2D or 2E cells, which also grew similarly to wild-type, suggesting that the 
substitution of T189 and T195 of Cdc45 with alanine, glutamic acid or aspartic acid probably 
does not affect its function during replication. 
Although the growth analysis did not show any growth differences between wildtype and 
mutant Cdc45, it is still possible that these mutations affected the expression of Cdc45. For 
this reason, I wanted to verify the expression of wild-type and mutant Cdc45. Because, there 
is no commercial yeast Cdc45 antibody, I purified a polyclonal Cdc45 antibody for the rest of 
experiments (Figure 5-13). To validate if the purification yielded that was specific for Cdc45, 
cdc45-td cells were used as a control, because cdc45-td cells only have a fusion protein which 
is approximately 20 KDa bigger than full length Cdc45. Western blot analysis indicated that 
 
Figure 5-12 Cdc45 T189, T195 A, D or E double mutants are viable. Growth analysis of 
Cdc45 mutants. A second copy of either wild type or mutant Cdc45 mutants were tested in a 
cdc45-td background. Corresponding genotypes are indicated in the box. 
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serum has non-specific binding to a band very close to wildtype Cdc45 proteins (Figure 
5-13.A). However, this nonspecific binding disappeared after purification, suggesting that this 
antibody could be used for probing Cdc45 (Figure 5-13.B). This antibody also detected cdc45-
td fusion proteins, however purified antibody still had nonspecific binding very close to cdc45-
td. 
After purification of the Cdc45 antibody, I analysed the effect of 2A, 2D, 2E mutations on the 
expression level of Cdc45. Figure 5-14.C shows that these substitutions did not affect the 
stability of Cdc45 as their expression were similar to wildtype Cdc45. I next analysed the effect 
of Cdc45 double mutants on Sld3 phosphorylation following DNA damage as in Figure 5-8. 
Western blot analysis of second copy Cdc45 showed that wild-type and mutant proteins were 
expressed similarly to each other in trp1-1 locus and there was no wild-type expression in the 
cdc45-td strain (Figure 5-14.C). In addition, the majority of cdc45-td protein was degraded 
following a temperature shift. Finally, I analysed the mobility shift of Sld3 by western blot. As 
expected, the mobility shift of Sld3 was greatly reduced compared to control cells after the 
addition of 4-NQO. The minor shift of Sld3 could be due to the inefficient degradation of cdc45-
td in this experiment. Sld3 phosphorylation in the Cdc45 2A, 2D and 2E cells was also 
abrogated, as in cdc45-td cells (Figure 5-14.C). The main conclusion of this experiment is that 
 
Figure 5-13 Purification of specific antibody for Cdc45. Membranes were probed with 
non-purified serum A) or purified antibody B).  
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the two TXXD motifs in the disorganized loop of Cdc45 are required for Rad53-dependent Sld3 
phosphorylation upon DNA damage. Considering the work of Aucher et al. (2010) in which an 
in vitro interaction of a Cdc45 (154-270) fragment with the FHA1 domain of Rad53 was shown, 
it is likely that Rad53 binds to the disorganized loop of Cdc45 for Sld3 phosphorylation in vivo.  
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Figure 5-14 Cdc45 T189, T195 residues are essential for Rad53 dependent Sld3 
phosphorylation in cdc45-td cells in G-2 phase. A) Schematic representation of the 
experimental steps. B) Flow cytometry analysis of the cells. C) Western blot analysis of Rad53 
and Sld3. An anti-Myc antibody was used for Sld3 detection. Ponceau-S staining of the 
membrane was used as a loading control. All strains were isogenic PGAL-UBR1. The 
expression of the second copy of Cdc45 was under its own promoter (PCDC45). 
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As for the single mutants of Cdc45, I mutated endogenous CDC45 with cdc45-2A by the 
modified 2-step replacement strategy as I described before in Figure 5-9. After verifying the 
endogenous cdc45-2A strain with Sanger sequencing, I compared the phosphorylation of Sld3 
in wild-type, cdc45-1A and cdc45-2A cells in S-phase upon DNA damage as in Figure 5-11. 
The mobility shift of Sld3 after DNA damage was reduced in a cdc45-1A background compared 
to wild type cells as in Figure 5-11, however, the mobility shift of Sld3 was even further reduced 
in the cdc45-2A mutant upon DNA damage (Figure 5-15.C). It is important to note that, 
although hyper-phosphorylation of Rad53 decreased over time in both the wild type and cdc45-
1A background, the hyper-phosphorylation of Rad53 did not change. In summary, I have 
demonstrated that the TXXD motifs in the disorganized loop of Cdc45 are required for the 
phosphorylation of Sld3 by Rad53 upon fork stalling.  
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5.4. Cdc45 is phosphorylated in a Rad53-dependent 
manner upon DNA damage 
Although in vitro studies indicate that the FHA1 domain of Rad53 binds preferentially to 
phosphorylated TXXD-containing peptides, the phosphomimetic approach did not show 
constitutive Cdc45-Rad53 interaction (Figure 5-14). There are two potential explanations for 
this result. Either the phosphorylation of T198 and T195 are not required for binding of Rad53 
 
Figure 5-15 Cdc45 T189, T195 residues are essential for Rad53 dependent Sld3 
phosphorylation in S-phase. A) Schematic representation of the experimental steps. B) Flow 
cytometry analysis of the cells. C) Western blot analysis of Rad53 and Sld3. An anti-Myc 
antibody was used for Sld3 detection. Ponceau-S staining of the membrane was used as a 
loading control. 
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to Cdc45, or D or E substitutions were not able to mimic phosphorylation successfully. To test 
the first possibility, I wanted to investigate whether Cdc45 is phosphorylated upon DNA 
damage. To do so, I compared the phosphorylation status of Cdc45 in wildtype, rad53D sml1D 
and cdc45-2A cells upon DNA damage. Because checkpoint-dependent Cdc45 
phosphorylation has not been observed with the standard SDS-Page protocol upon DNA 
damage (Figure 5-14), the Phos-TAG-SDS-PAGE protocol was used to resolve Cdc45. 
Interestingly, a distinct slow running subset of Cdc45 was observed in wild type cells treated 
with hydroxyurea, indicating that Cdc45 was phosphorylated upon replication stress. 
Importantly, this was significantly reduced in rad53D sml1D cells which suggests that Cdc45 
may also be a Rad53 target. However, whether this phosphorylation was performed directly 
by Rad53 or another Rad53-dependent kinase such as Dun1 is unknown. In addition, a slow 
running subset of Cdc45 was not observed in cdc45-2A cells, suggesting that either the 
disordered loop of Cdc45 is phosphorylated by Rad53 or that Rad53 binds to the disordered 
loop of Cdc45 (which was destroyed in cdc45-2A cells) and phosphorylates some residues on 
it.  
 
 
 
Figure 5-16 Rad53-dependent phosphorylation of Cdc45. A) Schematic representation of 
the experimental steps. B) Western blot analysis of Cdc45. Samples separated with Phos-Tag 
SDS-Page gel. An anti-Cdc45 antibody was used for Cdc45 detection.  
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5.5. Epistasis analysis between cdc45-2A and Rad53 
Cdc45 is an essential DNA replication factor, and it is possible that the observed phenotype of 
cdc45-2A in S-phase was due to inefficient DNA replication. It was therefore crucial to confirm 
that cdc45-2A was a true separation of function mutant and its replication function was intact. 
Hypomorphic replication mutants are synthetic lethal with checkpoint mutants. In order to test 
if cdc45-2A was a hypomorphic mutant for DNA replication, the synthetic lethality of cdc45-2A 
with rad53D was tested. To do so, tetrad analysis of a diploid strain which was heterozygous 
for sml1D, rad53D and cdc45-2A was performed (Figure 5-17). No synthetic lethality was 
observed between rad53∆ and cdc45-2A alleles, as rad53∆ cdc45-2A sml1∆ spores were 
viable. Synthetic sickness was also not observed and the size of rad53∆ cdc45-2A sml1∆ and 
rad53∆ sml1∆ spores were similar. Tetrad analysis of yeast exhibits a Mendelian distribution 
and the distribution of genotypes can be quantified. In summary, cdc45-2A was epistatic with 
rad53D which suggests that its replication function was intact.  
 
Figure 5-17 cdc45-2A is not a hypomorhic replication mutant. Tetrad analysis of 
heterozygous cdc45-2A  rad53D sml1D diploid cells. A total of 68 isolates were analyzed. 
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5.6. cdc45-2A bypasses the function of Sld3 in the 
inhibition of late-origin firing 
The regulation of DNA replication by checkpoint kinases upon DNA damage occurs through 
two distinct mechanisms: the first is stabilisation of active replication forks, and the second is 
blocking late origin firing (Zegerman & Diffley, 2010). It has been shown before that Sld3 and 
Dbf4 are the minimal substrates of Rad53 for the blockage of late origin firing (Zegerman & 
Diffley, 2010). The sld3-A dbf4-4A double mutants in which Rad53 phosphorylation sites are 
replaced with alanine can bypass the checkpoint-dependent inhibition of late origin firing 
(Zegerman & Diffley, 2010). Although the Rad53-dependent mobility shift of Sld3 was 
significantly reduced in cdc45-2A cells, Sld3 could still be phosphorylated to some extent. 
Rad53-dependent Sld3 phosphorylation occurs at multiple residues and requires 37 serine to 
alanine substitutions in order to bypass the inhibition of late-origin firing. To understand the 
extend of the inhibition of Sld3 phosphorylation in cdc45-2A cells, I wanted to use a functional 
assay that can monitor the inhibition of late origin firing. Because wildtype cells cannot fire late 
origins upon DNA damage (Zegerman & Diffley, 2010), their replication slows down drastically 
which can be monitored by flow cytometry analysis. Therefore, I decided to test if cdc45-2A 
dbf4-4A double mutants can bypass the inhibition of late origin firing upon DNA damage. Given 
that cdc45-2A prevents Rad53-dependent Sld3 phosphorylation, I wondered if cdc45-2A dbf4-
4A could prevent the checkpoint-dependent block of origin firing.   
To test this, I arrested dbf4-4A, cdc45-2A and cdc45-2A dbf4-4A cells in G1 phase with a-
factor, released them into S-phase in the presence of 0.05% MMS and collected samples every 
20 minutes. MMS is used in this experiment as a DNA-damaging agent because cells can still 
replicate upon MMS treatment (Tercero & Diffley, 2001). However, the progression of 
replication is very limited due to the inhibition of late origin firing (Tercero & Diffley, 2001). The 
dbf4-4A cells were used as a control because the late origin firing would be inhibited by Sld3 
phosphorylation (Zegerman & Diffley, 2010). Mobility shift of Rad53 in western blot analysis 
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showed that the checkpoint was activated normally in all tested strains. As expected, minor 
DNA replication was observed in dbf4-4A and cdc45-2A cells even after 2 hours of incubation 
as assessed by the flow cytometry profile (Figure 5-18.B). On the other hand, cdc45-2A dbf4-
4A double mutants traversed the S-phase in contrast to dbf4-4A or cdc45-2A cells and their 
bulk DNA amount seemed to double, most probably due the global derepression of late origin 
firing. In conclusion, preventing Sld3 phosphorylation by cdc45-2A is efficient to bypass the 
regulation of Sld3 by Rad53 for the block to late origin firing.  
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Figure 5-18 Analysis of late origin firing upon DNA damage. A) Schematic representation 
of the experimental steps. B) Flow cytometry analysis of the cells.  
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5.7. Discussion  
Although Rad53 is a very important effector kinase in DNA damage checkpoint, very little is 
known about how Rad53 targets its substrates. In this chapter, I have shown that a solvent 
accessible flexible loop of Cdc45 is required for Rad53-dependent Sld3 phosphorylation upon 
DNA damage.  
Dr. Zegerman observed that Sld3 is not phosphorylated by Rad53 upon DNA damage in 
cdc45-HA cells, in which endogenous CDC45 is C-terminally HA tagged (data not shown). 
Based on this observation, I have shown that Cdc45 is required for Rad53-dependent Sld3 
phosphorylation by taking advantage of cdc45-td cells (Figure 5-2). Given that reduced Sld3 
and Cdc45 interaction decreased Sld3 phosphorylation (Figure 5-3), I concluded that Cdc45-
Sld3 interaction is necessary for Rad53 dependent Sld3 phosphorylation. Further 
investigations  with dpb11-1 cells indicated that Cdc45, but not Dpb11 is required for Sld3 
phosphorylation (Figure 5-4). In addition, Cdc45 is required for Sld3 but not Dbf4 
phosphorylation (Figure 5-5).  
At least two different hypotheses could explain the requirement of Cdc45 for the 
phosphorylation of Sld3 by Rad53. Either the Cdc45-Sld3 interaction changes the 3D 
conformation of Sld3 and exposes a binding domain for Rad53, or the binding of Rad53 to 
Cdc45 is required for Sld3 phosphorylation. Although Rad53 is one of the least specific yeast 
kinases (Mok et al., 2010), the FHA1 domain of Rad53 has binding specificity to the phospho-
peptide pTXXD in vitro (Liao et al., 2000). As, it has been previously suggested that Cdc45 
(154-270) fragment interacts with Rad53 FHA1 and two TXXD domains (T189 and T195) of 
Cdc45 are located in this fragment (Aucher et al., 2010), I wondered whether these domains 
were required for Sld3 phosphorylation. Given that, these residues are also aligning with the 
disordered loop of human Cdc45 (Simon et al., 2016), I hypothesized that they might be 
accessible by Rad53. Interestingly, I have shown with different approaches that although the 
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alanine substitution of Cdc45-T189 (cdc45-1A) significantly decreases Sld3 phosphorylation 
(Figure 5-8 and Figure 5-11), double alanine substitution of T189 and T195 (cdc45-2A) almost 
fully abrogated the phosphorylation of Sld3 upon DNA damage (Figure 5-15). I concluded from 
these experiments that the TXXD domains on Cdc45 are required for the Rad53 dependent 
Sld3 phosphorylation. However, because T195A alone have never been tested, it is not known 
whether T189 and T195 together or T195 alone is required for Sld3 phosphorylation.  
Given that the FHA1 domain of Rad53 has a binding preference for phosphorylated TXXD 
peptides, I used a phosphomimetic approach to test if it is possible to create a constitutive 
interaction between flexible loop of Cdc45 and Rad53. However, both single T189 and double 
T189 T195 substitutions with glutamic acid or aspartic acid showed similar Sld3 
phosphorylation pattern with alanine substitutions suggesting that phosphomimetic approach 
was not successful. There are different explanations for the failure of this phosphomimetic 
approach: 1) the glutamic acid or aspartic acid substitutions are not enough to mimic pT, 2) 
phosphorylation of Cdc45 is not required for Rad53 binding. Given that Cdc45 was 
phosphorylated in a Rad53-dependent manner (Figure 5-16), mapping the phosphorylation 
sites on Cdc45 would allow us to understand why the phosphomimetic approach on the flexible 
loop of Cdc45 did not work.  
Although this chapter provides evidence that mutating the potential FHA1 biding domain on 
the disordered loop of Cdc45 is sufficient to prevent Sld3 phosphorylation, it does not show 
direct binding of Rad53 on Cdc45. But given that Aucher et al. has shown that the Cdc45 (154-
270) fragment interacts with the FHA1 domain of Rad53 in vitro, it is possible that Rad53 
interacts via its FHA1 domain with the flexible loop of Cdc45 in vivo. On the other hand, whether 
the FHA2 domain of Rad53 has biological significance for the Sld3 phosphorylation is 
unknown. The significance of FHA2 domain of Rad53 could be addressed by using a rad53-
11 allele, in which the FHA2 domain cannot bind its substrates. The phosphorylation status of 
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Sld3 upon DNA damage in rad53-11 cells could potentially reveal the significance of the FHA2 
domain on the Sld3 phosphorylation.  
At least two different models could explain the mechanism of Rad53-dependent Sld3 
phosphorylation based on the evidence obtained in this chapter and the literature. Either the 
FHA1 domain binds to the flexible loop of Cdc45 which is then handed over to Sld3 (Model 1) 
or Rad53 binds to the flexible loop of Cdc45 and phosphorylates Sld3 (Model 2) (Figure 5-19). 
These 2 models could be tested by different biochemical tools such as Chemically Induced 
Dimerization (CID) (Fegan et al., 2010). With this technique, the flexible loop of Cdc45 could 
be forced to dimerize with the FHA1 domain of Rad53. In such a case, If Sld3 is phosphorylated 
upon DNA damage, then the second model would probably be true. However, if Sld3 is not 
phosphorylated after the constitutive dimerization of the flexible loop of Cdc45 with Rad53, 
then the first model would probably be true. On the other hand, whether there is a function of 
Rad53-dependent Cdc45 phosphorylation in these models is not yet known. Mapping the 
Rad53-dependent phosphorylation sites of Cdc45 using biochemical assays such as mass 
spectrometry analysis would determine the direction of the research.  
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While cdc45-2A prevents Sld3 phosphorylation, it could still be a hypomorphic allele for its 
functions for replication. Cells carrying hypomorphic replication alleles are usually synthetic 
lethal with rad53D which has been observed for cdc45-HA (personal communication with Dr 
Zegerman). Interestingly, epistasis analysis with rad53D suggested that the function of cdc45-
2A is probably intact during replication, because rad53D sml1D cdc45-2A cells were viable. 
However, more detailed research could be performed through DNA fiber analysis with double 
staining. With this technique both the number of replication initiations and the speed of the 
 
Figure 5-19 Possible models for the mechanism of Rad53 dependent Sld3 
phosphorylation. 
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replication fork could be determined which would allow us to understand the possible small 
degree of loss of function in cdc45-2A (Etienne Schwob et al., 2009).  
On the other hand, since Sld3 is phosphorylated at multiple residues (Zegerman & Diffley, 
2010), there could be still some phosphorylation which was not observed by western blot 
analysis in cdc45-2A cells. In the case of some residual phosphorylation in cdc45-2A cells 
upon DNA damage, it would be expected to inhibition late origin firing. To rule out this 
possibility, a functional experiment was carried out in which the inhibition of late origin firing 
observed by monitoring the progression of DNA replication upon DNA damage. The flow 
cytometry analysis indicated that, although dbf4-4A cells did not fire late origins after MMS 
treatment, the bulk DNA amount increased in cdc45-2A dbf4-4A cells (Figure 5-18). This 
experiment proved that the inhibition of late origin firing cannot happen through the 
phosphorylation of Sld3 in cdc45-2A cells. Unexpectedly, cdc45-2A showed a sign of late origin 
firing. Initial research that identified the Sld3 as a target for the inhibition of late origin firing 
suggested that the sld3-A mutant cannot fire late origin firing alone (Zegerman & Diffley, 2010). 
However, this could be due to incomplete mapping of phosphorylation sites of Sld3. Although 
this experiment had enough evidence to suggest that cdc45-2A dbf4-4A mutants prevent late 
origin firing, it could be further validated by more sensitive techniques such as 2D gel 
electrophoresis or replication intermediate analysis in order to show directly the replication 
initiations from the late origins. Together, I conclude that, cdc45-2A is a separation of function 
mutant that prevents Sld3 phosphorylation by Rad53 upon DNA damage but does not affect 
its function during DNA replication. 
Nucleotide depletion via HU or other nucleotide analogues results in decreased polymerase 
activity and increased amount of ssDNA which activates S-phase checkpoint (Hustedt et al., 
2013). Rad53 activation by DNA damage result in the regulation the nucleotide pool via 
transcriptional control of ribonucleotide reductase (RNR) (Huang et al., 1998) and the 
degradation RNR inhibitors by Dun1 (Lee et al., 2008; Zhao & Rothstein, 2002). Further 
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production of dNTPs results in increased dNTP level as well as polymerase activity and 
decreased ssDNA. Because of this adaptation, dephosphorylation of Rad53 was observed in 
wildtype cells after 90 minutes HU treatment (Figure 5-15). However, dephosphorylation of 
Rad53 was not observed in cdc45-2A cells suggesting that either more replication origins fire 
in cdc45-2A cells upon HU treatment which results in more damage, or Cdc45 is also involved 
in dephosphorylation of Rad53 after the recovery from DNA damage. Because some degree 
of late origin firing was observed in cdc45-2A cells after MMS treatment (Figure 5-18), the lack 
of Rad53 dephosphorylation after 90 minutes HU treatment is possibly due to an increased 
number of origin firing. However, the observation that cdc45-2A fires some late origins upon 
DNA damage should be tested with the more precise techniques mentioned above.  
This chapter provides some evidence that Cdc45 is not required for the phosphorylation of 
Dbf4 upon DNA damage, which is in line with the previous work showing that Rad53 directly 
binds to and phosphorylates Dbf4 (Chen et al., 2013). However, as mentioned above, in 
addition to its function in replication initiation, Cdc45 also travels with the replication fork which 
suggests that Cdc45 might be required for the phosphorylation of the other replication fork 
components. The next chapter (6) attempts to address this question in detail.  
The regulation of the Sld3 human homolog Treslin by checkpoint kinases is still not clear. Gao 
et al. (2015) recently proposed that Chk1 associates with the C-terminal domain of Treslin 
which is not present in yeast Sld3. Although the flexible loop of Cdc45 is conserved among the 
different organisms but TXXDs are not (Figure 5-6), the requirement of Cdc45 for Chk1-
dependent Treslin phosphorylation might be lost during evolution. However, this loop could still 
be required for the phosphorylation of other factors on the replication fork.  
According to the cryo-EM structure of yeast CMG complex, there is another solvent accessible 
loop on yeast Cdc45 between 436-461 and a TXXD (T437) domain is located in this region 
(Yuan et al., 2016). Whether this domain is also important for Rad53-dependent 
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phosphorylation of replication factors is unknown. Considering cdc45-2A bypasses the Rad53 
dependent Sld3 phosphorylation, this putative domain is not required for Sld3 phosphorylation. 
However, this domain might have another function during replication. Surprisingly, this loop is 
also conserved in human Cdc45 (E384-D395), suggesting that possible roles of this second 
loop during replication could also be conserved. 
Considering previous studies and this chapter, solvent accessible TXXD domains could be 
used for the prediction of the possible Rad53 interaction sites which might help to find novel 
Rad53 substrates. For instance, Sld5 the yeast GINS subunit has a solvent accessible TXXD 
domain at T259 which could be a possible binding site for Rad53. However, it is important to 
keep in mind that this approach relies on the available protein structures which could be a 
bottleneck for further research. 
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Chapter 6  
Cdc45 is involved in the stabilisation of 
stalled fork 
6.1. Introduction  
The inhibition of the progression of polymerase or helicase by endogenous or exogenous 
sources (see chapter 1.5.1) results in replication fork stalling which leads to activation of the 
DNA damage checkpoint in S-phase. Stalled replication forks produce aberrant DNA structures 
and their detection by sensor proteins promote the activation of two master checkpoint kinases, 
ATM and ATR in humans (Mec1 and Tel1 in yeast). These master kinases transduce the signal 
to the effector kinases Chk1 and Chk2 in humans (Rad53 and Chk1 in yeast) to execute 
several responses including the stabilization of stalled replication forks. 
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Stalled forks could produce aberrant DNA structures such as excessive single strand DNA 
(ssDNA), single strand-double strand DNA junctions (ss-dsDNA), double stand breaks (DBSs) 
or single strand breaks (SSBs) (Hustedt et al., 2013). For instance, small DNA base adducts 
created by MMS or dNTP depletion with HU can stop the progression of the polymerase which 
generates long tracks of ssDNA due to the continuous DNA unwinding by the helicase (Poli et 
al., 2012; Tercero & Diffley, 2001). These long tracks of ssDNA are rapidly coated by 
replication protein A (RPA) (Alani et al., 1992). Mec1 and Ddc2 is recruited to ssDNA track by 
RPA and results in the activation of Mec1 (Zou & Elledge, 2003). However, in Xenopus, ssDNA 
is not sufficient to activate the checkpoint (MacDougall et al., 2007). Free 5’ or 3’ ends are 
compulsory for the effective checkpoint activation (MacDougall et al., 2007). The free 5’ end 
can be generated during lagging strand synthesis whereas free 3’ ends can be generated 
during both lagging and leading strand synthesis. Free 5’ and 3’ ends create ss-dsDNA 
junctions in which the PCNA-like loading clamp 9-1-1 complex (Ddc1-Rad17-Mec3) is loaded 
by Rad24-RFC (Majka & Burgers, 2003). Mec1 phosphorylates Ddc1 on 9-1-1 complex which 
further stimulates Mec1 activation by the recruitment of Dpb11 (Puddu et al., 2008). On the 
other hand, DSBs are recognized by the MRX complex (Mre11-Rad50-Xrs2) which promotes 
resection of a single strand (D’Amours & Jackson, 2001). This resection creates an ss-dsDNA 
junction which then is loaded onto the 9-1-1 complex as well as RPA and promotes Mec1 
activation.  
Activation of the checkpoint response kinase Rad53 upon replication fork stalling requires 
different mediator proteins such Mrc1, Rad9 and Sgs1 in yeast (Hustedt et al., 2013). Mrc1 is 
a replication fork component and travels with the fork during replication (Katou et al., 2003). 
DNA replication slows down in the absence of Mrc1 during unperturbed replication, suggesting 
that Mrc1 is required for the maintenance of the replication fork (Alcasabas et al., 2001). In 
addition, Mrc1 is the key mediator protein upon replication fork stalling in which its 
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phosphorylation by Mec1 results in the activation of Rad53 (Alcasabas et al., 2001). It also 
interacts with Tof1-Csm3 to form a stable pausing complex upon fork stalling (Bando et al., 
2009; Katou et al., 2003). Rad53 activation can be mediated also by Rad9 (Sanchez et al., 
1999). Phosphorylation of Rad9 by Mec1/Tel1 upon DNA damage results in the recruitment 
and activation of Rad53 (Emili, 1998). Finally, RecQ family helicase Sgs1 can also activate 
Rad53 (Frei & Gasser, 2000). Sgs1 constitutively associates with the replication fork and is 
phosphorylated in a Mec1-dependent manner upon DNA damage (Frei & Gasser, 2000). 
Double deletion of Sgs1 and Rad24 has been shown to reduce Rad53 activation, suggesting 
that Sgs1 is required for Rad53 activation (Bjergbaek et al., 2005).  
The replication forks cannot continue to synthesise DNA after transient fork stalling in 
checkpoint-deficient yeast cells (Tercero et al., 2003). Checkpoint kinases are mandatory for 
the stabilisation of stalled forks in order for their restart after removal of the block (Tercero et 
al., 2003). Forks are stabilized by the checkpoint kinases Mec1 and Rad53 to prevent 
irreversible fork collapse in yeast upon stalling (Lopes et al., 2001). Because replication fork 
factors cannot be reloaded upon helicase activation (Labib et al., 2000), collapsed forks could 
be rescued by a fork fired from an adjacent origin (McIntosh & Blow, 2012). However, if two 
converging forks irreversibly collapse, the DNA between these two forks cannot be replicated 
which could generate genomic instability (Blow et al., 2011). For this reason, the stabilisation 
of stalled replication forks must be achieved by a robust mechanism to ensure that stalled forks 
do not collapse. As the stabilisation of the replication fork is of vital importance to the faithful 
duplication of genomic DNA, understanding the molecular mechanisms underlying replication 
fork stabilisation could have potential implications in the treatment of several diseases.  
Stalled replication fork components still associate with chromatin in rad53D cells (De Piccoli et 
al., 2012). In addition, some replication proteins are phosphorylated in a Rad53-dependent 
manner such as Mrc1, Sgs1, Srs2, Rrm3 and Exo1 (Alcasabas et al., 2001; Hegnauer et al., 
2012; Liberi et al., 2000; Morin et al., 2008; Rossi et al., 2015). These two observations suggest 
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that Rad53 could be required for the modification of replication fork components to keep stalled 
forks functional until the removal of the block. Although Rad53 associates with stalled 
replication forks (Katou et al., 2003), exactly how it targets stalled forks is unknown. 
Understanding how Rad53 targets stalled replication forks might allow for the discovery of 
mechanisms of fork stabilisation.  
In chapter 5, I showed that Cdc45 is required for Rad53-dependent Sld3 phosphorylation. 
Cdc45 is required for both replication initiation and elongation (Tercero et al., 2000). Given that 
Cdc45 associates with chromatin in G1 phase (Aparicio et al., 1999) and travels with the 
replication forks during S-phase (Moyer et al., 2006), the flexible loop of Cdc45 might serve as 
a binding site for Rad53 to target and phosphorylate stalled replication fork components. In 
this chapter, I investigated whether the flexible loop of Cdc45 targets Rad53 to stalled 
replication forks for their stabilisation (Figure 6-1).  
 
 
Figure 6-1 How is Rad53 recruited to stalled replication forks?  
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6.2. Checkpoint mediators do not a have synthetic 
growth phenotype in cdc45-2A mutants 
 
If Cdc45 is required for the binding of Rad53 to replication forks upon DNA damage, then the 
cdc45-2A mutant, which cannot bind to Rad53, could prevent the recruitment of Rad53 to the 
stalled forks. This would lead to inefficient fork stabilization and growth defects. To test this, 
the effect of mutated Cdc45 (cdc45-2A) upon DNA damage on cell growth was tested on 
different drug plates. As expected, wild type cells grew on all tested conditions and rad53D 
sml1D died on drug-containing plates. However, no growth deficiency was observed in cdc45-
2A cells on different types of drug plates compare to wild type cells, suggesting that either 
mutating the disordered loop of Cdc45 alone does not sufficiently affect cell viability or the 
flexible loop of Cdc45 is not required for the stabilization of stalled replication forks (Figure 
6-2).  
Although the disordered loop of Cdc45 could act as a binding site for Rad53 to stabilize the 
replication fork upon fork stalling, it does not necessarily mean it is the only binding site for 
Rad53. It is possible that the stabilization of replication fork requires other possible Rad53 
 
Figure 6-2 cdc45-2A does not have growth phenotype upon DNA damage. Exponentially 
growing cells were counted and 3-fold serial dilutions spotted onto plates containing the 
indicated DNA damaging agents.  
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binding sites, which might compensate the lack of Rad53 binding to Cdc45. I hypothesized 
that if other possible Rad53 substrates on the stalled replication forks are involved in the fork 
stabilization, then decreasing the local Rad53 concentration around the stalled forks could 
exacerbate the effect of Rad53 binding on Cdc45. Given that checkpoint mediators possibly 
increase the local concentration of Rad53 around replication forks (Hustedt et al., 2013), lack 
of those mediators might decrease the concentration of Rad53 around stalled forks, resulting 
in growth defects. To test this hypothesis, I analyzed the growth of individual null mutants of 
MRC1, SGS1, RAD9 or 9-1-1 subunits DDC1, MEC3, or RAD17 with or without cdc45-2A on 
different drug plates (Figure 6-3,4,5,6). The cdc45-2A cells grew similarly to wild type cells in 
all tested conditions, in agreement with previous observations (Figure 6-2). However, cdc45-
2A did not exacerbate the growth defect of any of the null mutants tested on different drug 
plates suggesting that cdc45-2A is not synthetic lethal with mrc1D, rad9D, sgs1D, mec3D, 
rad17D or ddc1D upon DNA damage. 
 
 
Figure 6-3 cdc45-2A is not synthetic lethal with mrc1D on drug plates.  Exponentially 
growing cells were counted and 3-fold serial dilutions were spotted onto plates containing 
indicated DNA damaging agents. 
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Figure 6-4 cdc45-2A is not synthetic lethal with rad17D or sgs1D on drug plates.  
Exponentially growing cells were counted and 3-fold serial dilutions were spotted onto plates 
containing indicated DNA damaging agents. 
 
Figure 6-5 cdc45-2A is not synthetic lethal with ddc1D on drug plates. Exponentially 
growing cells were counted and 3-fold serial dilutions were spotted onto plates containing 
indicated DNA damaging agents. 
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Although, cdc45-2A did not exacerbate the growth defect of any of the single checkpoint 
mediator null mutants, it is possible that the availability of other checkpoint mediators might 
increase the local concentration of Rad53, which could be enough to stabilize the stalled 
replication forks. In order to decrease the Rad53 concentration around the stalled forks even 
further, I decided to test the effect of cdc45-2A on double checkpoint mediator null mutants. 
To do so, I analyzed the growth of ddc1D sgs1D, rad9Dddc1D and ddc1D mrc1D on different 
drugs with wild type Cdc45 or with cdc45-2A (Figure 6-7, Figure 6-8 and Figure 6-9). Although 
wild type and single null cells grew on drug plates, cells carrying the combination of different 
double knockout genes were not viable on drug plates. The rad9D ddc1D cells grew on 50 mM 
HU but cdc45-2A did not exacerbate the growth defect of rad9D ddc1D cells (Figure 6-9). 
Decreasing the concentration of DNA damaging drugs allowed some growth in ddc1D mrc1D 
cells (Figure 6-8). However, cdc45-2A did not affect the growth of mrc1D ddc1D cells. Given 
 
Figure 6-6  cdc45-2A is not synthetic lethal with rad9D or mec3D  on drug plates.  
Exponentially growing cells were counted and 3-fold serial dilutions were spotted onto plates 
containing indicated DNA damaging agents. 
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that almost all double checkpoint cells were not viable on drug plates possibly due to the 
ineffective checkpoint activation, it was not possible to observe the effect of inhibited Cdc45-
Rad53 interaction.  
 
 
 
 
Figure 6-7 cdc45-2A is not synthetic lethal with ddc1D sgs1D double knouckouts   on 
drug plates.  Exponentially growing cells were counted and 3-fold serial dilutions were 
spotted onto plates containing indicated DNA damaging agents. 
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Figure 6-8 cdc45-2A is not synthetic lethal with ddc19D mrc19D double knouckouts   on 
drug plates.  Exponentially growing cells were counted and 3-fold serial dilutions were 
spotted onto plates containing indicated DNA damaging agents. 
 
Figure 6-9 cdc45-2A is not synthetic lethal with ddc19D rad9D double knouckouts   on 
drug plates.  Exponentially growing cells were counted and 3-fold serial dilutions were spotted 
onto plates containing indicated DNA damaging agents. 
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Because decreasing Rad53 concentration around the replication fork by removing checkpoint 
mediators was either ineffective (single knockout cells) or lethal (double knockout cells), I 
decided to decrease the total Rad53 in cells in order to address whether decreasing Rad53 
around stalled replication forks would exacerbate the effect of cdc45-2A. It has been shown 
before that C-terminally tagged Rad53 (rad53-HA) has reduced expression compared to wild 
type (Cordón-Preciado et al., 2006). This information was used to address if the reduction of 
Rad53 levels sensitizes cdc45-2A cells to HU. In addition, since Mrc1 is an important mediator 
for Rad53 activation around stalled replication forks (Alcasabas et al., 2001), an Mrc1 null  
mutant was used to decrease the local concentration of Rad53 around stalled replication forks. 
In order to verify the previous work (Cordón-Preciado et al., 2006), first the expression level of 
Rad53-HA was verified by western blot analysis of Rad53. Western blot analysis of Rad53 
indicated that Rad53-HA was expressed less than wild type Rad53 (Figure 6-10). Since the 
level of Rad53 was very low, a long blot exposure was required to get a Rad53 signal from 
rad53-HA cells. However, even after a very long exposure, phosphorylated rad53-HA signals 
were not detected.  
 
 
Figure 6-10 The protein expression of rad53-HA. Western-blot analysis wild-type and 
rad53-HA cells. Cells were arrested in G1 and relaesed into YPD media contaning 200 mM 
HU. The blot was probed with an anti-Rad53 antibody.  
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Because it was verified that rad53-HA had reduced Rad53 expression, I wanted to test whether 
cdc45-2A cells had any growth defect when Rad53 expression was lower than the 
physiological level. To do so, cells were subjected to growth analysis on YPD plates containing 
different concentrations of HU. Growth analysis of the cells indicated that wild-type and cdc45-
2A cells grew at all tested HU concentrations similar to YPD plates (Figure 6-11). In addition, 
rad53-HA, mrc1D, rad53-HA cdc45-2A, mrc1D cdc45-2A cells grew like wild type cells up to 
15 mM HU and their growth gradually decreased with increasing concentration of HU. On the 
other hand, mrc1D rad53-HA cells exhibited a decreased growth phenotype from 15mM HU 
onwards and were completely dead on 50 mM HU. However, mrc1D rad53-HA cdc45-2A cells 
showed a decreased growth phenotype from 5 mM and were completely dead on 10 mM HU. 
This experiment indicated that mrc1D rad53-HA and cdc45-2A are synthetic lethal at very low 
concentrations of HU.  
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To test whether the HA tag prevents the function of Rad53, I made an N-terminally HA tagged 
Rad53 (HA-rad53). Western-blot analysis of Rad53 showed that HA-rad53 cells had lower 
expression than wild type cells as well (Figure 6-12.A). However, it seemed that the 
expression level of HA-rad53 was higher than rad53-HA. In addition, the hyper-
phosphorylation of HA-rad53 was also observed in G2 phase upon DNA damage suggesting 
that the HA tag did not affect the activation of Rad53 upon DNA damage (Figure 6-12.B). 
 
Figure 6-11 cdc45-2A is synthetic lethal with mrc1D rad53-HA on HU plates.  
Exponentially growing cells were counted and 3-fold serial dilutions were spotted onto plates 
containing indicated concentration of HU. 
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After the verification of the expression and hyper-phosphorylation of HA-rad53, cells were 
subjected to growth analysis, in order to test whether decreased Rad53 expression would 
increase the genomic instability when the Rad53-Cdc45 interaction was inhibited by cdc45-2A 
upon fork stalling. Because HA-rad53 expression was greater than rad53-HA, higher 
concentrations of HU were used. Growth analysis showed that HA-rad53 cells exhibited a 
decreased growth phenotype on 200 mM HU plates compare to wild type and cdc45-2A cells 
(Figure 6-13). Furthermore, HA-rad53 cdc45-2A cells were almost completely dead on 200 
mM HU. In conclusion, cdc45-2A is synthetic lethal with HA-rad53 upon replication fork stall 
by HU. 
 
 
Figure 6-12 Western blot analysis wild-type and HA-rad53 cells. A) Cells were arrested in 
G1 and released into YPD media contaning 200 mM HU. B) cells were arrested in G2 with 
nocodazole and 10µg/ml 4-NQO was added. The blot was probed with an anti-Rad53 antibody.  
 
Figure 6-13 cdc45-2A is synthetic lethal with HA-rad55 on HU plates.  Exponentially 
growing cells were counted and 3-fold serial dilutions were spotted onto plates containing 
indicated concentration of HU. 
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The growth phenotype that was observed in the cdc45-2A background when rad53 expression 
was low could be due to fork collapse generated by inefficient replication fork stabilization upon 
fork stalling. I hypothesized that, if the replication fork stabilization is not efficient in these cells, 
then their stalled replication forks should not restart when the block is relieved. To investigate 
this possibility, HA-rad53 and HA-rad53 cdc45-2A were subjected to replication fork restart 
analysis. To do so, cells were arrested in G1 phase with a-factor and released into YPD 
containing 200 mM HU. After 1h incubation with HU, cells were released into YPD and the 
DNA replication was analyzed after HU was removed. Western blot analysis indicated that 
Rad53 was hyper phosphorylated in wild type, cdc45-2A, HA-rad53 and HA-rad53 cdc45-2A 
cells (Figure 6-14.C). Rad53 was immediately dephosphorylated after washing away of HU in 
wild type cells. However, it took longer for cdc45-2A cells since Rad53 was mostly 
phosphorylated 20 minutes after HU removal. It took even longer for HA-rad53 cells with 
dephosphorylation starting approximately 1h after HU removal. Dephosphorylation took 
longest for HA-rad53 cdc45-2A cells, with Rad53 still fully hyper phosphorylated 1h after HU 
removal and mostly hyperphosphorylated after 100 minutes.  
Flow cytometry analysis indicated that wild type cells continued DNA replication after the 
removal of HU and their bulk DNA amount doubled 40 minutes after HU removal (Figure 
6-14.B). Although it has been before shown that rad53D sml1D cells cannot continue 
replication after 180 minutes fork stalling with HU (Lopes et al., 2001), slight replication was 
observed in rad53D sml1D after the removal of HU (Figure 6-14.B) but replication occurred 
very slowly. The replication progression of cdc45-2A cells was similar to wild type cells. On the 
other hand, HA-rad53 and HA-rad53 cdc45-2A cells restarted replication later than wild type 
cells and their bulk DNA amount was doubled 80 minutes following HU removal. In addition, 
some HA-rad53 cells started a new cell cycle as the G1 population appeared 150 minutes after 
HU removal, but all HA-rad53 cdc45-2A cells were retained in G2 until the end of the 
experiment suggesting that HA-rad53 cdc45-2A cells might have more genomic instability to 
repair, delaying the entry into mitosis.  
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Although cells progressed to S-phase after HU removal in flow-cytometry analysis, the 
increase in bulk DNA could be due to the activation of new replication forks after HU removal 
from late or dormant origins. However, given that stalled but not stabilized forks could create 
genomic instability, it is expected that viability would decrease if forks are not stabilized. To 
understand if stalled forks were restarted properly and did not create any DNA damage upon 
fork stalling, the viability of the cells was investigated by colony formation assay. To do so, a 
known number of cells were collected at the 2 different time points – after a-factor arrest and 
1 hour after HU removal - and spread onto YPD plates and incubated at 30°C for 48 hours. 
The colony formation assay indicated that wild type and cdc45-2A cells were completely 
rescued after HU treatment and were viable. Although rad53D sml1D cells replicated slightly 
after HU arrest, cells were not able to survive after fork stalling. 60% cell viability was observed 
in HA-rad53 cells and this dropped to 38% in HA-rad53 cdc45-2A cells suggesting that the 
stalled forks collapsed more in HA-rad53 cdc45-2A cells, possibly due to inefficient stabilization 
(Figure 6-14.D).  
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Figure 6-14 Fork restart analysis. A) Diagram showing experimental design. B) Flow 
cytometry analysis of the cells. C) western blot analysis of the cells. The blot was probed with 
anti-Rad53 antibody. D) Viability assay of the cells. 3X100 cells were spread on YPD plates at 
indicated time points.  
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6.3. Cdc45 does not regulate the phosphorylation of 
the other replication fork components by Rad53 
As Cdc45 is required for Rad53 dependent phosphorylation of Sld3 (Chapter 5), and Cdc45 
travels with replication forks during DNA replication (Moyer et al., 2006), it might also be 
required for the phosphorylation of replication fork components by Rad53. Considering that 
fewer HA-rad53 cdc45-2A cells survived after transient replication fork stalling (Figure 6-14.D), 
this could be due to the lack of Rad53-dependent phosphorylation of other replication fork 
factors. It has been shown before that Rad53 phosphorylates some replication factors upon 
DNA damage such as Mrc1, Sgs1, Srs2, Rrm3 and Exo1 (Alcasabas et al., 2001; Hegnauer 
et al., 2012; Liberi et al., 2000; Morin et al., 2008; Rossi et al., 2015). Given that Mrc1 also 
travels with the CMG complex (Gambus et al., 2006) and Rad53 phosphorylates Mrc1 upon 
DNA damage (Alcasabas et al., 2001), I hypothesized that Cdc45 could be required for the 
Rad53-dependent Mrc1 phosphorylation upon DNA damage. To do so, the phosphorylation 
status of Mrc1 was analyzed in cdc45-2A cells. Because it is not possible to resolve Rad53-
dependent phosphorylation of Mrc1 with conventional SDS-Page analysis, the Phos-Tag-SDS-
PAGE protocol was used (Chapter 3). In addition, as Mrc1 is both phosphorylated by Rad53 
and Mec1 (Alcasabas et al., 2001), rad53D cells were used to distinguish Mec1- and Rad53-
dependent phosphorylation. The mobility shift of Mrc1 in wildtype cells - but not in rad53D cells 
- indicated that Rad53 phosphorylated Mrc1 upon DNA damage (Figure 6-15.C). However, 
the mobility shift of Mrc1 in cdc45-2A showed a very similar pattern to wild type cells, 
suggesting that the flexible loop of Cdc45 is not required for Rad53-dependent Mrc1 
phosphorylation. 
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As Mrc1 is not the only known Rad53 substrate during replication fork stalling, I decided to 
check the phosphorylation status of other known Rad53 substrates on the replication fork in 
order to investigate whether the flexible loop of Cdc45 is required for their Rad53 dependent 
phosphorylation upon DNA damage. For this, the phosphorylation status of Rrm3, Sgs1, Srs2 
and Exo1 were analyzed in a cdc45-2A background by using the Phos-Tag-SDS-PAGE 
 
Figure 6-15 Western blot analysis of wild type and cdc45-2A cells. Cells were arrested in 
G1 and released into YPD media containing 200 mM HU. 13-myc tagged A) TOF1, B) DNA2 
C) SGS1 D), SRS2  cells. Flow cytometry analysis performed to control G1 arrest.  Blots were 
probed with anti-Rad53 and anti-Myc antibodies. 
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protocol. The mobility shift of Rrm3, Srs2, Exo1, Sgs1 showed no differences in cdc45-2A cells 
compared to wild type cells, suggesting that the flexible loop of Cdc45 is not required for the 
Rad53-dependent phosphorylation of Rrm3, Srs2, Exo1, Sgs1 (Figure 6-16).  
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Figure 6-16 Western blot analysis wild-type and cdc45-2A cells. Cells were arrested in G1 
and relaesed into YPD media contaning 200 mM HU. 13-myc tagged A) Exo1, B) Rrm3 C) 
SGS1 D), SRS2  cells. Flow cytometry analysis was performed to control G1 arrest.  Blots was 
probed with anti-Rad53 and anti-Myc antibodies. 
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6.4.  Discussion  
Cdc45 is an essential protein which is required for replication initiation and travels with the 
DNA replication fork (Aparicio et al., 1999; Moyer et al., 2006). In Chapter 5, I have shown that 
the disordered loop of Cdc45 is required for Rad53-dependent Sld3 phosphorylation. Because 
Cdc45 also travels with the replication fork, I hypothesised that the disordered loop of Cdc45 
might be a binding site for Rad53 upon DNA damage in order to stabilize the stalled replication 
fork. I have shown in this chapter that the flexible loop of Cdc45 has a role in replication fork 
stabilisation.  
First, I hypothesized that if the flexible loop of Cdc45 is required for the stabilisation of 
replication fork by Rad53 upon DNA damage, mutating this loop would fail to stabilize the 
stalled replication forks and would cause cell death. However, the cdc45-2A cells did not show 
any growth defect on DNA damaging drug-containing plates, suggesting that this loop on its 
own is not sufficient for the stabilisation of stalled forks and perhaps other regulatory 
mechanisms compensate for the lack of Cdc45-dependent Rad53 recruitment (Figure 6-2).  
Although the flexible loop of Cdc45 is a possible binding site for Rad53, Rad53 might also bind 
to the other factors on the stalled replication fork. To rule out this possibility, I hypothesised 
that decreasing the local concentration of Rad53 around the replication forks would result in 
inefficient replication fork stabilization and eliminating a possible binding site directly by cdc45-
2A would result in even fewer stabilized forks upon stalling. The checkpoint mediators are 
assumed to increase the local concentration of active Rad53 around the stalled or damaged 
replication forks (Hustedt et al., 2013). To decrease the amount of Rad53 around the stalled 
replication forks, I used different checkpoint mediator knockouts (mrc1D, sgs1D, ddc1D, 
mec3D, rad17D and rad9D). However, cdc45-2A did not exacerbate the growth defect of none 
of the tested knockout cells compared to wild type Cdc45 on drug plates, possibly as removal 
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of single checkpoint mediators was not enough to decrease the local concentration of Rad53 
(Figure 6-3,Figure 6-4, Figure 6-5 and Figure 6-6). To decrease the local Rad53 
concentration even more, I decided to use double checkpoint mediator-knockouts. However, 
double mutants (ddc1D rad9D, ddc1D mrc1D, ddc1D sgs1D) that were tested showed limited 
growth on drug plates, possibly due to the inefficient checkpoint activation (Figure 6-7, Figure 
6-8 and and Figure 6-9).  
Because decreasing the local concentration of Rad53 by removing mediators did not decrease 
the fitness of cdc45-2A cells on drug plates, I decided to decrease the total Rad53 amount in 
the cell. Although, both C- (rad53-HA) and N- (HA-rad53) terminal HA tagging decreased the 
expression of Rad53, the expression of HA-rad53 was higher than rad53-HA (Figure 6-10 and 
Figure 6-12). The growth analysis of rad53-HA cdc45-2A cells did not show significant any 
difference compared to rad53-HA on HU plates, however mrc1D rad53-HA cdc45-2A cells 
were more sensitive to low concentrations of HU compared to mrc1D rad53-HA (Figure 6-11). 
Interestingly, HA-rad53 cdc45-2A cells were almost dead upon exposure to high 
concentrations of HU whereas HA-rad53 showed minor growth defect (Figure 6-13). These 
results suggest that either decreased levels of Rad53 is synthetic lethal with cdc45-2A or that 
HA-Rad53 is hypomorphic and shows synthetic lethality with cdc45-2A upon DNA damage.  
It could be hypothesized that if replication fork stabilization is abrogated in HA-rad53 cdc45-
2A cells, then stalled replication fork cannot restart. To test this, I decided to perform replication 
fork restart analysis (Figure 6-14). However, some experimental difficulties did not allow me 
to establish a complete answer. The main problem of this analysis was that the amount of DNA 
in rad53D sml1D cells increased after the removal of HU. It is possible that not all origins were 
fired during the 60 minutes of HU treatment, and that the remaining origins were fired after 
removal of HU which resulted in DNA replication.  
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However, that experiment still provided some useful information. Dephosphorylation of Rad53 
took longer in HA-rad53 cdc45-2A cells compared to HA-rad53 after the removal of HU (Figure 
6-14.C). This could be explained by two ways. Either more origins are fired – possibly late 
origins - in HA-rad53 cdc45-2A cells than in HA-rad53 cells, which increase the number of fork 
collapse or because of inefficient stabilization, more replication forks collapsed in HA-rad53 
cdc45-2A which took a longer time to repair. However, it is important to note that these 
explanations are not mutually exclusive. It is possible that inefficient fork stabilization in HA-
rad53 cdc45-2A cells required more Rad53 around the collapsed forks to repair, leaving less 
Rad53 for inhibition of origin firing and other responses. It is possible to rule out whether the 
difference in the viability that was observered between HA-rad53 cdc45-2A and HA-rad53 cells 
is due to more origin firing. Given that sld3-A dbf4-A alleles in which Rad53-dependent 
phosphorylation sites were replaced with alanine can fire late origins upon replication fork 
stalling (Zegerman & Diffley, 2010), these alleles could be introduced to HA-rad53 cdc45-2A 
and HA-rad53 cells in order to fire all origins upon replication fork stalling. Because the number 
of active forks would be very similar in this condition for both cells, the requirement of Cdc45 
could be tested. If HA-rad53 cdc45-2A sld3-A dbf4-A cells showed less viability than HA-rad53 
sld3-A dbf4-A cells, then the requirement of the disordered loop of Cdc45 would be supported.  
Although, the growth assay (Figure 6-13) and the viability assay (Figure 6-14.D) indicate that 
the flexible loop of Cdc45 has a role in the stabilisation of the replication fork, they do not reveal 
its function. Two different hypotheses could explain its role. Either the Rad53 dependent-
phosphorylation of Cdc45 (Figure-5.16) has a function for replication fork stabilisation, or 
Rad53 binds on the flexible loop of Cdc45 for the phosphorylation of other replication fork 
factors. Given that Cdc45 is located on the Mcm2-Mcm5 gate (Yuan et al., 2016), the 
phosphorylation of Cdc45 might prevent the escape of ssDNA from Mcm2-Mcm5 gate upon 
fork stalling. On the other hand, it is known that some replication factors are phosphorylated 
by Rad53 upon DNA damage such as Mrc1, Exo1, Rrm3, Srs2 and Sgs1. I hypothesized that 
the flexible loop of Cdc45 could be required for the phosphorylation of these factors. However, 
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cdc45-2A did not prevent the Rad53 dependent phosphorylation of Mrc1, Exo1, Rrm3, Srs2 
and Sgs1 upon fork stall (Figure 6-15 and Figure 6-16). However, because Rad53 substrates 
on the replication fork have not been fully characterized yet, this result does not necessarily 
mean that Cdc45 is not required for the phosphorylation of stalled fork components. It could 
be very interesting explore all Rad53 targets and test whether the flexible loop of Cdc45 is 
required for their phosphorylation. The binding of Rad53 on the flexible loop of Cdc45 could 
still be tested by other biochemical techniques such as chromatin immunoprecipitation with 
massively parallel DNA sequencing (ChIP-Seq). If less DNA was enriched after Rad53 
immunoprecipitation in cdc45-2A cells compare to wild type cells upon replication fork stalling, 
it would provide evidence for the binding of Rad53 on the flexible loop of Cdc45 on the 
replication fork.  
Given that there is no consensus sequence for Chk1 binding (Rad53 functional homolog in 
humans), it is difficult to address Chk1 targets in human. However, considering the 
conservation of the flexible loop of Cdc45 among eukaryotes, it could be possible to specifically 
investigate Chk1 targets on the replication fork. Understanding the mechanisms of fork 
stabilization could have potential implications such as in the treatment of cancers. As drug 
resistance is one of the biggest problems facing cancer treatment, preventing the stabilization 
of the replication fork could be a potential target. Inhibition of fork stabilization by a small 
molecule could increase the efficacy of chemotherapeutic drugs which target DNA replication 
- such as methotrexate or 5-fluorouracil – due to increased genomic instability, and could lead 
to cell death before the drug resistance occurs.  
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